





Erythropoietin as a driver of neurodifferentiation, 
neuroplasticity and cognition – A continuum view of the 




Debia Wakhloo  
Born in Kashmir, India 
 
Dissertation  
for the award of the degree  
Doctor of Philosophy (Ph.D.) 
 
 
In the doctoral program Center for Systems Neuroscience  







Doctoral thesis committee: 
 
Prof. Dr. Dr. Hannelore Ehrenreich Department of Clinical Neuroscience, 
(Supervisor – 1st Referee) Max Planck Institute of Experimental 
Medicine, Göttingen. 
  
Prof. Dr. Dörthe Katschinski Department of Cardiovascular Physiology 
(2nd Referee) Universitätsmedizin Göttingen, Göttingen. 
  
Prof. Dr. Ralf Heinrich Department of Cellular Neurobiology,  
 Schwann-Schleiden Research Centre, 
Göttingen. 
  
Prof. Dr. Wolfram-Hubertus 
Zimmermann 
Institute of Pharmacology and Toxicology, 





Prof. Dr. Klaus-Armin Nave Max Planck Institute of Experimental 
Medicine, 
 Clinical Neuroscience, Göttingen. 
  
Prof. Dr. Susann Boretius Department of Functional Imaging, 





Date of thesis submission: 30.09.2019 











I hereby declare that this Ph.D. thesis "Erythropoietin as a driver of 
neurodifferentiation, neuroplasticity and cognition – A continuum view of the 
neuronal lineage" has been written independently and is an outcome of my own work 
with no other sources and aids unless cited.  
The second and third chapter of my result section is adapted from the manuscript 
"Functional hypoxia drives neuroplasticity and neurogenesis via brain 
erythropoietin", currently submitted in a peer-review journal, which summarizes my 














































“Sic parvis magna” 
“Greatness from small beginnings” 
“नम्र शुरुआत से महत्तत्तवपूर्ण उपलब्धियों की ओर” 















‘True progress is when you begin with one question and end 

























‘‘We often take for granted the very things that most deserve our gratitude.”  
– Cynthia Ozick 
I would like to dedicate this thesis to my parents, Amrita Wakhloo and Rajnath 
Wakhloo, who have provided me with a great platform despite several difficulties they 
had to face. I hope to make them proud. 
The last four years have been an integral part of my life. I owe my gratitude to many 
people and I hope to carry them in my memories forever.  
I begin with expressing my deepest gratitude towards my supervisor, Prof. Dr. Dr. 
Hannelore Ehrenreich for giving me an opportunity to work on a project that is very 
close to her heart. This has been an exciting yet a challenging project. She always 
encouraged me to develop as a researcher and more importantly, an independent 
thinker. Despite our difference in opinions on certain aspects, she always encouraged 
me to voice my opinion that made my scientific journey more beautiful and immensely 
educational. I am greatly indebted for her wisdom and her zealous nature, which has 
led me to be a better version of myself. I have immense admiration for her as a strong 
driven woman and I hope to mirror some of her qualities in the tough journey of life, 
which lies ahead. 
I am also thankful to Prof. Dr. Klaus-Armin Nave for giving me an opportunity to join 
this prestigious institute. I am sincerely grateful for his constructive criticism and 
insightful discussions throughout the project. His collaboration has been of 
tremendous help.  
I would also like to thank my thesis committee members Prof. Dr. Dörthe Katschinski, 
Prof. Dr. Ralf Heinrich and Prof. Dr. Wolfram-Hubertus Zimmermann, who have always 
taken time to give their scientific input and provide immense support during my PhD. I 
would also like to thank my examination board members, Prof. Dr. Klaus-Armin Nave 
and Prof. Dr. Susann Boretius for taking the time to consider and judge my work. 
The journey of a PhD student is exciting but riddled with difficult times. I want to 
express my sincere love towards my colleagues, without whom, this journey would 
VI 
 
have been impossible to complete. I am thankful to Anja Ronnenberg and Sahab 
Arinrad who were always present to lift me up, when I felt like I had hit rock bottom. A 
good chat with them over coffee or alcohol has always helped me to strive harder and 
accomplish more. I am sorry that they had to be the primary victims of my erratic 
behavior at times. I am also immensely thankful to my project team, Dr. Franziska 
Scharkowski, Yasmina Curto and Agnes Steixner for their support and generous 
contributions to the work. I feel blessed to have the opportunity to work with them. I 
would like to thank the entire technical assistance team who doing an incredible job, 
especially the animal caretaker Steffi Thiel who has been extremely helpful. I would 
also like to thank Wiebke Timner, Nadine Schopf and Viktoria Pfander (Danke für die 
Deutsche Übung) and especially for providing me with emotional support, in my 
numerous times of need. You all have been my family away from home.  
I am especially grateful for my PhD gang members Hong Pan and Jan Seidel with whom 
I have had my most memorable moments in the past four years. ‘Misery Loves Company’ 
never fitted perfectly than in our case and this journey would have been much more 
difficult without their lovely companionship. 
Not only has the pristine beauty of Austria smote me, but also I feel lucky to have met 
amazing souls like my Austrian sweethearts – Sandra Kogler and Agnes Steixner. Thank 
you for being a constant source of motivation to make me strive harder and accomplish 
more. More importantly, reminding me to believe in myself, when things looked dire. 
I will miss our crazy fun moments like adopting ‘Franz and Kafka’, the ‘shady cab ride’, 
the Hemmingway cocktails and my funny swimming lessons. 
Last but not least, I would like to thank my entire family and my friends back home in 
India for their constant support and helping me to maintain my sanity. I have missed 
them dearly in the past four years. 
Above all, I would like to express my deepest appreciation to my dear husband Dr. 
Sameehan Mahajani, who has been a constant support in my life. I would say that he 
almost did a second PhD with me, due to our constant scientific discussions. I thank 
you for proof reading my thesis and your immense support, care and love. 
  
DEBIA WAKHLOO 1 
 
Table of contents 
Number Title Page 
Number 
   
I. Declaration II 
II. Acknowledgement V 
III. Table of Contents 1 
IV. List of Figures 4 
V. List of Tables 7 
VI. List of Boxes 7 
VII. Abstract 8 
   
1. Introduction 9 
   
1.1. Neurogenesis 10 
1.1.1. Evolutionary aspects of neurogenesis. 10 
1.1.2. Embryonic neurogenesis. 11 
1.1.3. Adult neurogenesis. 15 
1.1.4. Migration and synaptic integration of newly generated 
neurons in the adult brain. 
18 
1.1.5. Tracking adult neurogenesis and limitations. 20 
1.1.6. Other Neurogenic zones. 22 
1.1.7. Importance of adult hippocampal neurogenesis. 24 
1.1.8. Factors involved in neurogenesis. 26 
1.2. Hypoxia. 32 
1.2.1. Hypoxia as a critical microenvironment in neurogenic niches. 32 
1.2.2. Hypoxic neurogenic niches in humans and rodents. 35 
1.2.3. Importance of hypoxia in regulating ‘Stemness’. 36 
1.2.4. Hypoxia induced transcriptional control. 38 
1.2.5. Hypoxic upregulation of erythropoietin. 40 
1.3. Erythropoietin. 42 
1.3.1 History of EPO. 42 
1.3.2. EPO and the blood brain barrier. 44 
1.3.3. Importance of EPO. 45 
1.3.4. Role on EPO on neurogenesis. 47 
   
2. Rationale and Research Aims 48 
   
3. Materials and Methods 51 
   
3.1. Experimental models and mouse genetics. 52 
3.1.1. Mouse strains. 52 
3.1.2. Breeding strategy. 54 
3.1.3. Genotyping. 55 
3.2. In-vitro cell cultures. 58 
3.2.1. Hippocampal neuronal culture. 58 
3.2.2. Microglia culture. 58 
  
DEBIA WAKHLOO 2 
 
3.2.3. Oligodendrocyte culture. 59 
3.2.4. Astrocyte culture. 59 
3.3. Quantitative Real-Time PCR (qRT-PCR). 60 
3.3.1 RNA extraction. 60 
3.3.2. cDNA synthesis and qRT-PCR. 60 
3.4. Mouse treatments. 61 
3.4.1. Tamoxifen. 61 
3.4.2. EPO. 61 
3.4.3. Hypoxia. 62 
3.4.4. Complex running wheels (CRW). 62 
3.5. Immunohistochemistry (IHC). 63 
3.6. Imaging and analysis. 65 
3.6.1. Pyramidal neurons. 65 
3.6.2. Dendritic spines. 66 
3.6.3. RNAscope in-situ hybridization (ISH). 66 
3.7. Drop sequencing. 67 
3.7.1. Tissue dissociation. 67 
3.7.2. Single-cell barcoding and library preparation. 67 
3.7.3. Single cell RNA-seq processing. 68 
3.7.4. Filtering and data normalization. 68 
3.7.5. Canonical correlation analysis. 69 
3.7.6. Clustering and visualization. 69 
3.7.7. Cell trajectory (pseudotime) analysis. 69 
3.7.8. Differential expression and gene ontology (GO) analyses. 69 
3.8. Quantification and statistical analysis. 70 
   
4. Results 71 
   
4.1. Effect of EPO on neural precursors. 72 
4.1.1. EPO induced increase in pyramidal neurons is not mediated 
via Nestin positive precursors. 
72 
4.1.2. EPO regulates the differentiation of Gli positive precursors 
into astrocytes, but not neurons. 
75 
4.1.3. EPO induced increase in pyramidal neurons could potentially 
be via Sox2 positive precursors. 
81 
4.2. Effect of EPO on pyramidal neurons. 87 
4.2.1. Substantial generation of pyramidal neurons in the CA1 of 
adult mice and its amplification by EPO. 
87 
4.2.2. EPO leads to an increase in the dendrites and spine density 
of pyramidal neurons in the CA1. 
89 
4.2.3. EPO mediated increase in neurons is accompanied by 
changes in other cell types in the CA1.  
92 
4.2.4. Drop-sequencing analysis demonstrates increase in the 
number of immature glutamatergic neurons after EPO 
treatment. 
96 




DEBIA WAKHLOO 3 
 
4.2.6. EPO increases the expression of immature neuronal markers 
such as Tbr1 and Tle4. 
103 
4.2.7. EPO increases the expression of Lnc-RNA ‘RMST’ in 
immature glutamatergic neuronal cluster. 
106 
4.3. Effect of EPO and Hypoxia on cognitive learning. 110 
4.3.1. Elevated expression of EPO and EPOR in pyramidal neurons 
upon Complex Running Wheel (CRW). 
110 
4.3.2. Hypoxia inducible gene EPO and its EPOR are master 
regulators of enhanced learning. 
112 
4.3.3. Labelling of increased hypoxic neurons in the CA1 upon 
CRW. 
113 
4.3.4. Exogenous mild hypoxia acts synergistically with CRW on 
generation of pyramidal neurons in the CA1. 
115 
4.3.5. Targeted deletion of EPO and EPOR in pyramidal neurons 
attenuates hypoxia-induced motor learning and endurance. 
117 
   
5. Discussion 121 
   
5.1. Role of EPO on neuronal precursors situated in adult 
hippocampus. 
122 
5.2. EPO acts on multiple precursors analogous to the 
hematopoietic system. 
127 
5.3. EPO mediates neurogenesis in the hippocampus. 128 
5.4. EPO supports a continuum view for neuronal lineage. 130 
5.5. EPO mediated enhancement in synaptic plasticity. 131 
5.6. Mechanism of EPO action – Activity mediated adult 
hippocampal neurogenesis. 
134 
5.7. EPO/EPOR system central to physiological hypoxia induced 
hippocampal neurogenesis. 
135 
   
6. References 139 
   
7. Appendices 166 
   









DEBIA WAKHLOO 4 
 
List of Figures 
Figure Title Page 
Number 
   
1. Introduction  
   
Fig. 1 Symmetric and asymmetric divisions of progenitor cells. 11 
Fig. 2 Symmetric divisions of progenitor cells. 12 
Fig. 3 Examples of canonical progenitor cell lineages to neurons in 
developing neocortex. 
13 
Fig. 4 Differentiation of embryonic neuroepithelial cells of the neural 
tube to radial glial cells. 
14 
Fig. 5 Schematic representation of adult neurogenesis. 17 
Fig. 6 Maturation of Granule cells. 19 
Fig. 7 Consequences of species differences in the course of 
neurogenesis. 
21 
Fig. 8 Neurogenesis mediates cognitive flexibility by allowing the 
formation of new memory traces. 
25 
Fig. 9 Potential cellular intrinsic signaling pathways regulating adult 
neurogenesis. 
27 
Fig. 10 Role of Sox2 positive NSCs in adult neurogenesis. 29 
Fig. 11 Involvement of Pax6 positive radial glial cells to adult 
neurogenesis. 
29 
Fig. 12 Mechanism of Sox2-RMST during neurogenesis. 32 
Fig. 13 Postnatal brain stem cells and surrounding niche. 34 
Fig. 14 Oxygen tension measurements in different stem cell 
compartments. 
36 
Fig. 15 Role of hypoxia and HIF-1a in astrocyte differentiation and 
neurogenesis. 
37 
Fig. 16 Influence of oxygen levels on proliferation and lineage 
specification of NSCs. 
38 
Fig. 17 Cellular responses to hypoxia. 39 
Fig. 18 Schematic representation of EPO and factors controlling 
hypoxic EPO induction. 
40 
Fig. 19 Regulation of EPO under hypoxia in kidney and liver. 41 
Fig. 20 Main sites of EPO production. 43 
   
3. Materials and Methods  
   
Fig. 21 Generation of EPORfl/fl mice. 53 
Fig. 22 Breeding strategy for the generation of inducible double 
transgenic mice. 
55 





4. Results  
  
DEBIA WAKHLOO 5 
 
   
Fig. 24 Multiple EPO treatment does not give rise to TdTomato 
positive neurons in NestinCreERT2::TdTomato mice, but 
decreases the Nestin cell numbers in the SVZ of the DG. 
73 
Fig. 25 Fate mapping of NestinCreERT2::TdTomato mice upon single 
dose of EPO does not give rise to neurons in the CA1. 
74 
Fig. 26 Multiple EPO injections lead to an increase in Gli labelled 
TdTomato positive cells in the GliCreERT2::TdTomato mice 
without proliferation, but does not give rise to CA1 neurons. 
76 
Fig. 27 Fate mapping over time of GliCreERT2::TdTomato mice upon 
single dose of EPO does not give rise to neurons in the CA1. 
78 
Fig. 28 No unspecific TdTomato expression observed in Oil injected 
control GliCreERT2::TdTomato mice. 
79 
Fig. 29 TdTomato labelled Gli positive cells co-localize with other cell 
types in the hippocampus upon multiple placebo or EPO 
injections. 
80 
Fig. 30 EPO administration led to a significant decrease in the number 
of Sox2 positive cells in the CA1 region of 
GliCreERT2::TdTomato mice. 
82 
Fig. 31 EPO administration led to an increase in the number of 
TdTomato labelled Sox2 positive cells in the CA1 region of 
Sox2CreERT2::TdTomato mice. 
83 
Fig. 32 Unspecific TdTomato expression observed in Oil injected 
control Sox2CreERT2::TdTomato mice. 
85 
Fig. 33 EPO increases number of pyramidal neurons in the CA1 region 
of the hippocampus. 
88 
Fig. 34 EPO increases the dendritic and total spine density in the CA1 
region of the hippocampus. 
90 
Fig. 35 EPO increases the density of immature stubby spine type in the 
CA1 region of the hippocampus. 
91 
Fig. 36 EPO decreases the number of Iba1 positive microglia in 
juvenile mice in the CA1 region of the hippocampus. 
93 
Fig. 37 Endogenous mRNA levels of EPOR in cultured neurons, 
microglia, astrocytes and oligodendrocytes. 
95 
Fig. 38 Determination of major hippocampal cell types and cell type-
specific gene markers. 
97 
Fig. 39 Drop-Sequencing analysis demonstrates increase in the 
number of immature glutamatergic neurons after EPO 
treatment. 
99 
Fig. 40 Trajectory analysis (Monocle) demonstrates EPO induced 
maturation of immature glutamatergic neurons. 
102 
Fig. 41 EPO treatment increases the expression of immature neuronal 
marker gene Tbr1. 
104 
Fig. 42 EPO treatment increases the expression of immature neuronal 
marker gene Tle4. 
105 




DEBIA WAKHLOO 6 
 
Fig. 44 EPO treatment increases the expression of immature neuronal 
marker gene Dcx, Satb1 and Sox5. 
108 
Fig. 45 EPO increases the local expression of EPO/EPOR in pyramidal 
neurons in the CA1 region of the hippocampus. 
111 
Fig. 46 Learning improved upon EPO treatment. 113 
Fig. 47 Voluntary running induces hypoxia in pyramidal neurons. 114 
Fig. 48 Voluntary running induced hypoxia gives rise to new pyramidal 
neurons in CA1 region. 
116 
Fig. 49 Voluntary running induced learning is mediated by EPOR. 119 
   
5. Discussion  
   
Fig. 50 Complexity of neuronal lineage as compared to 
oligodendrocytic lineage. 
123 
Fig. 51 EPO induced generation of newly differentiated neurons in the 
CA1 region of the hippocampus. 
130 
Fig. 52 Model illustrating suggested mechanisms and effects of 






















DEBIA WAKHLOO 7 
 
List of Tables 
Table Title Page 
Number 
   
1. Introduction  
   
Table. 1 Results depicting positive and negative results of adult 
neurogenesis in different brain regions. 
23 
Table. 2 Effect of growth factors on adult hippocampal neurogenesis. 28 
Table. 3 Effect of low Oxygen tension on proliferation and 
differentiation of human neural stem cells. 
38 
   
3. Materials and Methods  
   
Table. 4 Various transgenic mouse model used in this thesis. 54 
Table. 5 Composition of contents for genotyping. 56 
Table. 6 Sizes of expected bands after genotyping. 56 
Table. 7 PCR procedure. 57 
Table. 8 Forward and reverse primers for genotyping of all mouse 
lines. 
57 
Table. 9 qRT-PCR procedure. 61 
Table. 10 Forward and Reverse primers used for RT-PCR. 61 
Table. 11 List of primary antibodies used in this thesis. 64 
 
List of Boxes 
Box Title Page 
Number 
   
1.  Introduction  
   
Box. 1 Neural Stem Cells. 12 
Box. 2 Apical progenitor cells, Basal progenitor cells and Transit-
amplifying cells 
15 
Box. 3 Radial Glial Cells. 16 
Box. 4 BrdU. 20 
Box. 5 Cre-loxP recombination. 22 
Box. 6 Morphogens. 26 
Box. 7 Hypoxia and Normoxia. 34 
   
3. Materials and Methods  
   
Box. 8 Cre-ERT2 54 
  ABSTRACT 
 
  




Erythropoietin (EPO), named after its role in hematopoiesis, has been best studied in 
the hematopoietic system. Studies emphasizing the expression of EPO in the central 
nervous system have sparked an interest in its role in the brain. Interestingly, EPO has 
consistently led to improved cognition in animal models and in patients suffering from 
neuropsychiatric disorders such as schizophrenia. However, the mechanism by which 
EPO mediates its effects on cognition have remained obscure. The present work 
focuses on EPO mediated action on the Central Nervous System (CNS). This thesis 
replicated the EPO mediated increase in pyramidal neuron numbers of the CA1 region 
previously published by our group (Hassouna et al, 2016) and extended this finding 
using a novel approach. Moreover, this thesis demonstrated EPO mediated increase in 
neurodifferentiation (NexCreERT2) and neuroplasticity (Thy1-YFP) in young and adult 
mice. Single cell sequencing after EPO injection also revealed and strengthened these 
findings on a transcriptome level. These results represent a new perspective of EPO 
mediated neuronal differentiation. Despite technical limitations of using transgenic 
mouse lines, the present work could hypothesize that EPO induces the differentiation 
of precursors into different progenies (GliCreERT2) in other regions of the brain 
(NestinCreERT2) or differentiate into neurons (Sox2CreERT2). These findings reveal a 
continuum like view of neuronal lineage and demonstrate that EPO acts on multiple 
precursors known or unknown, alone or synergistically, to contribute to the increase in 
the number of pyramidal neurons in the CA1, and thereby improving cognition. The 
present work in addition provides a cellular mechanistic insight, which hypothesized 
that exposure to a learning paradigm such as complex running wheel (CRW) could 
upregulate EPO/EPOR in pyramidal neurons of the CA1.  As EPO is a hypoxia inducible 
gene, this thesis demonstrated that neuronal networks engaged in cognitive tasks 
undergo hypoxia (CAGCreERT2ODD). EPO mediated improved learning is imitated by 
exposure to mild exogenous/inspiratory hypoxia. The present work provides the first 
evidence that EPO/EPOR are central to cognitive improvement upon physiological/mild 
exogenous hypoxia as the effects are attenuated in conditional knockout mice lacking 
EPO (NexCre::EPO-KO) or EPOR (NexCre::EPOR-KO) gene. Taken together, these results 
indicate a novel model of neuronal plasticity where neuronal networks challenged by 
cognitive tasks drift into transient hypoxia triggering neuronal EPO/EPOR expression. 
This provides insight for the importance of EPO in cognition and perhaps its relevance 










































1.1.1. Evolutionary aspects of neurogenesis. 
 
The capability of the evolutionary primitive organisms to regrow significant body parts 
(Fuchs & Segre, 2000) made them highly intriguing and therefore, researchers 
wondered if this regenerative potential could also be a feature of evolutionarily 
complex, high-order organisms. Over the past years, it has been evident that the 
complex organisms retain this capacity to repair tissue damage throughout adult life 
but to a limited extent. This potential of regeneration is bestowed upon ‘stem cells’, 
which have been implicated to give rise to various cell types (Barker et al., 2010; 
Morrison & Spradling, 2008). The hematopoietic system is the most well studied 
system with a great stem cell potential wherein adult stem cells can fully reconstitute 
all cell types for a tissue (Ye et al., 2017). 
For numerous years, the adult central nervous system was thought to lack any 
regenerative potential and therefore, was postulated to be not required or even 
detrimental to normal brain function (Rakic, 1985). Santiago Ramón y Cajal, who 
extensively depicted pyramidal neurons and their dendritic arborizations in the brain 
for the first time, famously quoted that the mature central nervous system was a place 
where “everything may die and nothing may be regenerated” (Cajal and May, 1913). 
However, several years later, Altman and Das challenged this theory and provided the 
first evidence of putative proliferating cells in the rat hippocampus. They suggested 
that neurogenesis occurs in the adult mammalian brain, which goes way beyond early 
embryonic development (Altman & Das, 1965). This publication led to increased 
optimism in the field that endogenous neurogenesis could be harnessed to repair the 
injured or diseased brain. Adult hippocampal neurogenesis has been demonstrated in 
primates, including marmosets (Gould et al., 1998) as well as in macaques (Gould et al., 
1999; Kornack & Rakic, 1999). When compared to rodents, the rate of adult 
hippocampal neurogenesis was observed to be approximately 10 fold lower in adult 




DEBIA WAKHLOO 11 
 
rate of neurogenesis in the Sub-Granular Zone (SGZ) of the hippocampus was lower in 
older macaques as compared to younger ones and the rate subsequently decreased 
linearly with age (Leuner et al., 2007). This decline was also observed in older rats and 
mice, which occurred in midlife before the onset of ‘old age’ (Leuner et al., 2007). The 
majority of these newly born cells mature into neurons, which was observed in 
primates as well as in rodents (Gould et al., 2001). 
In the past two decades, there has been increasing evidence suggesting that adult 
mammalian brains possess stem cells and can generate new, functional cells. These 
findings open new avenues for the field of regenerative medicine. 
1.1.2. Embryonic neurogenesis. 
 
The generation of new neurons by differentiation of stem cells is known as 
neurogenesis.  A ‘Neurogenic Zone’ is the region of the brain, which supports 
neurogenesis. This zone demonstrates the presence of immature progenitor cells (stem 
cells) and a microenvironment secreting various factors that is permissive for the 
generation of new neurons. The widely accepted neurogenic zones where majority of 
neurogenesis takes place are the Sub-Ventricular Zone (SVZ) and the Sub-Granular 
Zone (SGZ) of the hippocampus (Balu & Lucki, 2009). Three hypothesis concerning the 
pattern of neurogenesis were considered (Kriegstein & Alvarez-Buylla, 2009). The first 
hypothesis consisted of the presence of a founder Neural Stem Cells (NSCs; Box. 1), 
which undergoes multiple symmetric divisions to give rise to other NSCs, which could 
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The second hypothesis suggested the presence of NSCs, which undergo asymmetric 
division, giving rise to one daughter NSC as well as another intermediate NSC, which 
differentiates into neurons (Fig. 1).  
Box. 1. Neural Stem Cells. 
 
Neural stem cells are multipotent adult stem cells present in the adult central nervous 




The third and the last hypothesis suggested the presence of NSCs, which undergo 
symmetric division, giving rise to one daughter NSC as well as one intermediate 
progenitor cell, which can undergo further proliferation and differentiation into 





Figure 1. Symmetric and asymmetric divisions of progenitor cells. (Left) Schematic 
illustrations of radial glial (R) cells undergoing symmetric divisions in the ventricular zone 
during embryonic cortex development.  (Right) Schematic illustrations of radial glial (R) cells 
undergoing asymmetric divisions in the ventricular zone during embryonic cortex 
development, giving rise to radial glial cells (R) and neurons (blue). Adapted from Kriegstein 
et al, 2006. 
Figure 2. Symmetric divisions 
of progenitor cells. Schematic 
illustrations of radial glial (R) 
cells undergoing symmetric 
divisions in the ventricular zone 
during embryonic cortex 
development, giving rise to 
radial glial cells (R) and 
intermediate progenitors 
(yellow). These intermediate 
progenitor cells differentiate 
into neurons (blue). Adapted 
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The neurogenesis in rodents and in primates follow a different mode as seen in Fig. 3 
(Namba & Huttner, 2017).  
 
 
In rodents, during early corticogenesis, the progenitor cells of the SVZ make the switch 
from symmetric to asymmetric cell division (Gotz & Huttner, 2005). At this time, there 
is a considerable reduction in the number of progenitor cells as they proliferate 
asymmetrically to differentiate into cortical neurons. However, the differentiated 
cortical neurons accumulate above the sub-plate (SP) in an inverted ‘inside-out’ 
sequence. That is, the earliest born neurons are destined to become a part of the 
innermost layer 6 whereas the neurons born at a later stage forms the outer layer 2 of 
the cortical plate (Statler et al., 2007). Apical progenitor cells and basal progenitor cells 




Figure 3. Examples of canonical progenitor cell lineages to neurons in developing 
neocortex. Direct neurogenesis via asymmetric divisions of Radial Glial Cells (aRGCs) to give 
rise to another aRGC and a daughter neuron (N; Left). In rodent (Middle), an aRGC undergoes 
asymmetric division to give rise to an intermediate progenitor (nbIP), which further 
undergoes symmetric divisions to give rise to two neurons (N). In primates (Right), an aRGC 
undergoes asymmetric division to give rise to another RGC or IP, which further undergo 
symmetric proliferative division to give rise to two RGCs/IPs. They can further undergo 









 However, during human brain development, neurogenesis involves a highly precise 
orchestrated sequence of cellular events. The brain development begins with the 
formation of the neocortex at the rostral end of the neural tube, near the embryonic 
cerebral vesicle (Sidman & Rakic, 1973). The neural tube closes at embryonic day 30 
i.e. during the fifth week of gestation (O'Rahilly & Muller, 2010). After the fifth week of 
gestation, the amniotic fluid is trapped within the central canal and the ventricular 
system begins to form. Rapid brain enlargement begins when a rise in intraventricular 
fluid pressure is initiated by neural tube closure (Budday et al., 2015). Based on the 
above-mentioned literature, the embryonic neurogenesis in rodents and humans 




Figure 4. Differentiation of embryonic neuroepithelial cells of the neural tube to radial glial 
cells. Neurogenesis takes place from E11 to E18. The neuroepithelial cells first differentiate 
into radial glial cells, which further differentiates into neurons. Astrocytic differentiation 
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Box. 2. Apical progenitor cells. 
 
The term apical progenitor cells (APs) refer to cells undergoing mitosis at the apical 
surface of the ventricular zone. There are three types of apical progenitors: 
neuroepithelial cells, and the derivative apical radial glia and apical intermediate 
progenitors. 
 
Basal progenitor cells. 
 
The term Basal progenitor cells (BPs) refer to cells, which undergo mitosis in the 
secondary germinal zone located basally, compared to the ventricular zone. BPs are 
generated by divisions of apical radial glia and move basally via a process known as 
delamination. There are two types of basal progenitors: basal intermediate 




These cells are known as neural progenitor cells, which are differentiation committed 
cells derived from the asymmetric division of stem cells and endowed by elevated 
proliferative but no self-renewal capacity. 
 
 
1.1.3. Adult neurogenesis. 
 
Using rodents as experimental models, multiple reports have led to increasing our 
understanding of the origin of the newly generated neurons, their maturation, and 
their integration into the existing neuronal circuitry in the adult hippocampus (Geil et 
al., 2014). The SGZ and the SVZ are the most well studied zones for adult neurogenesis. 
The newly generated neurons, during development, show the expression of temporally 
ordered expression of stage-specific markers and changes in morphological and 
functional properties (Costa et al., 2015). For example, during early neurogenic lineage 
commitment, the transient amplifying Type II cells express various markers including 
Sox2. However, at later stages of differentiation, the progenitors express neuronal 
transcription factors like NeuroD (Kronenberg et al., 2003; Seki, 2002) and immature 




DEBIA WAKHLOO 16 
 
protein. The expression of immediate early genes such as c-FOS and ARC, a molecular 
marker of neuronal activity, provides the evidence of newly generated neurons actively 
integrating into the existing circuitry (Costa et al., 2015). 
Genetic fate mapping studies have demonstrated that neuronal progenitor cells are 
situated in the SGZ between the granular cell layer and the hilus. These neuronal 
progenitor cells are the main source of newly generated neurons in the dentate gyrus 
(DG) of the hippocampus (Dhaliwal & Lagace, 2011). These cells are commonly referred 
to as radial glial Type I cells (Box. 3). These cells possess radial processes spanning 
through the molecular layer and express radial glia marker expressing glial fibrillary 
acidic protein GFAP (Kriegstein et al., 2009).  
Box. 3. Radial Glial Cells. 
 
These neurogenic cortical progenitors can undergo either symmetric or asymmetric 
divisions to give rise to neurons and to undergo self-renewal. Radial Glial Cells (RGCs) 
are situated in the cortical Ventricular Zone (VZ). These cells show a distinctive 
polarized morphology characterized by an apical process towards the Ventricle and 
a long basal process towards the pial surface.  
 
 
Type I cells, when active, give rise to transient amplifying neural precursor cells (NPCs), 
which are referred to as Type II cells. These Type II cells further mature into granular 








Maturation of these granular neurons are marked by the development of dendritic 
trees into the molecular layer of the DG and the projection of axons towards CA3 to 
become functionally integrated (Hastings & Gould, 1999; Toni et al., 2007). Bonaguidi 
and colleagues have also demonstrated that other non-radial precursors cells located 
within the SGZ can give rise to newly generated neurons (Fig. 6; Bonaguidi et al., 2012). 
It is also interesting to highlight that majority of these newly generated neurons in 
rodent hippocampus die within the first four days of their birth (Sierra et al., 2010) or 
within one to three weeks after birth (Tashiro et al., 2006). After this scheduled 
apoptosis, less than 25% of the newly generated neurons survive to mature and form 
functional synapses with other surviving neurons.  
 
 
Figure 5. Schematic representation of adult neurogenesis. Two adult neurogenic niches i.e. 
Sub-ventricular zone (SVZ; Left) and Sub-granular zone (SGZ; Right), where neurogenesis 
takes place. In the SVZ, slow dividing quiescent NSCs give rise to fast dividing NSCs that 
subsequently generates transit amplifying progenitors (TAPs) and finally neuroblasts. 
However, in the SGZ, quiescent radial glial like (RGL) progenitors become activated to give 
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1.1.4. Migration and synaptic integration of newly generated neurons in the adult 
brain. 
 
In the SVZ, during adult neurogenesis, the newly generated neurons migrate through 
the rostral migratory stream (RMS) to reach the olfactory bulb and further settle into 
different layers of the cortical plate (Statler et al., 2007) through radial migration. 
Various molecules such as β1-integrin, PSA-NCAM, GABA and Slits act as environmental 
extracellular cues to regulate the stability, mobility and the direction of these migrating 
neurons (Ming & Song, 2005; Zhao et al., 2008). However, in the hippocampus, the 
newly generated neurons in the DG migrate locally into the inner granular cell layer. 
The newly generated neurons from the SGZ rapidly extend their axons through the hilus 
region to reach the CA1 region within two weeks after birth, while their dendrites reach 
the molecular layer (i.e. CA1) within the next week (Ge et al., 2006; Zhao et al., 2006). 
The migration of newly generated neurons from the SGZ is not well defined as 
compared to the migration of newborn neurons in the SVZ (Duan et al., 2008).  
The dorsal and ventral hippocampus has been reported to be implicated in learning 
and memory. Altman and colleagues suggested that newly generated neurons are 
essential for continued learning and memory formation (Altman & Das, 1967). 
Jessberger and colleagues demonstrated that ambient GABA activates the neural 
progenitors and immature neurons before receiving functional synaptic inputs during 








Once the neuronal maturation begins, GABA depolarizes the newly generated neurons 
due to the high chloride content and promotes the formation of GABAergic and 
glutamatergic synaptic inputs (Ge et al., 2006). These newly generated neurons exhibit 
hyper-excitability and enhanced synaptic plasticity of their glutamatergic inputs during 
maturation in the hippocampus. This enables the newly generated neurons to integrate 
into the existing architecture and make unique contributions to information 
processing. At cellular level, long-term potentiation (LTP) of evoked field potentials is 
abolished by radiation to abrogate adult neurogenesis (Snyder et al., 2001). Many have 
reported that even a small number of neurons can influence behavior (Brecht et al., 
2004; Shadlen et al., 1996). 
 
 
Figure 6. Maturation of Granule cells. In the first week after birth, the neural progenitors 
are characterized by irregular shape, immature spikes and no synaptic activity. The next 
week, the cells migrate into the granule cell layer and develop dendrites lacking spines. They 
also show slow GABAergic synaptic inputs. The week after, they start to form afferent 
connections from the performant pathway of the cortex and the CA3. At this stage, there is 
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1.1.5. Tracking adult neurogenesis and limitations. 
 
For almost two decades, the DG was considered as the only brain region where adult 
neurogenesis takes place in humans (Eriksson et al., 1998). However, novel techniques 
for retrospective cellular birth dating in humans provided the first evidence that robust 
neurogenesis takes place in the adult human striatum (Ernst et al., 2014). This cellular 
birth dating was performed using isotope Carbon-14 (14C). The level of 14C in genomic 
DNA was used to reliably determine the time at which DNA was synthesized and 
populations of cells were generated without the use of exogenous markers (Spalding 
et al., 2005). Adult neurogenesis was found to be remarkably similar across various 
species, but dramatically different in the rates of neurogenesis (Jakovcevski et al., 
2011). Contradicting reports suggest that it is difficult to determine how rates of 
neurogenesis compare within species, as 14C birth dating cannot be employed in 
rodents due to their short lifespan, whereas bromodeoxyuridine (BrdU) (Box. 4) is 
never used in humans due to its toxic nature. Therefore, immunohistochemistry for 
endogenous markers of immature neurons have been useful in identifying newly 
generated neurons in different species and their various brain regions (Liu et al., 2009). 
However, this technique still is unsuitable for cross-species rate comparisons due to 
different rates of cell death, maturation, downregulation of endogenous immature 
neuronal markers as well as postmortem stability across different species (Amrein et 
al., 2014; Snyder et al., 2009).  
Box. 4. BrdU. 
 
Bromodeoxyuridine (5-bromo-2'-deoxyuridine and BrdU) is an analog of thymidine 
and a synthetic nucleoside. BrdU is used in the detection of proliferating cells in living 
tissues. BrdU can be introduced into the newly synthesized DNA of replicating cells 
and can substitute for thymidine during DNA replication. Specific antibodies can then 
detect the incorporated BrdU (see immunohistochemistry), thereby demonstrating 







DEBIA WAKHLOO 21 
 
The major disadvantages of radioactive thymidine labelling include the uptake by cells 
undergoing DNA repair as well as it can cause DNA strand breaks. It is also diluted after 
every replication cycle and therefore cannot be used for a longer period if labelling of 
progenitor cells is performed (Breunig et al., 2007). Similarly, BrdU labelling also has its 
disadvantages such as causing DNA breaks, DNA transcription errors, toxic in higher 
doses as well as dilutes after every replication cycle (Breunig et al., 2007).   
 
 
Certain experiments using Cre-LoxP (Box. 5) suggested that astrocytes expressing GFAP 
show radial glial properties and are adult NSCs (Alvarez-Buylla & Lim, 2004). However, 
a limitation of using wide range of animal models and marker genes is that several of 
these markers are not specific to quiescent or cycling progenitors as revealed by single 
cell RNA Sequencing (Hochgerner et al., 2018). Moreover, many of these transgenic 
mouse lines have shown variable levels of unspecific signal, thereby limiting our 




Figure 7. Consequences of Species differences in the course of neurogenesis. Among 
methodological considerations, a hypothetical concept of a temporal decoupling of the stages 
of adult neurogenesis and species differences in marker expression. This could partially explain 
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Box. 5. Cre-loxP recombination. 
 
Cre-Lox recombination is a technology that can be used for carrying out deletions, 
insertions, translocations and inversions at various specific sites in the DNA sequence 
of eukaryotic or prokaryotic cells. DNA modifications can be targeted to a cell type or 
be triggered by an external stimulus (e.g. Tamoxifen). The system consists of an 
enzyme, Cre recombinase that recombines with a pair of short sequences. These 
sequences are called the Lox sequences. Lox sequences are appropriately placed so 
as to allow genes to be activated, repressed, or exchanged for other genes. These 
DNA changes are targeted and are specifically useful in lineage tracing, where global 
mutants are embryonic lethal. 
 
 
Contradictory reports suggest the existence of adult hippocampal neurogenesis in 
humans. Sorrells and colleagues reported that humans uniquely appear to lack adult 
hippocampal neurogenesis (Sorrells et al., 2018). The authors used well-known markers 
of neural progenitors and immature neurons in post mortem brain sections, and 
observed that neurogenesis rapidly decreased with advancing age, with no signs of 
neurogenesis observed in individuals older than 13 years. On the other hand, Boldrini 
and colleagues demonstrated that adult hippocampal neurogenesis does occur in 
humans and it does not decline with age (Boldrini et al., 2018). Even though the authors 
used similar markers to detect adult neurogenesis as Sorrells et al., 2018, they used a 
stereological approach to quantify the total cell numbers observed in the entire DG 
region. Moreno-Jimenez and colleagues, in part corroborated these results by 
demonstrating numerous immature neurons in the DG region of healthy humans up to 
90 years of age (Moreno-Jimenez et al., 2019). These contradicting results provide 
insight on the technical difficulties and variations in determining the extent of adult 
hippocampal neurogenesis in humans. 
1.1.6. Other Neurogenic zones. 
 
There is immense controversy in the field of adult neurogenesis as mentioned above 
due to the methodological limitations. There have been multiple reports of constitutive 
neurogenesis in various regions of the brain of primates and rodents such as neocortex 
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the dorsal vagal complex of the brainstem (Bauer et al., 2005) and in the spinal cord 
(Yamamoto et al., 2001). Other regions of the brain where reported neurogenesis takes 
place are the substantia nigra (Zhao et al., 2003), the amygdala (Bernier et al., 2002) 
and rodent CA1 region of the hippocampus (Rietze et al., 2000). 
Even though numerous reports have indicated that adult neurogenesis takes place 
specifically in the SVZ and SGZ, other regions containing NSCs should not be 
underestimated (Ortega & Costa, 2016). For example, multipotent NSCs have been 
isolated from uninjured postnatal mouse cerebral cortex (Belachew et al., 2003; Costa 
et al., 2007; Marmur et al., 1998; Seaberg et al., 2005) or after inducing traumatic injury 
(Buffo et al., 2008; Sirko et al., 2013). The inner core of the olfactory bulb (OB) of 
rodents and humans have also been described to possess adult NSCs (Ortega et al., 
2016). Reports have also demonstrated that injuries and pathological stimuli such as 
stroke activate neurogenesis outside the two established neurogenic zones (Ming et 
al., 2005). Similar reports have shown that adult neurogenesis also takes place in the 
peripheral nervous system (PNS), such as the generation of olfactory neurons in the 
olfactory epithelium (Leung et al., 2007) and neural crest lineages in the carotid bodies 
(Pardal et al., 2007). More recent evidence suggests that lesions may also activate 
`dormant` or `quiescent` NSCs via release of certain signaling molecules such as 
Vascular Endothelial Growth Factor (VEGF), basic Fibroblast Growth Factor (bFGF) and 
sonic hedgehog (Luo et al., 2015; Sirko et al., 2013). However, the contribution of these 
`dormant` NSCs to any periodical or unnoticed turnover of various neuronal 
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Table 1. Results depicting positive and negative results of adult neurogenesis in 
different brain regions (Adapted from Gould, 2007). 
 
1.1.7. Importance of adult hippocampal neurogenesis. 
 
Adult hippocampal neurogenesis can contribute indirectly to brain function via 
alteration in structural properties of the circuitry (Geil et al., 2014). At a systemic level, 
a variety of computational models of adult neurogenesis has demonstrated that newly 
generated neurons alter neural network properties (Aimone & Gage, 2011). Multiple 
reports have demonstrated that the newly generated neurons show enhanced synaptic 
plasticity for a limited time after their differentiation (Ge et al., 2007). This enhanced 
synaptic plasticity is crucial for their role in mediating pattern separation in memory 
formation and cognition in rodents (Clelland et al., 2009; Nakashiba et al., 2012; Sahay 
et al., 2011). Various reports have demonstrated that adult hippocampal neurogenesis 
facilitates cognitive flexibility by the formation of new distinct memories (Dupret et al., 
2008; Epp et al., 2016; Garthe et al., 2009). In an experiment, where mice were first 
exposed to Morris water maze, they were able to find the safety platform without 
difficulties. However, mice with higher rate of adult hippocampal neurogenesis were 
able to find the safety platform even when its position was changed. The mice with 
lower rate of adult hippocampal neurogenesis were unable to find the changed safety 
platform and were observed to be searching for the platform in its prior location. The 
authors suggest that due to the higher rate of adult hippocampal neurogenesis; the 
earlier memory of the safety platform was cleared quickly, which enabled the mice to 
find the new location of the platform. They term this phenomenon cognitive flexibility. 
In contrast, the mice with lower rate of adult hippocampal neurogenesis show 
cognitive inflexibility, were unable to clear the earlier memory, and therefore could not 








Toni and colleagues demonstrated that adult neurogenesis could disrupt the existing 
synapses of mature neurons due to the competition during new neuron synaptic 
integration (Toni et al., 2008; Toni et al., 2007). Moreover, adult neurogenesis in the 
hippocampus leads to an increased number of astrocytes that migrate into the hilus, 
the granular cell layer and the molecular layer (Bonaguidi et al., 2011; Encinas et al., 
2011). Multiple reports have further demonstrated that adult hippocampal 
neurogenesis influences experience and mood (Sahay & Hen, 2007) and is implicated 
in neurological disorders such as depression, schizophrenia and cognitive dysfunction. 
An interesting question in the field, which suggests that increasing adult hippocampal 
neurogenesis would be sufficient to improve memory and cognition, remains to be 
determined (Sahay et al., 2011). Based on the above-mentioned literature, it is evident 
that upregulation or downregulation of adult hippocampal neurogenesis could led to 
various neuropsychiatric disorders. 
 
Figure 8. Neurogenesis 
mediates cognitive flexibility 
by allowing the formation of 
new memory traces. (a) With 
high neurogenesis, engrams are 
cleared faster. This efficient 
memory clearance reduces 
proactive interference between 
the memory of the previous 
location and the ability to 
encode a new location. This 
facilitates cognitive flexibility 
and promote the finding of the 
new location of the platform. 
(b) With low neurogenesis, 
engrams of previous memories 
are not cleared. Due to this, 
new memory engrams might 
not be encoded properly, 
thereby increasing proactive 
interference and reduce 
cognitive flexibility and impair 
the ability to find the new 
location of the platform. 
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1.1.8. Factors involved in neurogenesis. 
 
Various morphogens (Box. 6) such as Bone Morphogenetic Protein (BMPs), Notch, WNT 
and Sonic Hedge-Hog (SHH) are reported to be extremely critical for tissue patterning 
and specification during embryonic development (Fig. 9). They also continue to 
regulate adult NSCs (Faigle & Song, 2013). BMP signaling negatively regulates SVZ 
neurogenesis by promoting the differentiation of NSCs to astrocytes as well as causing 
quiescence in NSCs of the SGZ (Bonaguidi et al., 2005; Mira et al., 2010). On the other 
hand, Notch signaling can induce proliferation and maintenance of NSCs in both adult 
niches (SVZ and SGZ), but the inhibition of Notch signaling triggers the NSCs to exit the 
cell cycle and transition to a progenitor cell stage (Breunig et al., 2007; Ehm et al., 
2010).  
Box. 6. Morphogens. 
 
The term morphogen describes a type of signaling molecule that can act on cells to 
induce distinct cellular responses in a concentration-dependent manner. During 
development, various cells differentiate according to the morphogens induced 
positional information. Morphogens act as signaling molecules that originate from a 
region and distribute from their source to form a concentration gradient. The fate of 
other cells in the field depend on the morphogen concentration and the gradient 
defines the pattern of development. 
 
 
Similarly, SHH signaling is essential to maintain the NSCs in the SVZ, however, 
upregulated signaling promotes symmetric division leading to expansion of NSCs but 
ultimately depleting their numbers (Ferent et al., 2014). Another factor important for 
maintenance of NSCs is WNT signaling. Use of WNT signaling inhibitors such as 
Dickkopf-1 (Dkk1) and secreted frizzled related protein 3 (sFRP3) promotes NSCs 
quiescence along with the maturation of newborn neurons (Jang et al., 2013). Other 
factors such as growth factors and neurotrophins play an important role in regulating 








Lot of signaling molecules such as epidermal growth factor (EGF), fibroblast growth 
factor-2 (FGF-2), brain derived neurotrophic factor (BDNF), glial cell line derived 
neurotrophic factor (GDNF), stem cell factor (SCF), vascular endothelial growth factor 
(VEGF), insulin like growth factor-1 (IGF-1), nitric oxide (NO) and erythropoietin (EPO) 
have been reported to be involved in neurogenesis (Kokaia & Lindvall, 2003; Wiltrout 
et al., 2007). Moreover, most of these above-mentioned factors regulate neurogenesis 
by inducing or interacting with important transcription factors (TFs).  
Figure 9. Potential cellular intrinsic signaling pathways regulating adult 
neurogenesis. A schematic of a single cell proposes a hypothesis that different 
intrinsic signaling pathways may act in concert or in opposition to regulate different 
stages of adult neurogenesis. Solid lines indicate direct signaling, whereas dashed 
lines show indirect signaling. These signaling pathways could influence 
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Table 2. Effect of growth factors on adult hippocampal neurogenesis (Modified from Balu and 
Lucki, 2009). 
 
Transcription factors regulate neurogenesis in embryonic as well as adult NSCs (Hsieh, 
2012). TFs promoting neuronal progenitor cell proliferation and/or neuronal cell fate 
commitment could increase the generation of new neurons. However, at normal 
physiological condition, certain TFs control proliferation, while others affect 
differentiation of NSCs towards either a neuronal or a glial phenotype (Tonchev & 
Yamashima, 2007). 
Sox2. One such transcription factor is Sex determining region Y – box 2 (Sox2). Sox 
family proteins bind to DNA via their high-mobility group (HMG) domains that are 
conserved TFs which play an important role in cell fate specification and differentiation 
of many tissues (A. B. Abraham et al., 2013; B. J. Abraham et al., 2013; Kamachi & 
Kondoh, 2013). Sox2 has also been characterized as one of the essential `Yamanaka 
factors` required for the generation of induced pluripotent stem cells (iPSCs) from 
fibroblasts (Takahashi & Yamanaka, 2006). Moreover, Sox2 is highly expressed in 
embryonic and adult NSCs of both niches and reduction in its expression leads to 
depletion in the numbers of NSCs. Sox2 is also expressed in Embryonic stem (ES) cells 
and neural epithelial cells during development (Avilion et al., 2003; Ferri et al., 2004; 
Zappone et al., 2000). Various reports have demonstrated that NSCs also express Sox2 
in vitro (Bylund et al., 2003; Ferri et al., 2004; Graham et al., 2003). Suh and colleagues, 
in vivo, demonstrated that Sox2 was expressed by a population of cells in the SGZ of 
the DG in the hippocampus, capable of producing differentiated neural cells as well as 
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cells possess the ability to proliferate as well as differentiate into neurons. The authors 
also demonstrate that Sox2 positive precursors undergo symmetric division (Fig. 10) 
i.e. the size of Sox2 positive NSCs pool remains unchanged (Suh et al., 2007).    
 
Pax6. Paired-box 6 (Pax6) is another conserved TF which is highly expressed in cells 
originating from embryonic neural development and adult neurogenic zones (Betizeau 
et al., 2013; Florio & Huttner, 2014). Pax6 is required for regulating neurogenesis and 
proliferation of NSCs (Haubst et al., 2004). Upon Pax6 expression, several TFs such as 
Neurogenin 2 (Ngn2), T-box brain gene 2 (Tbr2), Neurogenic differentiation 1 (NeuroD) 
and T-box brain gene 1 (Tbr1) are activated. These TFs are expressed sequentially (Pax6 
-> Ngn2 -> Tbr2 -> NeuroD -> Tbr1), which lead to neuronal differentiation (Fig. 11; 
Haubst et al., 2004). 
 
  
Figure 10. Role of Sox2 
positive NSCs in adult 
neurogenesis. Radial Sox2 
positive NSCs can proliferate 
and differentiate to give rise to 
non-radial Sox2 positive NSCs. 
These cells have the ability to 
proliferate to produce more 
non-radial Sox2 positive NSCs. 
They can also differentiate to 
give rise to neurons or 
astrocytes. Modified from Suh 
et al., 2007. 
Figure 11. Involvement of Pax6 positive radial 
glial cells in adult neurogenesis. 
Differentiation of Pax6 positive RGC to neurons 
can take place via either direct or indirect 
approach of neurogenesis. In direct 
neurogenesis, Pax6 positive RGCs 
differentiated into Tbr1 positive neurons 
directly, whereas in indirect neurogenesis 
approach, these Pax6 positive RGCs first 
differentiate into an intermediate stage, which 
express Tbr2, which then further differentiates 
into Tbr1 positive neurons. Adapted from 
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Gli1. Gliotactin 1 (Gli1) is a transcription factor, which is activated by sonic hedgehog 
(SHH) signaling pathway (Lai et al., 2003; Machold et al., 2003). Gli1, therefore, has 
been routinely used as a sensitive readout of SHH activity in cells (Rimkus et al., 2016). 
SHH responsive NSCs have been reported to possess the ability of proliferation and 
differentiation into neurons, thereby increasing in number as well as generating more 
neurons (Ahn & Joyner, 2005). In the SVZ, the stem cells (B – cells) give rise to amplifying 
cells (C – cells) which act as progenitors to form neuroblasts (A – cells). Gli1 is expressed 
in B – cells and C – cells, which was confirmed with single cell RT-PCR (Palma et al., 
2005) as well as analysis of transgenic Gli1-nLacZ mice (Ahn et al., 2005). 
Immunohistochemistry on this mice showed that Gli1 was expressed in the SVZ, 
specifically in NSCs (B – cells) and their progenies (C – cells).  However, in the SGZ, SHH 
administration increased the number of proliferating cells (Lai et al., 2003; Machold et 
al., 2003), thereby indicating that SHH acts as a regulator of adult hippocampal NSCs. 
In this case as well, Gli1 was found to be transcriptionally induced after the activation 
of SHH pathway in the SGZ (Galvin et al., 2008). Further, Encinas and collaborators 
crossed Gli1CreERT2 mouse line with a reporter Rosa26 (CMV-LoxP-stop-LoxP-GFP) 
mouse line (Balordi & Fishell, 2007), to drive the expression of GFP exclusively in the 
NSCs of the SGZ (Encinas et al., 2011). These labeled NSCs were first quiescent in 
nature, which undergo asymmetric division to give rise to amplifying NSCs. 
Tle4. Gro/Tle4 proteins are transcriptional corepressors, which are active in many cells 
during development. Tle4 is also known to suppress Notch signaling. However, Tle do 
not directly bind to the DNA, but they are recruited via a protein-protein interaction 
with specific DNA binding proteins such as bHLH and Fox Family proteins, Tcf/LEF, Hhex 
and Runx1 (Buscarlet & Stifani, 2007; Jennings & Ish-Horowicz, 2008). Tle4 and Tle3 are 
expressed in ESC (Cloonan et al., 2008), indicating its importance in the proliferation of 
ESCs. Tle3/4 acts by displacing Tcf3 from β-catenin, a byproduct of Wnt signaling. It 
directly interacts with Tcf3 on Nanog (Pereira et al., 2006) and Oct4 (Tam et al., 2008) 
promoters. Tle3/4 can also regulate differentiation in ESCs by interacting with various 
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Tbr1. The T-box brain 1 (Tbr1) is expressed in the developing cerebral cortex, 
hippocampus and the olfactory bulb (Bulfone et al., 1995; Puelles, 2017). Tbr1 is a 
transcription factor, which promotes frontal identity in post mitotic neurons as well as 
implementing fate to initially specified radial progenitors cells. Several reports have 
demonstrated that Tbr1 is expressed downstream of Pax6, Tbr2 and NeuroD1, which 
implies its role in late stage glutamatergic neuronal differentiation (Hevner et al., 2006; 
Hodge et al., 2008; Roybon et al., 2009; Schuurmans et al., 2004). Moreover, 
overexpression of Tbr1 resulted in the inhibition of astrocyte production in the 
developing olfactory bulb as well as promoting neuronal and oligodendrocytic 
differentiation in vitro. Puelles and colleagues demonstrated that evolutionarily, Tbr1 
and Dcx positive cells are present in the pallial derivatives (homologous to the 
amygdala) of reptiles (Puelles, 2017). This was in congruence with the proposal put 
forth by Luzzati and colleagues regarding the presence of a conserved pallial cell type, 
indicating the possibility of a population of slowly maturing DCX positive cells shared 
by multiple domains, which remain conserved during evolution (Luzzati, 2015).   
Lnc-RNAs. The above mentioned signaling mechanisms activate certain transcriptional 
programs in part by interacting with cellular epigenetic mechanisms including their 
interaction with chromatin remodeling enzymes and regulating fate of NSCs with the 
help of non-coding RNAs (Mercer et al., 2008; Puthanveettil et al., 2013). In recent 
years, the role of long non-coding RNAs (lnc-RNAs) in adult neurogenesis has been 
highlighted. Barry and colleagues reported that lnc-RNAs have been previously linked 
to embryonic neurogenesis (Barry et al., 2015). Moreover, several lnc-RNAs such as 
MALAT1, BCYRN1, MIAT, SOX2-OT, TUG1 and RMST were expressed in the SVZ of the 
adult human brain (Barry et al., 2015). Various other lnc-RNAs such as DLX1AS, SIX3OS 
and PNKY were also demonstrated to be functionally essential in adult mouse 
neurogenesis (Ramos et al., 2015; Ramos et al., 2013; Spalding et al., 2013). It is highly 
likely that any alteration in the levels of these essential lnc-RNAs could have 
pronounced effect on NSCs proliferation, amplification, differentiation into 
neuroblasts and potentially leading to impaired neurogenesis. Lnc-RNAs are greater 
than 200 nucleotides in size and can aid in regulating gene transcription, post-
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2015). Lnc-RNAs could also drive neurogenic fate of NSCs, as shown (Ng et al., 2013). 
The authors demonstrate that knockdown of lnc-RNA RMST inhibits neuronal 
differentiation and is essential for the binding of Sox2 to promoter regions of 
neurogenic transcription factors (Fig. 12; Ng et al., 2013).  
 
In 2015, single cell RNA-Sequencing analysis of adult NSCs dynamics demonstrated that 
activation of quiescent NSCs is accompanied by downregulation of glycolytic 
metabolism accompanied by upregulation of mitochondrial oxidation in both 
neurogenic niches (SVZ and SGZ; Shin et al., 2015). 
HIF-1. HIF-1, a heterodimer composed of HIF-1α and HIF-1β, is a transcription factor 
(Cummins & Taylor, 2005). HIF-1α is oxygen-regulated protein, which is continuously 
synthesized and degraded. It is absent in normoxic cells. Studies have demonstrated 
that a link exists between hypoxia, HIFs and certain crucial differentiation regulating 
molecules such as OCT4 and c-Myc, which act in a HIF-dependent system to regulate 
stem cell function (Maherali et al., 2007; Okita et al., 2007; Wernig et al., 2007).  
1.2. Hypoxia. 
1.2.1. Hypoxia as a critical microenvironment in neurogenic niches. 
 
A critical question regarding what constitutes a niche for stem cell has often-troubled 
researchers. Over several years, this concept has been better understood. It is defined 
as a compartment containing cellular as well as acellular components, which release 
signals to create a microenvironment that regulates stem cells (Scadden, 2006).  The 
most basic element of a niche is contact and communication between these various 
Figure 12. Mechanism of Sox2-
RMST during neurogenesis. In 
NSCs, when RMST is absent, 
Sox2 binds to its transcriptional 
targets to maintain NSC 
identity. However, during the 
onset of neurogenesis, RMST 
binds to Sox2 to allow the 
expression of neurogenic 
transcription factors. Adapted 
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elements. As mentioned before, the Sub-Ventricular zone (SVZ) is the major neurogenic 
zone during early corticogenesis in rodents. This zone is populated by a variety of 
heterogeneous cell types. Doetsch and colleagues demonstrated that the multipotent 
NSCs (Type B cells) show linear progression to become proliferating, transit-amplifying 
cells (Type C cells) which would further lead to neuronal progenitors (Doetsch et al., 
1993). The Type B cells always maintain contact with both the ependymal cells as well 
as the basal lamina of the endothelial cells. The basal lamina of the endothelial cells is 
a component of the surrounding blood vasculature (Alvarez-Buylla et al., 2004). In 
addition to that, the Type B cells also contains ciliated processes that maintain contact 
with the cerebrospinal fluid (CSF) present in the ventricle (Fig. 13). In the SVZ, the 
endothelial, ependymal cells and the choroid plexus together constitute a niche. They 
are the main sources of instructive signals for the stem cells present in the SVZ. Similar 
niches have been observed in postnatal human brains (Quinones-Hinojosa et al., 2006). 
Each component of the niche plays a critical role in neurogenesis. The presence of 
astrocytes around the capillaries play a significant role in the proliferation of adult NSCs 
(Palmer et al., 2000).  The endothelial cells release soluble factors, which promote the 
proliferation of adult NSCs (Shen et al., 2004; Shen et al., 2008). On the other hand, 
ependymal cells secrete Noggin, which promotes neurogenesis by activating Type B 
cells (Lim et al., 2000). Noggin acts as a receptor for BMPs, which is a known 
differentiating factor. Vascular endothelial cells differentially control oxygen perfusion 
to either maintain or release NSCs from quiescence (Fig. 13). Even though adult NSCs 
are known for their extensive and long-term proliferative capacities, they possess the 
unique characteristic to remain quiescent (i.e. non-diving) for long periods. These 
quiescent NSCs thereby provide a regenerative reserve for age-related cell loss (Li & 
Clevers, 2010). This ‘stand by’ mode preserves the stem cells from uncontrolled 
expansion and premature exhaustion while leaving them poised to reactivate in case 
of need (Rodgers et al., 2014). These quiescent stem cells are located in niches with 
low oxygen tension (Gopinath et al., 2014), suggesting that the availability of oxygen 
could determine the fate of the cell. Milosevic and colleagues demonstrated that lower 
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of NSCs (Milosevic et al., 2005) and prevented neuronal differentiation (Gustafsson et 
al., 2005).  
Box. 7. Hypoxia. 
 
It is a state of reduced oxygen pressure below a certain threshold, which induces 
adaptive gene expression and if severe, restricts the function of organs, tissues or 




A normal state of oxygen pressure i.e. in the range of 2-9% of oxygen in most adult 
cells in vivo is termed physiological normoxia. 
 
 
Reports have described that this response of a cell to hypoxia involves a shutdown of 
oxidative phosphorylation thereby stopping proliferation to be brought about by 
hypoxia-inducible factors (HIFs).  These factors are activated when there is low oxygen 
availability (Majmundar et al., 2010). The authors also indicate that the hypoxic 
signaling helps in maintenance of NSCs, by reinforcing cell quiescence and/or 
promoting proliferation at the expense of differentiation.  Decreasing the oxygen levels 
can activate quiescent NSCs to proliferate, yielding Type C cells that eventually 
differentiate in specific regions where oxygen levels are higher.  
 
One of the major advantage of stem cells located in a hypoxic niche is that the cells can 
maintain slow-cycling proliferation rates while avoiding the oxidative stress, yielding 
Figure 13. Postnatal brain stem 
cells and surrounding niche. (a) 
Stem cells maintain contact with 
ependymal (Ep) cells, endothelial 
(En) cells and with the 
ventricular lumen. (b) Changing 
oxygen tension regulates stem 
cell quiescence and activation to 
generate transit amplifying cells 
and their differentiated progeny. 
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Type C cells that eventually differentiate in specific regions where oxygen levels are 
higher (Cipolleschi et al., 1993; Eliasson & Jonsson, 2010; Lekli et al., 2009). 
1.2.2. Hypoxic neurogenic niches in humans and rodents. 
 
With all the reports published so far, researchers have started manipulating oxygen 
levels to demonstrate that lower oxygen levels significantly influence both embryonic 
and adult stem cells (Eliasson et al., 2010; Panchision, 2009). In humans, the neural, 
mesenchymal and hematopoietic are the three niches where different stem cells 
reside. The hematopoietic stem cell niche is one of the best characterized niches in 
humans (Yin & Li, 2006). In the bone marrow, the hematopoietic stem cell niche 
showed the oxygen levels to be approximately 1-6% O2 (Grant and Root, 1947; 
Cipolleschi et al., 1993; Eliasson and Jonsson, 2010). The architecture of the medullary 
sinuses and arterial blood flow are responsible for generating an oxygen gradient 
within the bone marrow. Cipolleschi, Parmar and colleagues demonstrated that HSCs 
are naturally distributed within the oxygen gradient in the bone marrow, with HSCs 
mostly residing in the most hypoxic niches (Cipolleschi et al., 1993; Parmar et al., 2007). 
Following multiple reports, the oxygen levels in mesenchymal stem cell niche present 
in the adipose tissue was found to be approximately 2-8% O2 (Harrison et al., 2002; 
Kofoed et al., 1985; Matsumoto et al., 2006; Pasarica et al., 2009). In the SVZ, direct 
measurements from the neural stem cell niche has never been performed, but various 
regions of the rodent brain have shown the oxygen levels to be as low as 0.55% O2 
(Dings et al., 1998; Erecinska & Silver, 2001; Panchision, 2009). In rodent brain, the 
pressure of oxygen is significantly lower and ranges from 0.55% in the mesencephalon 
to 8% at the surface of the brain (Erecinska et al., 2001). However, in comparison, the 
pressure of oxygen in the human brain as measured by catheter electrodes varies from 
approximately 3% at a location of 22-27mm deep at the dura to 4% at 7-12mm under 
the dura (Dings et al., 1998). This demonstrates that physiological oxygen gradient is 
observed at its highest in the alveolar space and lowest in tissues (Fig. 14). These data 









1.2.3. Importance of hypoxia in regulating ‘Stemness’. 
 
During development, cortical vascular network formation occurs simultaneously with 
neurogenesis. During corticogenesis at E10.5 in rodents, a hypoxic environment 
induces and maintains high levels of HIF-1a in radial glial cells, due to the absence of 
blood vessels at this time point. Due to such a low oxygen level, the radial glial cells 
undergo symmetric divisions, thereby increasing their numbers rapidly. At this time, 
the presence of high levels of HIF-1a restricts the radial glial cells to prematurely 
commit to produce differentiated progeny. However, at a later stage at E13.5, HIF-1a 
levels are needed for the blood vessel formation, since it has been reported to be 
impaired in the absence of HIF-1a (Morante-Redolat & Farinas, 2016). This blood vessel 
formation thereby increases the oxygen levels in the tissue.  
Figure 14. Oxygen tension measurements in different stem cell compartments. Schematic 
models based on available literature for hematopoietic, mesenchymal and neural stem cells 
in their respective niches namely, bone marrow, adipose tissue and the sub-ventricular zone. 








Due to this sudden rise in the oxygen levels, HIF-1a is degraded and its downregulation 
leads the radial glial cells to undergo asymmetric divisions and initiate neurogenesis 
(Morante-Redolate and Farinas, 2016). This shows that hypoxia and HIF-1a creates an 
auto-regulatory loop ensuring initial radial glial expansion via proliferation and 
subsequent induction of their asymmetric divisions to generate higher number of 
neurons (Fig. 15). Hypoxia during early developmental stages thereby regulates 
differentiation and tissue repair (Burton et al., 2017; Zhang et al., 2016). This has been 
demonstrated in vitro as well (Table. 3). 
 
Figure 15. Role of hypoxia and HIF-1a in astrocyte differentiation and neurogenesis. At 
E10.5, the absence of blood vessels results in a hypoxic environment that induces and 
maintains high levels of HIF-1a in radial glial cells. However, at E13.5 the growth of blood 
vessels leads to an increase in the oxygen levels in the tissue. Due to this, HIF-1a is degraded 
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Table 3. In-vitro effect of low Oxygen tension on proliferation and differentiation of 
human neural stem cells (De Filippis & Delia, 2011).  
 
In rodents, there have been reports suggesting the fine-tuned control of hypoxia on 
neurogenesis as demonstrated (Xie & Lowry, 2018).  
 
1.2.4. Hypoxia induced transcriptional control. 
 
All cells need a continuous supply of oxygen, even the cells present within the fetus. 
Oxygen is delivered to all cells by red blood cells through the vasculature. Cells usually 
activate mechanisms, which are essential for their optimal function in response to 
either reduction or increase in oxygen levels (Semenza, 2010). Reduction in oxygen 
levels leads the cells to trigger enhanced mechanisms to promote the delivery of 
oxygen. One such mechanism is centered on the upregulation of transcription factor 
complex known as Hypoxia Inducible Factor (Bruick et al., 2010). HIF consists of two 
subunits, one acts as a regulatory subunit sensitive to oxygen and other is constitutively 
Figure 16. Influence of oxygen 
levels on proliferation and 
lineage specification of NSCs. 
Mild hypoxia promotes 
neurogenesis and 
oligodendrocyte differentiation, 
whereas severe hypoxia induces 
the generation of astrocytic 
differentiation. Adapted from 




DEBIA WAKHLOO 39 
 
expressed oxygen insensitive b-subunit (HIF-1b). HIF-1b is also known as Aryl 
Hydrocarbon Receptor Translocator (ARNT). There are three subunit genes present in 
the mammalian genome, namely; HIF-1a, HIF-2a and HIF-3a. HIF-1a is the most widely 
studied and possess the broadest tissue distribution as compared to the others. In the 
presence of low oxygen levels, HIF-1a protein is stabilized which allows it to interact 
with ARNT and further recruit the coactivators such as CREB binding protein (CBP), E1A 
binding protein p300 (EP300). This complex then also binds to the hypoxia regulatory 
elements (HREs) associated with other target genes which further encode proteins that 
help the cell to regulate adaptations to hypoxia (Kaelin & Ratcliffe, 2008). However, 
when oxygen levels are back to normal, HIF-1a subunits undergo hydroxylation on the 
prolyl residues by a family of oxygen sensitive prolyl hydroxylases (PHD1, PHD2 and 
PHD3). This hydroxylation then facilitates the HIF-1a subunit to associate with the Von-
Hippel-Lindau (VHL) protein, thereby leading to its ubiquitination, followed by its 




Figure 17. Cellular responses to hypoxia. In normoxia, PHD hydroxylate HIF-1a allowing VHL 
protein to ubiquitinate HIF-1a resulting in degradation of HIF-1a. However, in hypoxia, HIF-
1a is stable and can dimerize with ARNT, also recruit CBP/EP300 and bind to hypoxia/HIF 
response elements (HRE). The binding induces hypoxia responsive genes encoding proteins 
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In response to induced or endogenous hypoxia, gene-expression studies have revealed 
that over thousands of genes are activated by HIF1-a. Majority of those genes are 
involved in pathways that control O2 consumption and delivery, inhibition of growth 
and development, and promotion of anaerobic metabolism (Bruick, 2003; Carmeliet et 
al., 1998; Iyer et al., 1998). Vascular endothelial growth factor (VEGF), glucose 
transporters (Slc2a1) and erythropoietin (EPO) are some of the examples of oxygen-
regulated genes, which are activated by HIF1-a (Loike et al., 1992; Shweiki et al., 1992).  
1.2.5. Hypoxic upregulation of erythropoietin.  
 
As mentioned before, there is a strong induction of HIF-1a in the brain during hypoxia, 
which leads to a transcriptional regulation of target genes (Chavez et al., 2000). Stroka 
and colleagues demonstrated that sustained high levels of HIF-1a lead to an 
upregulation of erythropoietin (EPO) during hypoxic exposure (Stroka et al., 2001). EPO 
is one of the examples of a gene regulated in an oxygen dependent manner. Semenza 
and Wang, identified EPO to be the first target gene of HIF-1 (Semenza & Wang, 1992). 
The discovery of HIF was found by studies on the DNA-protein interactions at the 3’ 
hypoxia response element (HRE) of erythropoietin (Fig. 18; Wang and Sememza, 1995).  
 
 
Figure 18. Schematic representation of EPO and factors controlling hypoxic EPO induction. 
Under hypoxic condition, HIF-2a is stabilized and binds with HIF-1β, translocate to the 
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As the severity of hypoxia increases, the mRNA expression of EPO increases from 3 to 
20 fold in the brain as compared to 200 fold in the kidney (Marti et al., 1996). However, 
the temporal pattern is different. EPO expression upon hypoxia in liver and kidney is 
transient between 6 to 24 hours in vivo and 6 hours in vitro (Fig. 19), depending on the 
severity of hypoxia (Fandrey et al., 1990). In the brain, the mRNA levels of EPOR are 
observed to be elevated throughout the hypoxic exposure. Researchers discovered 
that relative hypoxic conditions were sufficient to increase the expression level of EPO 
mRNA and maintain an elevated level for at least 12 hours (Morita et al., 2003). When 
mice were exposed to hypoxic conditions, Yeo and colleagues suggested that the EPO 
transcription in the brain was primarily induced by HIF-2a instead of HIF-1a. They also 
demonstrated that EPO was present in the nuclei after 1 hour of hypoxia exposure (Yeo 
et al., 2008). This was one contradicting report suggesting that EPO is induced by HIF-
2a; whereas multiple other reports corroborate the evidence, indicating HIF-1a induces 






With the help of more in vitro studies, cultured primary mouse astrocytes showed 
approx. 100-fold increase in EPO mRNA expression after hypoxia exposure (Marti et 
al., 1996). Youssoufian and colleagues used in vitro cultures of NSCs to show that after 
treatment with hypoxia, the expression of EPO was significantly increased (Youssoufian 
et al., 1993). Similar increase in the expression of EPO mRNA was observed in cultured 
neurons after hypoxia treatment (Bernaudin et al., 2000). Cultured hippocampal 
Figure 19. Regulation of EPO under hypoxia in 
kidney and liver. Schematic representation of 
hypoxia regulated upregulation of HIF-1a/HIF-
1β, which further leads to an upregulation of EPO 
that can bind to its receptor EPOR. Modified from 
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neurons after exposure to hypoxia showed an upregulation of EPOR mRNA expression 
(Lewczuk et al., 2000). Shingo and colleagues suggested that hypoxia induced 
upregulation of EPO could act directly on NSCs, by promoting neurogenesis after 
hypoxia (Shingo et al., 2001). Similarly, VEGF expression is also observed to be 
upregulated via hypoxia, thereby increasing adult neurogenesis (Jin et al., 2002; 
Shweiki et al., 1992). Moreover, EPO treatment also enhanced the survival and 
differentiation of dopaminergic neurons from NSCs in vitro (Studer et al., 2000). In 
terms of NSCs maintenance, hypoxia has been proven to increase proliferation of NSCs 
through EPO in vitro and in vivo via the NF-κB signaling. Upon activation, there is a 
significant increase in the expression of Mash1, a transcription factor promoting 
neurogenesis (Shingo et al., 2001). The increased expression of receptors for EPO in 
the developing rodents and human CNSs after hypoxia/ischemic exposure (Juul et al., 
1998; Juul et al., 1999; Liu et al., 1997; Siren et al., 2001; Siren et al., 2006) supports a 
possible role for EPO in the CNS development. 
1.3. Erythropoietin. 
1.3.1. History of EPO. 
 
Paul Bert, the pioneer of aviation medicine, first recognized an increase in the red blood 
cells at reduced oxygen levels (Bert, 1882). He looked at the animals surviving at higher 
altitudes and hypothesized the existence of a genetic reason for their elevated oxygen 
capacity of the blood. Another researcher also recognized that acute exposure to high 
altitude could increase the number of erythrocytes (Viault, 1890). Further, down the 
line, Paul Carnot and Deflandre first proposed the regulation of erythropoiesis (Carnot 
and Deflandre, 1906). Following that, in 1948, Bonsdorff and Jalavisto coined the name 
‘erythropoietin’ (EPO; Bonsdorff, 1949). EPO is primarily found to be produced in the 
kidney or liver of adults and in the liver of fetal and neonatal mammals (Jacobs et al., 
1985). Jelkmann in 1992 demonstrated the functionality of EPO, where he 
demonstrated that EPO is essential for the maintenance and renewal of red blood cells 
(Jelkmann, 1992). Although initially thought to be restricted to the hematopoietic 
system, research during the last 20 years has revealed important functions of EPO 
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nervous system (Masuda et al., 1994; Siren et al., 2001; Marti et al., 2004; Siren et al., 
2006; Noguchi et al., 2008). EPO is produced in three main sites in mammals namely, 
the central nervous system, the liver and the kidney. In the CNS, EPO is produced by 
astrocytes and neurons to exert neuroprotective effects. In the liver, EPO is produced 
in Ito-cells and in hepatocytes, where HIF-2a is the main regulator of hypoxic EPO 
induction. However, in the kidney, majority of EPO expression is influenced by the 
hypoxic response of the skin (Weidemann & Johnson, 2009).  
 
 
The mRNA expression levels of EPO were found to be at comparable levels in the brain 
of mice (Digicaylioglu et al., 1995), monkeys and humans (Marti et al., 1996). EPO, at 
its protein level, was detected in the cortex and hippocampus of human and rodent 
brain (Bernaudin et al., 1999; Siren et al., 2001). Critical role of EPO in development 
and maintenance of the CNS was demonstrated by its importance in neurogenesis and 
Figure 20. Main sites of EPO production. EPO is produced in three main sites in mammals 
namely, the central nervous system, the liver and the kidney. In the CNS, EPO is produced by 
astrocytes and neurons to exert neuroprotective effects. In the liver, EPO is produced in Ito-
cells and in hepatocytes, where HIF-2a is the main regulator of hypoxic EPO induction. 
However, in the kidney, majority of EPO expression is influenced by the hypoxic response of 
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neuroblasts migration (Tsai et al., 2006; Yu et al., 2002), neuronal differentiation (Park 
et al., 2006), oligodendrocyte differentiation and maturation (Iwai et al., 2010; Sugawa 
et al., 2002). EPO mediates its effect through binding to its receptor EPOR. This 
suggested that EPOR must be expressed at various sites in the CNS to enable EPO to 
initiate its effects. To prove this, several researchers demonstrated that the expression 
of EPOR mRNA and protein was observed in the brains of mouse, rat, monkey and 
humans (Digicaylioglu et al., 1995; Liu et al., 1997; Marti et al., 1996). Most types of 
neural cells express EPOR, including neurons, oligodendroglia lineage cells, astrocytes 
and microglia (Bernaudin et al., 2000; Bernaudin et al., 1999; Hasselblatt et al., 2006; 
Ott et al., 2015; Siren et al., 2001; Sugawa et al., 2002). 
1.3.2. EPO and the blood brain barrier. 
 
EPO is a 166 amino acid glycoprotein, which is a member of the type I cytokine 
superfamily (Brines & Cerami, 2005; Noguchi et al., 2008; Youssoufian et al., 1993). EPO 
consists of four α-helices connected through two disulfide bridges between cysteines 
6 and 161 and cysteines 29 and 33 (Lai et al., 1986). It consists of about 60% protein 
and 40% carbohydrate (Noguchi et al., 2008) and has three N-glycosylation sites and 
one O-glycosylation site (Sasaki et al., 1987). The molecular weight of EPO is 
approximately 30.4 kD, which is significantly higher than the threshold for lipid 
mediated transport across the blood brain barrier (BBB). Brines and colleagues 
demonstrated that EPOR was expressed in brain capillaries facilitating the transport of 
EPO across the blood-brain barrier (Brines et al., 2000). The brain uptake of EPO was 
calculated to be approx. 0.05-0.1% of the total injected dose per gram of the brain, 
which peaked at 3 hours after injection. Using rodent model, biotinylated EPO was 
administered and biotin localization was observed around the capillaries in mouse 
brain 5 hours after injection. This was subsequently eliminated by an increase of 
unlabeled exogenous EPO, indicating a specific receptor-mediated transport of EPO in 
the brain (Banks et al., 2004). An increase of EPO in the serum could suggest the 
dysfunction of BBB, whereas increase of EPO in CSF indicates the synthesis of EPO in 
the CNS (Marti et al., 1997). To corroborate this finding, when humans were given high 
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administration. This provided the first evidence that EPO transport inside the brain 
takes place via a first order transmembrane or a non-receptor mediated mechanism 
(Xenocostas et al., 2005). Moreover, intravenous injection of 111-labeled EPO in 
healthy individuals and patients led to the detection of significant radioactivity in the 
brain, which peaked at 4 hours after injection and was maintained constant for 2 days 
(Ehrenreich et al., 2004). These reports together provide evidence that EPO crosses the 
BBB in a dose-dependent manner and is found to be increased after brain injury (Statler 
et al., 2007).  
1.3.3. Importance of EPO. 
 
In a neonatal stroke model using P10 rats, the expression of HIF-1a and EPO was 
observed to have peaked 8 hours after ischemia (Mu et al., 2005). It was also reported 
that EPO treated animals showed earlier restored cognitive functions after traumatic 
head injury (Brines et al., 2000; Meng et al., 2012). EPO treatment in mouse cortical 
lesion model prevented long-term behavioral alterations like impaired learning and 
brain atrophy (Dayyat et al., 2012). As mentioned above, high-dose EPO is able to cross 
the blood brain barrier in mice and man (Brines et al., 2000; Ehrenreich et al., 2004). 
Cerebral EPO has therefore drawn much attention as a neurotrophic and a 
neuroprotective factor for cerebral diseases including Alzheimer's (Maurice et al., 
2013), depression (Miskowiak et al., 2010), epilepsy (Castaneda-Arellano et al., 2014) 
and ischemia (Nguyen et al., 2014). Pioneering work done in humans by Ehrenreich and 
colleagues, demonstrated a greater clinical significance. In clinical trials, high dose EPO 
treatment in patients with chronic progressive multiple sclerosis (MS) is both beneficial 
and safe (Ehrenreich, et al., 2007). Moreover, EPO treatment showed improvement in 
cognitive functions in chronic schizophrenic patients (Ehrenreich, et al., 2007) and in 
therapy resistant major depression patients as well (Miskowiak, et al., 2014). Kästner 
and colleagues identified novel association of EPO and EPOR genotypes with cognition 
(Kästner et al, 2012) in schizophrenic patients. As gray matter loss is one of main 
characteristics of schizophrenia, it was also reported that EPO would delay cortical 
atrophy in chronic schizophrenic patients (Wustenberg et al., 2011). Further studies 
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of the hippocampus in affective disorder patients (Miskowiak,  et al., 2014). These 
studies when interpreted together could indicate that loss of neurons could give rise 
to cognitive defects in these patients. EPO treatment and cognitive function studies in 
patients with schizophrenia and multiple sclerosis have shown that 8–12 weeks of high-
dose EPO treatment improved cognitive functioning that lasted up to 6 months after 
treatment completion, which exceeds the red blood cell normalization (Ehrenreich, et 
al., 2007; Ehrenreich, et al., 2007). This suggests that the pro-cognitive effects of EPO 
are not related to changes in the hematopoietic system. On the contrary, EPO induced 
effects on neuro-cognition in humans seem to be mediated through neurobiological 
actions rather than indirect increase in the number of red blood cells (Miskowiak et al., 
2007a; Miskowiak et al., 2007b). These clinical trials demonstrated that one high dose 
of EPO as compared to saline was capable of improving neural and cognitive measures 
of memory and executive functioning in healthy volunteers without affecting the 
number of red blood cells. Miskowiak and colleagues performed a clinical trial to 
examine the effects of EPO on mood symptoms and cognitive dysfunction in Treatment 
Resistant Depression (TRD) and Bipolar Disorder (Kimura et al., 2015) patients. The 
results indicated that EPO treatment significantly improved verbal memory in TRD 
patients and speed of complex cognitive processing across attention, memory and 
executive function in BD patients (Miskowiak, et al., 2014a; Miskowiak, et al., 2014b). 
Further analysis revealed a structural hippocampal increase and task-related neural 
activity change correlated with the observed improvements in EPO-treated patients’ 
cognitive functions. These improvements had no relation with the number of red blood 
cells, mood symptoms, age or gender of the patients treated (Miskowiak, et al., 2016a; 
Miskowiak, et al., 2016b; Miskowiak et al., 2015). 
Ehrenreich and colleagues conducted clinical trial for stroke patients. In the double 
bind proof of concept trial, the authors demonstrated that injecting of EPO daily for 
the first three days after stroke led to a significant increase in the functional outcome 
(determined by Barthel Index) and prominent reduction in neurological defects in EPO 
treated stroke patients (Ehrenreich et al., 2002) as well as in schizophrenic patients 
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In conclusion, EPO, as a candidate, has been demonstrated to be hypoxia-inducible, 
which could provide neuroprotection in rodents by targeting variety of mechanisms 
involving neuronal, glial and endothelial cellular functions. These results pointed 
towards the hypoxic regulation of the EPO gene and its implication on hippocampal 
neuro-differentiation and thereby enhancing cognition. 
1.3.4. Role on EPO on neurogenesis. 
 
Erythropoietin role in the differentiation of stem cells in the hematopoietic system was 
widely studied. Early fate maps of hematopoiesis depicted one initial hematopoietic 
stem cell (HSC) population differentiating into blood and immune cells. Hematopoietic 
progenitor cells (HPCs) are their progeny that have been `chosen` to differentiate 
rather than proliferate (Ceredig et al., 2009; Hattangadi et al., 2011). However, since 
the finding of EPO and EPOR in the CNS, our group wondered whether similar 
mechanisms might also apply in the central nervous system. Previous work from our 
lab, demonstrated that EPO administration in mice led to 20% increase in the number 
of pyramidal neurons and oligodendrocytes in the CA1 and CA3 region of the 
hippocampus of young mice, without undergoing proliferation, resembling similarities 
from the hematopoietic system. Enhanced pyramidal neuron numbers induced by EPO 
in young mice were shown to be maintained under conditions of ongoing cognitive 
challenge using the touch-screen paradigm but this effect was not observed in the 
absence of a cognitive challenge. This led to the hypothesis of `use-it-or-lose-it`. 
However, as opposed to the precursor identification in the oligodendrocyte cell 
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2. Rationale and research aims. 
 
Previous work from our group has demonstrated that EPO treatment induces an 
increase in the number of pyramidal neurons in the CA1 region of the hippocampus 
(Hassouna et al., 2015). Understanding the endogenous mechanisms by which EPO 
mediates this increase in the brain may open new avenues for the development of 
therapeutic strategies for modulation of adult neural precursor cells. Harnessing this 
mechanism for the treatment of various cognitive decline disorders led to the research 
aims of my PhD work.  
The main objectives of my PhD study were as follows: 
1. To locate the neuronal progenitor cells which respond to EPO and lead to an 
increase in the number of pyramidal neurons in the CA1. The increase in neurons 
upon EPO had to be attributed to certain neural precursors. Given the complexity of 
the neuronal lineage, This thesis attempted to determine the influence of EPO on 
number of progenitor cells as well as fate map these cells using transgenic mouse 
models like NestinCreERT2, GliCreERT2 and Sox2CreERT2 mice crossed with a 
reporter mouse line (R26R-TdTomato).  
2. To replicate and extend the previous findings of increased neuron numbers using 
a novel sophisticated method. One way of addressing the question of adult 
neurogenesis is by using precursor marker labelled additive method. However, a 
subtractive approach was employed where a transgenic mouse (NexCreERT2) was 
crossed with a reporter mouse line (R26R-TdTomato) and effects were studied in 
juvenile and adult mice. Yet another approach, to strengthen these claims was to 
observe the effect of EPO on RNA transcriptome level. Single cell Drop-Sequencing 
method was employed to elucidate the effect of a single high-dose of EPO on 
different cell populations in the CA1 region of the hippocampus.  
3. To elucidate the effect of EPO on synaptic connectivity of pyramidal neurons in the 
CA1 region of juvenile and adult mice. Having observed increased pyramidal 
neuronal numbers, next aim was to evaluate the role of EPO in neuroplasticity. To 
achieve this, a transgenic mouse model (Thy1) was crossed with a reporter mouse 
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line (EGFP) to label dendrites and spines of sparsely labelled pyramidal neurons in 
the CA1. 
4. To evaluate the endogenous mechanisms by which EPO mediated these 
neuroplastic effects. Exogenous EPO led to an increase in neuroplasticity but EPO 
being a hypoxia-regulated gene should be able to deliver similar effects upon 
hypoxia exposure was reasoned. Therefore, to understand the physiological 
underpinnings, a hypothesis was put forth that a learning/cognitive challenge such 
as Complex Running Wheel (CRW) could lead to an increase in the levels of EPO, its 
receptor EPOR and cause an increase in endogenous functional hypoxia in pyramidal 
neurons. This was achieved using a hypoxia sensitive transgenic mouse model (CAG-
ODD) crossed with a reporter mouse line (R26R-TdTomato). Further, this thesis 
aimed to determine the effect of physiological hypoxia (via Complex Running wheel) 
and/or exogenous hypoxia (via exposing mice to 12% Oxygen in chambers) on the 
number of pyramidal neurons as well as to determine whether any enhancement in 
cognitive learning and endurance is observed. Moreover, to specifically understand 
the importance of EPO and EPOR in the brain, the present work investigated the 
effect of a specific deletion of EPO or EPOR in pyramidal neurons. For this purpose, 
conditional transgenic pyramidal knockout mouse models like NexCre::EPOfl/fl or 
NexCre::EPORfl/fl mice were generated.
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3. Materials and methods 
3.1.1. Experimental models and mouse genetics. 
3.1.2. Mouse strains. 
All experiments were approved by and conducted in accordance with the regulations 
of the local Animal Care and Use Committee (Niedersächsisches Landesamt für 
Verbraucherschutz und Lebensmittelsicherheit, LAVES). NestinCreERT2 (Jackson 
Laboratory; 016261), GliCreERT2 (Jackson Laboratory; 007913), SoxCreERT2 (Jackson 
Laboratory; 007593), WT C57BL/6N (Charles River), NexCreERT2 (Agarwal et al., 2011), 
R26R-TdTomato (Madisen et al., 2010), Thy1-YFP (Feng et al., 2000; Jackson 
Laboratory, 003782), CAGCreERT2-ODD (Kimura et al., 2015), NexCre (Goebbels et al., 
2006), Ella-Cre (Holzenberger et al., 2000), EPOR-floxed (EPORfl/fl) and EPO-floxed 
(EPOfl/fl) mice were used for the experiments. Juvenile (P23) and adult (3 months old) 
mice were used in this study. For labelling radial glial like precursor cells, Sox2CreERT2 
and other precursors cells, NestinCreERT2 and GliCreERT2 mice were bred with Rosa26 
floxed-stop TdTomato (R26R-TdTomato) reporter mice to generate 
Sox2CreERT2::TdTomato, NestinCreERT2::TdTomato and GliCreERT2::TdTomato mice. 
For genetic labelling of projection neurons, NexCreERT2 mice were bred with Rosa26 
floxed-stop TdTomato (R26R-TdTomato) reporter mice to generate NexCreERT2::R26R-
TdTomato mice. For labelling cells undergoing hypoxia, CAGCreERT2-ODD mice were 
employed (Kimura et al., 2015). Briefly, a fusion protein consisting of the ODD domain 
of Hif1α and a ubiquitous CAGCreERT2 is expressed upon tamoxifen induction. 
CAGCreERT2-ODD were bred with R26R-TdTomato to generate CAGCreERT2-
ODD::TdTomato reporter mice. Upon tamoxifen induction, cells are irreversibly labeled 
with TdTomato containing stabilized Hif-1α. NexCre::Eporfl/fl mice were generated to 
specifically delete Epor in projection neurons. For the generation of Eporfl/fl mice, 
embryonic stem cells (ES) harboring an engineered allele (Eportm1a(KOMP)Wtsi) of the Epor 
gene were acquired from the Knockout Mouse Project (KOMP, University of California, 
Davis CA 95618, USA). ES cells were microinjected into blastocysts derived from 
C57BL/6N mice and the embryos were transferred to pseudo-pregnant foster mothers, 
yielding chimeric males. For ES clone EPD0316_5_A03, germline transmission was 
achieved upon breeding with C57BL/6N females, generating mice harboring the 
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Eportm1a(KOMP)Wtsi allele (termed EporlacZ-neo). The lacZ-neo cassette was excised in vivo 
upon interbreeding with mice expressing FLIP recombinase (129S4/SvJaeSor-
Gt(ROSA)26Sortm1(FLP1)Dym/J; backcrossed into C57BL/6N), yielding mice carrying the 
Eportm1c(KOMP)Wtsi allele (termed Eporflox). The construct validity of this mouse line was 
established using a deleter Ella-Cre mouse line. Breeding the Eporfl/fl mice with Ella-Cre 
mice for two generations led to a global knockout of EPOR in all cells. To recombine the 
Epor gene specifically in projection neurons, exons 3-6 were excised in vivo upon 
appropriate interbreedings of Eportm1c(KOMP)Wtsi mice with mice expressing Cre 
recombinase under control of the Nex/Neurod6 promoter (Goebbels et al., 2006), 
generating mice carrying the Eportm1d(KOMP)Wtsi allele (NexCre::Eporfl/fl mice).  
  
  
All mice were housed in a temperature-controlled environment (21±2°C) on a 12h 
light–dark cycle with food and water available ad libitum. Male mice of the same age 
were used for the experiments, unless stated otherwise.  
Summary of the mouse lines used in the project is listed below.  
Figure 21. Generation of EPORfl/fl mice. 
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Table 4. Various transgenic mouse models used in this thesis. 
 
3.1.2. Breeding strategy. 
Multiple transgenic (CreERT2) mice were used, in which CreERT2 recombinase (Box. 8) 
is functionally active in the presence of its ligand, i.e. tamoxifen.  
Box. 8. Cre-ERT2 
 
Cre-ERT2 is a ligand dependent chimeric Cre recombinase where a mutated form of 
human estrogen receptor (ER) ligand binding domain (LBD) is fused to Cre-
recombinase (Feil et al., 1997; Indra et al., 1999). In the chosen mutant Cre-ERT2, the 
mutation is such that Cre-ERT2 can be activated by the synthetic ligands Oestrogen 
4-hydroxytamoxifen (OHT), ICI or tamoxifen (TM), but remains insensitive to E2 (17β-
oestradiol), which is endogenous present in mice. Like Cre-recombinase, Cre-ERT2 is 
a site-specific recombinase that recognizes and binds to specific sites called LoxP 
(Nagy, 2000). Two IoxP sites recombine in the presence of Cre, allowing the DNA 
cloned between two such sites to be removed by Cre-mediated recombination after 
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This CreERT2 recombinase is placed under the control of a regulatory element of a cell 
type specific gene. These mice were bred with a reporter mouse, which contains an 
inactive TdTomato reporter gene that upon tamoxifen administration is activated in 




The genotypes of newborn pups were determined using specific primers. The DNA was 
extracted from the tail tips or ear biopsies as per the manufacturer’s protocol. Briefly, 
the biopsies or tail tips were cut into 25mg pieces and pre-lysis was performed at 56°C 
for 1-3 hours in the presence of 180µl T1 buffer supplemented with 25µl Proteinase K 
solution, with constant shaking. 200µl of B3 buffer was added to the samples and kept 
at 70°C for 10min. To enable DNA binding, 210µl of 96-100% ethanol was added to the 
samples and vortexed vigorously. Next, the sample was loaded in a Nucleospin® Tissue 
Column placed in the collection tube and centrifuged for 1min at 11000xg. Subsequent 
Figure 22. Breeding strategy for the generation of inducible double transgenic mice. 
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washes with 500µl of BW buffer and 600µl of B5 buffer were performed followed by 
centrifugation at 11000xg after each wash. Residual ethanol is removed by 
centrifugation for 1min at 11000xg. The DNA was eluted by adding 100µl of pre-
warmed (70°C) BE buffer to the column which was maintained at room temperature 
for 1min followed by centrifugation at 11000xg for 1min. 
 
Table 5. Composition of contents for genotyping. 
 
 
Table 6. Sizes of expected bands after genotyping. 
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Table 7. PCR procedure. 
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3.2. In-vitro cell cultures. 
3.2.1. Hippocampal neuronal culture. 
 
Pregnant mice were sacrificed by cervical dislocation and hippocampal neurons were 
isolated from embryos at E17 (Embryonic day 17). Firstly, the embryos were 
decapitated and placed into a dish with Hanks balanced salt solution (HBBS) 
(Invitrogen, 14060-40) containing 1% Penicillin/Streptomycin (PAA, P11-010) and 0.7% 
1M HEPES buffer (Invitrogen, 15630-056). The hippocampi were isolated and 
dissociated with pre-warmed trypsin (Invitrogen, 25300-054) solution for 5min at 37°C. 
Following washes with warm HBBS, the hippocampi were mechanically titurated and 
added to the MEM medium (Invitrogen, 21430-020) supplemented with 0.2% Sodium 
Bicarbonate (Invitrogen, 25080-060), 0.6% Glucose (Sigma, G-6152, anhydrous), 1mM 
Sodium Pyruvate (Invitrogen, 11360-039), 1% Pen/Strep (PAA, P11-010), 1% L-
Glutamine (PAA, M11-004) and 2% B27 (Invitrogen, 17504-044). Single dissociated cells 
(25,000 cells/well) were then plated on glass coverslips pre-coated with 0.05mg/ml 
Poly D-Lysine (Sigma, 7280) and incubated with complete MEM medium for 5 days at 
37°C with 5% CO2. 
3.2.2. Microglia culture. 
 
Microglia were isolated from the brains of P1 (post-natal day 1) mice. The meninges 
and cerebellum were excluded and the brain was digested using 0.05% trypsin/EDTA 
for 10min at 37°C. Following the trypsinization procedure, the cells were washed with 
pre-warmed HBBS and mechanically triturated with DMEM (Invitrogen, 41965-039) 
microglia medium containing 10% horse serum (Invitrogen, 26050-070) and 0.5% 
Pen/Strep and supplemented with 400 IU/brain of DNaseI (Invitrogen, 18068015). The 
dissociated cells were then centrifuged for 10min at 150g at room temperature. The 
cells were plated in 75cm2 flask pre-coated with 50µg/ml Poly D-Lysine.  The cells were 
maintained in complete DMEM microglia medium at 37°C, 5% CO2. The medium was 
replaced every 2-3 days. On day 5 and day 7, microglia cultures were treated with L929 
mouse fibroblast culture conditioned DMEM medium (1:3; 10% Fetal Calf Serum and 
1% Pen/Strep). The microglia were then detached by manual shaking of the flasks and 
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centrifuged for 10min at 800rpm. The cells were then seeded in DMEM medium 
supplemented with 1mM Sodium Pyruvate and 0.5% Pen/Strep until further analyzed. 
3.2.3. Oligodendrocyte culture. 
 
Oligodendrocytes were isolated from the brains of P1 newborn mice. The meninges 
and cerebellum were excluded and the brain was digested using 0.05% trypsin/EDTA 
for 10min at 37°C. Following trypsinization, the cells were washed with pre-warmed 
HBBS and mechanically triturated to obtain single cells. The cells were then plated in 
75cm2 flasks pre-coated with 50µg/ml Poly D-Lysine containing BME medium 
(Invitrogen, 41010-026) supplemented with 10% horse serum, 0.5% Pen/Strep and 1% 
Glutamax (Invitrogen, 35050-038). The cells were then maintained at 37°C, 5% CO2 and 
half of the medium was replaced every 3-4 days. On DIV 8, the oligodendrocytes were 
detached by manual shaking of the flasks and centrifuged for 10min at 900rpm. The 
cell number was quantified and 30,000 cells/well were plated on coverslips pre-coated 
with 50µg/ml Poly D-Lysine. The cells were maintained in Super-SATO medium 
containing DMEM medium, 2% B27, 1% Glutamax, 0.5% Pen/Strep, 1% horse serum, 
1% Pyruvate (Invitrogen, 11360-039) solution, 0.01% Triiodthyronin (Calbiochem, 
64245) solution and 0.013% L-Thryonin (Sigma, T1775) solution until further analyzed.  
3.2.4. Astrocyte culture. 
 
Astrocytes were isolated from the brains of P1 newborn mice. The meninges and 
cerebellum were excluded and the brain was digested using 0.05% trypsin/EDTA for 
10min at 37°C. Following trypsinization, the cells were washed with pre-warmed HBBS 
and mechanically triturated to obtain single cells. The cells were then plated in 75cm2 
flasks pre-coated with 50µg/ml Poly D-Lysine containing Astrocytes DMEM medium 
(Invitrogen, BE12707F) supplemented with 20% Fetal Calf Serum (FCS; heat 
inactivated) and 0.5% Pen/Strep. The cells were then maintained at 37°C, 5% CO2 and 
half of the medium was replaced every 2 days. On DIV 14, the astrocytes were detached 
by manual shaking of the flasks and centrifuged for 5min at 800rpm. The cell number 
was quantified and 150,000 cells/well were plated in flasks pre-coated with 50µg/ml 
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Poly D-Lysine. The cells were maintained in Astrocytes DMEM medium supplemented 
with 10% FCS and 0.5% Pen/Strep until further analyzed. 
3.3. Quantitative Real-Time PCR (qRT-PCR). 
3.3.1. RNA extraction. 
 
After 6h of treatment with either placebo or EPO, P28 old mice were anesthetised with 
0.5ml Avertin (1g tribromomethanol and 1ml of tetramylalcohol in 71.49ml millQ 
water). The hippocampi were dissected and stored at -80°C before RNA extraction. As 
a comparative study, RNA was also extracted from cultured cells (microglia, astrocytes, 
oligodendrocytes and E17 hippocampal neurons). The RNA extraction was performed 
via miRNeasy mini kit (Qiagen) following the manufacturer’s instructions. Briefly, the 
tissue or cells were homogenised or lyzed in Qiazol via mechanical disruption (tissue) 
or passing through syringes (cells), followed by the addition of chloroform for 2-3min. 
The samples were then centrifuged at 12000xg for 15min at 4°C to separate the RNA 
from DNA and protein content. The RNA concentration was measured with a 
photometer to detect the sample absorbance at OD260nm and the purity of RNA was 
evaluated via the ratio of OD260/OD280. 
3.3.2. cDNA synthesis and qRT-PCR. 
 
RNA was reverse transcribed using a RNA concentration of 20ng/µl for cells and 
100ng/µl for tissue, mixed with 0.6 pmol oligo dT-mix (AGCTlab, MPIem) and 50 pmol 
of hexamers (Invitrogen, N8080127). Annealing was performed at 70°C for 2min. The 
CDNA was then synthesized using SuperScript® III kit (Invitrogen, 18080051) according 
to manufacturer’s guidelines. The resulting cDNA was diluted to 1:5 (cells) and 1:10 
(tissue). 4µl of the diluted cDNA was used as template followed by the addition of 6µl 
of master mix containing specific primers (1pmol/µl) and 10µl of SYBR Green (Qiagen, 
204143) mix. Triplicates for each sample along with housekeeping genes such as 
GAPDH or β-actin were used. This reaction was run in Roche Lightcycler 480 and results 
were analyzed using LightCycler® 480 Software. The PCR cycle used and the sequence 
of primers are listed below. 
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Table 9. qRT-PCR procedure. 
 
 
Table 10. Forward and Reverse primers used for RT-PCR. 
 
3.4. Mouse treatments. 
3.4.1. Tamoxifen. 
Tamoxifen solution (10mg/ml) was freshly prepared by dissolving tamoxifen freebase 
(Sigma) in corn oil (Sigma) at room temperature for 45min. Postnatal CreERT2 activity 
in NexCreERT2, GliCreERT2, NestinCreERT2 and SoxCreERT2 mice was induced by a 
total of 5 intraperitoneal injections (i.p.) of 100mg/kg tamoxifen over the course of 
3days in juvenile mice. For CreERT2 induction in adult NexCreERT2 mice, a total of 10 
i.p. injections of 100mg/kg tamoxifen were administered over the course of 10 
consecutive days. For the desired induction of CreERT2 in CAGCreERT2-ODD mice, a 
single i.p. injection of 100mg/kg tamoxifen was sufficient.  
3.4.2. EPO. 
Male mice were i.p. injected with 5000IU/kg rhEPO (NeoRecormon, Roche) or placebo 
(solvent solution, 0.01ml/g). At 48h after the last tamoxifen injection, EPO/placebo 
treatment was initiated in P28 or 3months-old NexCreERT2, Thy1-YFPH mice and in P28 
old WT and NexCreEPORfl/fl mice, which was carried out every other day for 3 weeks. 
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For Drop-Seq analysis, EPO was administered once followed by tissue collection 6h 
later. Additionally, for labeling of proliferating cells, NexCreERT2 mice obtained 5-
Ethynyl-2'-deoxyuridine (EdU; 0.2mg/ml; ThermoFisher) via drinking water (exchanged 
on all alternate days).  
3.4.3. Hypoxia. 
The hypoxia chamber was designed in cooperation with Coy Laboratory Products Inc. 
(Grass Lake, MI, USA) with the dimensions 164cm x 121cm x 112cm. The system 
includes an air filtration system consisting of carbolime and activated charcoal. The 
oxygen and carbon dioxide levels were constantly detected and controlled via online 
monitoring. A gradual reduction of 3% oxygen per day resulted in 12% oxygen level in 
3 days and was maintained until the end of the experiment. During the course of the 
experiment, mice were treated with EdU via drinking water as described above. 
  
  
3.4.4. Complex running wheels (CRW). 
Post weaning, mice were single-housed and tamoxifen treatment was initiated for 
NexCreERT2::TdTomato mice (described above). NexCreERT2::TdTomato, 
NexCreEPORfl/fl mice were divided into 4 groups and monitored for 17 days. Groups 
included (1) normoxic room conditions (at 21% O2) in standard cages, (2) normoxic 
conditions with  voluntary running on CRW, (3) hypoxic conditions (hypoxia chamber 
to 12% O2) in standard cages, (4) hypoxic conditions with voluntary running on CRW. 
Figure 23. Hypoxia chamber used for experiments in this thesis. 
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CRW (TSE Systems, Bad Homburg, Germany) is characterized by randomized missing 
bars as previously described (Hibbits et al., 2009; Liebetanz et al., 2007; McKenzie et 
al., 2014). The testing period of 17 days was followed by 1 week of normal conditions 
for all groups (no running, normoxia). The mice that were previously running (in 
normoxic or hypoxic conditions) were finally exposed again to CRW for 4h (as cFos 
inducing challenge) before being sacrificed. For in-situ hybridization experiments, male 
WT mice (P55) were exposed to 5h, 9h, or 13h of CRW. For the experiment involving 
CAGCreERT2-ODD::TdTomato mice, animals were exposed to overnight complex wheel 
running. Running was voluntary at all times with ad libidum access to food and water. 
Control mice (no running) were housed in standard cages. Mice were sacrificed, 
perfused and brains collected as described below. Running was tracked automatically 
via Phenomaster software (TSE Systems, Germany) for the whole day. Since mice are 
mainly night-active (dark-phase), the total distance run between 6pm and 6am was 
summarized for every individual animal. The total distance run on each night was 
normalized to the average distance of each animal run in the first 3 nights (data 
expressed as % performance in relation to the first 3 nights). For the experiments 
involving EPO treatment, mice were treated with EPO (5000IU/kg, 11 i.p. injections on 
alternate days for 3 weeks), followed by 1 week break. They were then exposed to 12h 
of CRW overnight. Data for this experiment are expressed as distance run summarized 
for every 30min.    
3.5. Immunohistochemistry (IHC). 
Mice were anesthetized and perfused transcardially with 4% cold formaldehyde. 
Dissected brains were post-fixed in 4% formaldehyde at 4°C and equilibrated in 30% 
sucrose dissolved in phosphate-buffered saline (PBS) at 4°C overnight. Brains were then 
embedded in cryoprotectant (O.C.T.TM Tissue-Tek, Sakura) and stored at -80°C. Whole 
mouse brains were cut into 30μm thick coronal sections (coordinates from bregma: 
−1.34 to −2.54mm posterior) using a cryostat (Leica) and stored in a cryoprotective 
solution (25% ethylene glycol and 25% glycerol in PBS) at -20°C until further use. For 
analysis of dendritic spines and MAP2 dendrites, the right hemisphere, destined to the 
neuronal structural analysis, was cut in 100μm coronal sections with a vibratome (Leica 
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VT 1000E, Leica), collected in 3 subseries and stored at 4ºC in PB 0.1M with sodium 
azide (0.05%).  
For IHC, sections were permeabilized in PBS containing 0.3% Triton X-100 and blocked 
in 5% horse serum for 1h at room temperature. Brain sections were incubated with 
primary antibodies in blocking solution overnight at 4°C, followed by 2h incubation of 
appropriate fluorophore-conjugated secondary antibodies in blocking solution 
containing 3% horse serum (or 5% normal donkey serum) and counterstained with 4′,6-
diamidino-2-phenylindole (DAPI). The sections were then mounted on SuperFrostPlus 
Slides (ThermoFisher) with Aqua-Poly/mount (Polysciences, Inc). Primary antibodies 
used were: anti-Ctip2 (1:500; Guinea pig polyclonal; SYSY 325005), anti-Map2 (1:1000; 
mouse monoclonal; Sigma M9942), anti-TBR1 (1:200; rabbit monoclonal; Abcam 
ab183032), anti-Tle4 (1:200; rabbit polyclonal; Abcam ab64833) and anti-cFos (1:1000; 
rabbit polyclonal; SYSY 226003). Secondary antibodies used were: Alexa488 anti-
Guinea pig (1:500; Jackson Immuno Research 706-548-148) and Alexa635 anti-mouse 
(1:400; ThermoFisher A31575). Depending on the need for a triple or a quadruple 
staining, Alexa405 anti-rabbit (1:1000; Abcam 175652) or Alexa647 anti-rabbit (1:500; 
ThermoFisher A31573) were used. Following IHC, sections were stained for EdU using 
Click-iTTM EdU Alexa FluorTM 647 Imaging kit (ThermoFisher E10415), according to the 
manufacturer’s instructions.  
 
Table 11. List of primary antibodies used in this thesis. 
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3.6. Imaging and analysis. 
3.6.1. Pyramidal neurons. 
Imaging was performed using the Andor Eclipse TiE microscope system (Nikon, Tokyo, 
Japan) with a 40x objective (Plan Apoλ40x, NA = 0.95) to image the hippocampal layers. 
Ctip2+ cells among total neuron numbers were manually counted. Ctip2+ and 
TdTomato- cells were characterized as newly generated neurons. Quantifications are 
expressed as number of newly generated neurons divided by the total area of CA1 
stratum pyramidale (mm2). For Ctip2 stainings, a total of 16 hippocampi with 8 sections 
per animal were used. Quadruple (TdTomato, Ctip2, cFos and EdU) stainings were 
acquired with a TCS SP5-II System (Leica) equipped with a 20x objective (NA=0.70). For 
total Ctip2 positive cell counts, 6 hippocampi from 3 sections per animal were used. 
Quantifications for CRW mice were expressed as percentage of Ctip2 positive cells 
normalized to their respective non-running controls. Whole hippocampi were imaged 
and analyzed by Fiji software. Neurons showing positive immunoreactivity for cFos 
were identified and quantified manually. These neurons were further sub-categorized 
into pre-existing (cFos+, TdTomato+, Ctip2+) or newly generated (cFos+, TdTomato-, 
Ctip2+) neurons. Again, quantifications are indicated as cFos+ cells divided by the total 
area of the CA1 stratum pyramidale (mm2). For cFos stainings, a total of 8 hippocampi 
with 4 sections per animal were used. For quantification of hypoxic neurons, whole 
hippocampus sections of CAGCreERT2-ODD::TdTomato mice were imaged. The 
TdTomato+ cells were characterized as neurons undergoing hypoxia and manually 
quantified. Quantifications are expressed as number of hypoxic neurons divided by the 
total area of CA1 stratum pyramidale (mm2). A total of 10 hippocampi with 5 sections 
per animal were used. The cFos+ cells were also analyzed as described above. For 
Map2+ dendritic density analysis, the stratum radiatum of the CA1 region was imaged 
using a laser scanning confocal microscope (Leica TCS SPE). Per animal, 3 dorsal 
hippocampal slices were selected starting at bregma -1.58mm. Confocal z-stacks 
(0.38µm intervals) of whole sections were taken using a 63x objective (NA=1.40). Per 
hippocampus, 3 images were captured, and 4 fields of the dimension 
36.67µmx36.67µm were analyzed in each image (total 36 fields per animal). Images 
were processed using Fiji software and Map2+ principal apical dendrites were manually 
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quantified. The quantifications are expressed as number of Map2+ dendrites divided by 
the area of each image (1344.7m2). 
3.6.2. Dendritic spines. 
Images were captured using a 63x oil immersion objective (NA=1.40) and a 3.5x 
additional digital zoom to investigate the first 200µm of the principal apical dendrite in 
segments of 50µm. Confocal z-stacks (0.38µm intervals) of whole sections were 
performed. Dendrites included in the study were at least 200µm in length. Per animal, 
6 such dendrites of 6 different Thy1-YFPH expressing pyramidal neurons were 
randomly selected from the CA1 region. The stitching plugin in Fiji software (2.0.0) was 
used to reconstruct 3D images of the apical dendrites. The spines were further sub-
categorized as proximal (0–50µm), medial (50–100µm), medial-distal (100–150µm) 
and distal (150-200µm) segments of the dendrite, depending on their distance from 
the soma. The total density of spines was also analyzed. Based on their morphology 
(Guirado et al., 2013; Kasai et al., 2010), the spines were manually divided into (1) 
stubby, i.e. length of the protrusion was <1µm and no neck is observed; (2) mushroom, 
when a clear head-like structure could be observed (maximum diameter of the head 
was at least 1.5 times the average length of the neck) and the total length of the 
protrusion was <1.5µm; and (3) thin, i.e. the length of the protrusion was >1.5µm or 
the length was between 1 and 1.5µm  and a clear head-like structure could not be 
distinguished.  
3.6.3. RNAscope in-situ hybridization (ISH).  
RNAscope® 2.5 HD Brown Reagent Kit (322300), Advanced Cell Diagnostics (ACD), 
Hayward, CA, USA was used for the detection of EPO and EPOR mRNA. ISH was 
performed according to the manufacturer’s instructions. Briefly, coronal cryosections 
of 15µm thickness were mounted on SuperFrostPlus Slides, dried and stored at -80°C. 
Sections were then pretreated by dropwise addition of hydrogen peroxide and 
incubated for 10min at room temperature. Slides were immersed in boiling target 
retrieval buffer for 15min, followed by incubation with protease plus for 30min at 40°C. 
Sections were then hybridized with the corresponding target probe Mm-Epo-01 
(444941) or Mm-Epor (412351) for 2h at 40°C, followed by a series of amplification and 
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washing steps. Chromogenic signal detection was performed with 3,3'-
diaminobenzidine (DAB) incubation for 20min at room temperature. Sections were 
counterstained with 50% Mayer’s hemalum (Merck) and mounted with EcoMount 
(BioCare Medical). Brown punctate dots in the CA1 were counted in a total of 12 
hippocampi with 6 sections per animal using a light microscope (Olympus BX-50, Tokyo, 
Japan) equipped with a 100x oil immersion objective (NA=1.35) and normalized to the 
area of the respective region (mm²). Sagittal 15µm sections from kidney (P55) and 
heart (E11.5) of WT mice were used as positive controls for EPO and EPOR, respectively. 
According to manufacturer’s instructions, each dot represents a single molecule of 
mRNA in these sections. The quantification is normalized and presented as percentage 
of the mean dot number of groups and time points [% value = (number/mm²)/(mean 
dot number/mm²) *100].  
3.7. Drop sequencing. 
3.7.1. Tissue dissociation.  
Juvenile male WT mice (P28; 3 mice/group) were injected i.p with EPO and sacrificed 
after 6h. The hippocampi were dissected and sliced into 600µm sections using McIlwain 
Tissue chopper (Cavey Laboratory Engineering Co. Ltd). The CA1 region was digested 
with a working solution of Papain/DNaseI in Earle’s Balanced Salt Solution, according 
to manufacturer’s instructions (Worthington Biochemical Corp). The samples were 
then incubated at 37°C for 40min with constant agitation before gentle manual 
trituration. The samples were centrifuged for 10min at 200g at 4°C. After discarding 
the Papain/DNaseI supernatant, cells were resuspended in 1mL of sterile DMEM/F12 
(Sigma) without phenol-red containing 3% fetal bovine serum (FBS; Life Technologies) 
and the suspension was passed through a 40µm strainer cap (Corning) to yield a 
uniform single-cell suspension. 
3.7.2. Single-cell barcoding and library preparation.  
Barcoded single cells, or STAMPs (single-cell transcriptomes attached to 
microparticles), and cDNA libraries were generated following the protocol (Macosko et 
al., 2015). Briefly, single cell suspensions (100cells/μl), droplet generation oil (Bio-Rad) 
and barcoded microparticles (ChemGenes; 120beads/μl) were co-flowed through a 
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FlowJEM aquapel-treated DropSeq microfluidic device (FlowJEM) and droplets were 
generated for 15min. Captured RNA on the bead surface was recovered by washing the 
beads in saline-sodium citrate buffer (SSC) and perflurooctanol (PFO) solutions and 
then reverse transcribed using Maxima H minus reverse transcriptase kit 
(ThermoFisher). Excess primer on the surface of the bead uncaptured by an RNA 
molecule was digested using Exonucleases I kit (ThermoFisher). A cDNA amplification 
PCR was performed using 10µM SMART PCR primer and 2X Kapa HiFi HotStart 
ReadyMix (Kapa Biosystems) with 5000 beads per tube and amplified for 9 PCR cycles. 
The resulting samples were purified using AMPureXP beads (Beckman Coulter) and the 
quality and concentration of the cDNA was assessed using High sensitivity DNA 
bioanalyzer (Agilent Technologies). Library sizes were adjusted using the Nextera 
Amplicon Tagmentase enzyme and DNA was amplified for 14 cycles using 10µM New-
P5-SMART PCR hybrid oligo, 10µM Nextera Index and the Nextera PCR mix (Nextera XT 
DNA Library Preparation kit; Illumina). Tagmented libraries were again purified 
(AMPureXP), quality controlled (high sensitivity DNA Bioanalyzer), quantified (Qubit 
dsDNA HS assay kit; Life Technologies) and sequenced (Illumina Hi-seq 2500). All assays 
mentioned above have been performed according to manufacturer’s protocol.  
3.7.3. Single cell RNA-seq processing. 
Unique molecular identifier (UMI) gene counts for each group (placebo or EPO) was 
imported into R (v3.4.1). Seurat (v2.3.0) function within the R environment was used 
for filtering, normalization, canonical correlation analyses, unsupervised clustering, 
visualization and differential expression analyses.  
3.7.4. Filtering and data normalization.  
Cells with minimum and maximum of 1,000 and 8,000 genes expressed (≥ 1 count), 
respectively, and the genes that were expressed in at least 3 cells were retained. Cells 
with more than 40% of counts on mitochondrial genes were excluded. After filtering, 
there were 14,061 genes in 390 cells from placebo and 14,971 genes in 583 cells from 
EPO group. Gene UMI counts for each cell were normalized via natural-log 
normalization of gene UMI counts divided by total UMI counts per cell and scaled by 
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10000. After normalization, scaled expression (z-scores for each gene) for downstream 
analyses was calculated. 
3.7.5. Canonical correlation analysis. 
Integration of scRNA-seq data from two groups (placebo and EPO) was performed 
using canonical correlation analysis (CCA). Top 1000 highly variable genes from each 
group was used to calculate canonical correlation vectors (reduced dimension) and 
subsequently, first 20 vectors were aligned using dynamic time warping. 
3.7.6. Clustering and visualization. 
Clustering was performed using “FindClusters” function with default parameters with 
resolution set to 1 and first 20 CCA aligned dimensions were used in the construction 
of the shared-nearest neighbor (SNN) graph and to generate 2-dimensional 
embeddings for data visualization using t-SNE. Based on the visualization the 
glutamatergic cluster 0 and 1 were merged manually to represent a single cluster. The 
percentages of ‘immature glutamatergic cells’ for each mouse were placebo 1.6%, 2.3% 
and 4.3%, EPO 3.7%, 6.8% and 7.0%. 
3.7.7. Cell trajectory (pseudotime) analysis. 
Trajectory analysis of cells from the ‘Immature Glutamatergic’ and ‘Mature 
Glutamatergic1’ clusters (n=502) was performed in Monocle 223. The trajectory was 
constructed according to the documentation of Monocle 2. Prior to cell ordering, re-
clustering was performed to confirm robust detection of the immature cluster across 
methods which revealed 3 clusters (1 cluster largely corresponding to Seurat’s 
‘Immature Glutamatergic’ cluster and 2 corresponding to Seurat’s ‘Mature 
Glutamatergic1’ cluster; Supplementary Fig3a). Subsequently, dimension reduction 
using the ‘DDRTree’ method was performed. Differentially expressed genes (q<0.01) 
between the 3 clusters obtained by re-clustering in Monocle 2 were used as input for 
pseudotemporal ordering. 
3.7.8. Differential expression and gene ontology (GO) analyses. 
 “FindAllMarkers” function was used with default parameters and tested genes with a 
detected threshold of minimum of 25% of cells in either of the 2 clusters. Genes with 
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an adjusted p value <0.01 were considered to be differentially expressed. GO analysis 
was conducted using WEB-based Gene SeT Analysis Toolkit (WebGestalt 2013). Entrez 
protein-coding genes were used as background. An adjusted p value <0.05 using the 
Benjamini–Hochberg method for controlling the false discovery rate was set as 
significant for GO terms in biological processes.  
3.8. Quantification and statistical analysis. 
 
All statistical analysis was performed using GraphPad Prism 5. For comparisons across 
multiple groups, a 2-way analysis of variance (ANOVA) was used. For comparisons 
across 2 groups, an unpaired Student’s t test was performed. A p value<0.05 is 
considered statistically significant. Variance was similar between compared groups for 
their respective experiments. All values represent mean ± SEM (standard error of the 
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4. Results. 
4.1. Effect of EPO on neural precursors.  
4.1.1. EPO induced increase in pyramidal neurons is not mediated via Nestin 
positive precursors. 
 
Nestin is an intermediate filament protein expressed by radial glial cells, neural stem 
cells (NSCs) and neural progenitor cells (NPCs). Most glutamatergic neurons arise from 
Nestin positive progenitors situated in the sub-ventricular zone (SVZ) lining the lateral 
ventricles and the sub-granular zone (SGZ) within the dentate gyrus (DG) of the 
hippocampus during embryogenesis . The Nestin positive progenitors located in these 
stem cell niches have the capacity to proliferate and differentiate into neurons. A 
significant increase in the number of pyramidal neurons in the CA1 region of P55 mice 
hippocampi, when EPO was intraperitoneally administered for three weeks was 
previously recorded (Hassouna et al., 2016). Based on the literature, Nestin appeared 
to be a promising progenitor candidate that could give rise to these newly generated 
neurons under the influence of EPO. For this purpose, an inducible NestinCreERT2 
mouse line was crossed with a TdTomato (R26R-TdTomato) reporter mouse line.  
Following the similar treatment regimen as previously published by Hassouna et al., 
2016, with minor modifications, creERT2 activity was induced in 
NestinCreERT2::TdTomato mice by injecting them with tamoxifen (100mg/kg; 1x 
injection daily from P23-P27; Fig. 24A). The tamoxifen treatment labelled Nestin 
positive cells with TdTomato reporter tag. The tamoxifen administration was followed 
by 11 injections of either placebo or EPO (5000IU/kg; on alternate days from P28-P48). 
The mice were sacrificed as mentioned in Hassouna et al., 2016; at P55. Upon 
sectioning and staining of P55 brains, no TdTomato positive cells (red) were observed 
in the CA1 region of the hippocampus of either placebo or EPO treated mice (Fig. 24B-
C).  
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Figure 24. Multiple EPO treatment does not give rise to TdTomato positive neurons in 
NestinCreERT2::TdTomato mice, but decreases the Nestin cell numbers in the SVZ of the 
DG. (A) Experimental schematic where 5 i.p. injections of tamoxifen were administered from 
P23-P27 in NestinCreERT2::TdTomato mice, followed by 11 i.p. injections of either placebo 
or EPO (on alternate days) from P28-P48. Mice were then sacrificed at P55. (B) 
Representative images of the hippocampus at P55 of placebo or EPO treated 
NestinCreERT2::TdTomato mice, showing positive signal for Nestin as labelled by TdTomato 
(red) in the alveus of hippocampus (ALV) and the Sub-Granular Zone (SVZ). Nuclei were 
counterstained using DAPI (blue). Scale bar: 100µm. (C) Quantification of TdTomato 
labelled Nestin positive cells at P55 in the CA1, ALV and SVZ of placebo (black) and EPO (red) 
treated NestinCreERT2::TdTomato mice. Data represents average number of cells ± SEM. 
Quantification performed from 3-4 independent mice and p-values presented via unpaired 








Interestingly, after quantification of TdTomato positive cells, a significant decrease in 
the number of Nestin positive cells in the SGZ of the dentate gyrus of the EPO treated 
mice was observed as compared to the placebo treated group (Fig. 24C). Furthermore, 
no difference in the number of Nestin positive cells in the Alveus (ALV) of EPO or 
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placebo treated mice (Fig. 24C) was recorded. This data together, suggest that Nestin 
progenitors may give rise to neurons, which migrate to other regions of the brain, but 
not to the newly generated neurons found in the pyramidal layer of the CA1 upon EPO 
treatment.  To completely rule out this possibility, another experiment was performed, 
where the hypothesis was that our approach might be too late for labelling the Nestin 
positive cells after 11 EPO or placebo injections, and therefore, decided to fate map 
the Nestin positive progenitors with only a single high dose of EPO. The mice were as 
before treated with 5x injections of tamoxifen (P23-P27), followed by 1x injection of 
placebo or EPO (P28), and the mice were sacrificed at P55 (Fig. 25A). However, after 
sectioning and staining, no TdTomato positive cells in the CA1 region of the hippocampi 
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These results suggest that the increase in the number of pyramidal neurons upon EPO 
administration might not be mediated by Nestin positive type II radial glial progenitors, 
at least the ones labelled by the transgenic Nestin mouse line used in this thesis. As a 
control experiment for ectopic expression and to determine the robustness and 
efficiency of the transgenic NestinCreERT2::TdTomato mouse line, these mice were 
injected with only a carrier solvent i.e. corn oil (1x injection daily from P23-P27), instead 
of tamoxifen (Fig. 25C), and observed no signal for any unspecific TdTomato expression 
when sacrificed and stained at P28 (Fig. 25D).   
4.1.2. EPO regulates the differentiation of Gli positive precursors into astrocytes, 
but not neurons. 
 
As mentioned in the introduction, Gli positive precursors located in the SGZ of the 
hippocampus are implicated in adult neurogenesis (Ahn and Joyner, 2005). Sonic 
Hedgehog (SHH) signaling pathway plays a critical role during adult neurogenesis and 
acts a potent mitogen capable of giving rise to both neurons and oligodendrocytes (Lai 
et al., 2003). These Gli positive SHH responsive NSCs have the ability to proliferate and 
differentiate into neurons (Ahn et al., 2005). In-vitro experiments revealed the role of 
SHH signaling pathway in mediating the effects of EPO in regulating neuronal 
differentiation (Wang et al., 2007). Considering the available literature, Gli was 
considered as a good candidate for in-vivo lineage tracing experiments using EPO as a 
stimulator. In order to accomplish these experiments, an inducible GliCreERT2 mouse 
line was obtained and crossed with a TdTomato (R26R-TdTomato) reporter mouse line. 
Figure 25. Fate mapping of NestinCreERT2::TdTomato mice upon single dose of EPO does 
not give rise to neurons in the CA1. (A) Experimental schematic where 5 i.p. injections of 
tamoxifen were administered from P23-P27 in NestinCreERT2::TdTomato mice, followed by 
1 i.p. injection of either placebo or EPO on P28. Mice were then sacrificed at P55. (B) 
Representative images of the hippocampus at P55 of placebo or EPO treated 
NestinCreERT2::TdTomato mice, showing positive signal for Nestin as labelled by TdTomato 
(red) in the Alveus (ALV) and the Sub-Granular Zone (SVZ). (C) Experimental schematic 
where 5 i.p. injections of corn oil were administered from P23-P27 and mice was sacrificed 
at P28. (D) Representative image of the hippocampus at P28 of oil-treated 
NestinCreERT2::TdTomato mice, showing no signal for TdTomato (red). Nuclei were 
counterstained using DAPI (blue). Scale bar: 100µm. 
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Similar to previous experiments with NestinCreERT2::TdTomato mice, the protocol 
published by Hassouna et al., 2016 was followed. The GliCreERT2::TdTomato mice 
were injected with tamoxifen (1x injection daily from P23-P27) to label Gli positive 
precursors with TdTomato reporter. This was followed by 11x i.p. injections of placebo 
or EPO (alternate days from P28-P48) and mice were sacrificed at P55 (Fig. 26A). Upon 
sectioning and staining, no Gli positive cells in the CA1 region of the hippocampus in 







 RESULTS – EFFECT OF EPO ON NEURAL PRECURSORS 
 
  










Surprisingly, after quantification, a significant increase in the number of Gli positive 
cells in the stratum radiatum (SR) and in the alveus of hippocampus was recorded, but 
only an increased trend in the SGZ of the hippocampus after EPO treatment as 
compared to the placebo treated mice (Fig. 26C). However, upon staining these 
sections with a neuronal marker NeuN (green),  none of the NeuN positive neurons 
showed TdTomato expression, suggesting that Gli positive precursors did not give rise 
to the newly generated neurons in the CA1 upon EPO treatment (Fig. 26D). Moreover, 
labeling with EdU (green) did not reveal any co-localization of Gli positive cells with EdU 
signal (Fig. 26D), suggesting that EPO administration led to a significant increase in the 
number of Gli positive cells without undergoing proliferation. 
Similar to the experiment performed with Nestin mouse line; whether a single dose of 
EPO could have a similar effect on Gli positive precursors at different stages of mice 
development remained to be determined. To achieve this, GliCreERT2::TdTomato mice 
were treated with tamoxifen (P23-P27), followed by a single dose of placebo or EPO 
(P28) and sacrificed at P29, P55 and P120 (Fig. 27A).  
Figure 26. Multiple EPO injections lead to an increase in Gli labelled TdTomato positive 
cells in the GliCreERT2::TdTomato mice without proliferation, but does not give rise to 
CA1 neurons. (A) Experimental schematic where 5 i.p. injections of tamoxifen were 
administered from P23-P27 in GliCreERT2::TdTomato mice, followed by 11 i.p. injections of 
either placebo or EPO (on alternate days) from P28-P48. Mice were then sacrificed at P55. 
(B) Representative images of the hippocampus at P55 of placebo or EPO treated 
GliCreERT2::TdTomato mice, showing positive signal for Gli as labelled by TdTomato (red) 
in the Stratum Radiatum (SR), Alveus of hippocampus (ALV) and the Sub-Granular Zone 
(SGZ). (C) Quantification of TdTomato labelled Gli positive cells at P55 in the SR, ALV and 
SGZ of placebo (black) and EPO (red) treated hippocampi of GliCreERT2:TdTomato mice. 
Data represents average number of cells ± SEM. Quantification performed from 5-7 
independent mice and p-values presented via unpaired Student’s t-test. (D) Representative 
image of the hippocampus at P55 of EPO treated GliCreERT2::TdTomato mice, showing 
positive signal for TdTomato (red) and neuronal marker NeuN (right panel; green) or 
proliferation marker EdU (left panel; green). Nuclei were counterstained with DAPI (blue). 
Scale bars:  100µm.  
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Upon sectioning, staining (Fig. 27B) and quantification, an increase trend in Gli positive 
cells in SR of P29 (Fig. 27C) and P120 (Fig. 27E) mice treated with EPO was observed as 
compared to the age matched placebo control. Similar increased trend was also 
observed in the ALV of P29 (Fig. 27C) mice treated with EPO, but not in P55 (Fig. 27D) 
or P120 (Fig. 27E) EPO treated mice as compared to their respective age matched 
controls. As a control experiment to determine the robustness and efficiency of 
GliCreERT2::TdTomato mouse line, these mice were injected with a carrier solvent i.e. 
Figure 27. Fate mapping over time of GliCreERT2::TdTomato mice upon single dose of 
EPO does not give rise to neurons in the CA1. (A) Experimental schematic where 5 i.p. 
injections of tamoxifen were administered from P23-P27 in GliCreERT2::TdTomato mice , 
followed by 1 i.p. injection of either placebo or EPO at P28. Mice were then sacrificed at 
P29, P55 or P120. (B) Representative images of the hippocampus at P29, P55 and P120 of 
EPO treated GliCreERT2::TdTomato mice, showing positive signal for Gli as labelled by 
TdTomato (red) in the Stratum radiatum (SR), Alveus of the hippocampus (ALV) and the 
Sub-Granular Zone (SGZ). Nuclei were counterstained using DAPI (blue). Scale bar: 100µm. 
(C, D, E) Quantification of TdTomato labelled Gli positive cells at P29 (C), P55 (D) and P120 
(E) in the SR and ALV of placebo (black) and EPO (red) treated hippocampi of 
GliCreERT2::TdTomato mice. Data represents average number of cells ± SEM. 
Quantification performed from 1-4 independent mice and p-values presented via unpaired 
Student’s t-test.  
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corn oil (1x injection daily from P23-P27; Fig. 28A), and observed no signal for any 





Although the Gli positive precursors did not give rise to any new neurons under the 
influence of EPO treatment, the identity of these Gli positive cells remained unknown. 
Following similar treatment regime as described previously by Hassouna et al., 2016, 
mice were injected with tamoxifen (P23-P27), followed by 11x injections of placebo or 
EPO (P28-P48) and sacrificed these mice at P55. Upon labelling these cells with 
astrocytic markers (GFAP and s100β; green) and oligodendrocyte maker (PDGFRα; 
green), TdTomato signal co-localized with these respective markers (Fig. 29A, 29C and 
29E).  After quantification of cells where signal of these markers and TdTomato co-
localize, an increase trend in the number of Gli+/GFAP+ cells in the SR region (Fig. 29B) 
of the hippocampus of EPO treated mice was recorded as compared to the placebo 
treated mice.  
Figure 28. No unspecific TdTomato expression observed in Oil injected control 
GliCreERT2::TdTomato mice. (A) Experimental schematic where 5 i.p. injections of corn oil 
were administered from P23-P27 and mice was sacrificed at P28. (B) Representative image 
of the hippocampus at P28 of corn oil-treated GliCreERT2::TdTomato mice, showing no 
signal for TdTomato (red). Nuclei were counterstained using DAPI (blue). Scale bar: 100µm. 
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Moreover, significant reduction in the number of Gli+/s100β+ cells was observed in the 
SR region of the hippocampus after EPO treatment (Fig. 29D). On the other hand, no 
difference in the number of Gli+/PDGFRα+ cells in the SR region of the hippocampus 
was observed after EPO treatment (Fig. 29F). Similarly, no difference was recorded in 
the number of positive cells in the ALV region of the hippocampus after EPO treatment 
(Fig. 29B, 29D and 29F). The increase trend in Gli+/GFAP+ cells in the SR region of the 
hippocampus was as expected because Gli, expressed primarily by type I and type II 
Figure 29. TdTomato labelled Gli positive cells co-localize with other cell types in the 
hippocampus upon multiple placebo or EPO injections. (A; C; E) Representative images of 
the hippocampus at P55 of EPO treated GliCreERT2::TdTomato mice, showing positive 
signal for TdTomato (red) and immature astrocytic marker GFAP (green; A), mature 
astrocytic marker s100β (green; C) and oligodendrocytic precursor marker PDGFRα (green; 
E). Respective magnified images are shown in the right panel. Nuclei are counterstained 
with DAPI (blue). Scale bars: 100µm. (B; D; F) Quantification of TdTomato labelled Gli 
positive cells co-localizing with GFAP (B), s100β (D) and PDGFRα (F) at P55 in the SR and 
ALV of placebo (black) and EPO (red) treated hippocampi of GliCreERT2::TdTomato mice. 
Data represents average number of cells ± SEM. Quantification performed from 3 
independent mice and p-values presented via unpaired Student’s t-test. 
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radial glial cells, are also known to express GFAP (Ahn and Joyner, 2005). Taken 
together, this data suggests that EPO does not regulate neurogenesis in the 
hippocampus via type II (Nestin and Gli) precursors.  
4.1.3. EPO induced increase in pyramidal neurons could potentially be via Sox2 
positive precursors. 
 
Sox2, known as SRY (Sex determining region Y box 2) protein, is a transcription factor 
that plays a crucial role in cell fate commitment and differentiation (Kamachi and 
Kondoh, 2013). Interestingly, Sox2 marks NSCs in embryonic and adult mice as well as 
type I radial glial cells. It is also one of the Yamanaka factors required for the generation 
of induced pluripotent stem cells (iPSCs) from human fibroblasts (Takahashi and 
Yamanaka, 2006). Sox2 is involved in the maintenance of stem cells as well as their 
multipotent capabilities and self-renewal properties (Arnold et al., 2011; Suh et al., 
2007). Therefore, Sox2 was considered as a potential candidate, which could give rise 
to the increase in the pyramidal neurons upon EPO treatment. 
To begin with, a commercially available Sox2 antibody was used to stain sections from 
GliCreERT2::TdTomato mice after similar treatment protocol as published by Hassouna 
et al., 2016 (Fig. 30A-B).  
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After staining using antigen retrieval, Sox2 positive cells were observed in the CA1 
region of the hippocampus of placebo and EPO treated mice at P55. Upon 
quantification (Fig. 30C) of Sox2 positive cells, a significant decrease in the number of 
Sox2 positive cells in the pyramidal layer of the CA1 region of mice treated with EPO 
was quantified as compared to the placebo treated controls (Fig. 30D). This result 
Figure 30. EPO administration led to a significant decrease in the number of Sox2 positive 
cells in the CA1 region of GliCreERT2::TdTomato mice. (A) Experimental schematic where 
5 i.p. injections of tamoxifen were administered from P23-P27 in GliCreERT2::TdTomato 
mice, followed by 11 i.p. injections of either placebo or EPO (on alternate days) from P28-
P48. Mice were then sacrificed at P55.  (B-C) Representative images of the hippocampus at 
P55 of placebo or EPO treated GliCreERT2::TdTomato mice and representation of cells that 
were quantified (C), showing positive signal for Sox2 (green) in the CA1 region of the 
hippocampus. Nuclei were counterstained using DAPI (blue). Scale bar: 100µm. (D) 
Quantification of Sox2-positive cells at P55 in the CA1 region of placebo (black) and EPO 
(red) treated hippocampi of GliCreERT2::TdTomato mice. Data represents average number 
of cells ± SEM. Quantification performed from 9 independent mice and p-values presented 
via unpaired Student’s t-test.  
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suggests that EPO could increase the number of pyramidal neurons by forcing Sox2 
positive precursors to undergo asymmetrical differentiation. 
In order to fate map the Sox2 positive cells after EPO treatment, an inducible 
Sox2CreERT2 transgenic mouse line was crossed with TdTomato reporter mouse line 
(R26R-TdTomato; Madison et al., 2010). Following the treatment regimen as published 
in Hassouna et al., 2016, Sox2CreERT2::TdTomato mice were treated with 5x injections 
of tamoxifen to label Sox2 positive precursors with TdTomato. Placebo or EPO 
injections (11x, on alternate days) were administered from P28-P48, followed by 
sacrificing the mice at P55 (Fig. 31A). Upon sectioning and staining, TdTomato positive 
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Upon quantification of Sox2 positive cells, an increased trend in the CA1 region of EPO 
treated mice (p-value=0.12) was recorded as compared to the placebo treated mice 
(Fig. 31C). As TdTomato positive cells were present in the pyramidal layer of the CA1 
region of treated mice, a co-staining with a neuronal marker NeuN (green) 
demonstrated that NeuN positive neurons also showed TdTomato expression in EPO 
(Fig. 31D) treated pyramidal layer of the CA1. Magnified images of co-localization of 
NeuN (green) and TdTomato (red) are depicted in Fig. 31D. As a control experiment to 
confirm the robustness and efficiency of Sox2CreERT2::TdTomato mice, these mice 
were injected with a carrier solvent i.e. corn oil (5x, P23-P27), followed by sacrificing 
the mice at P55 (Fig. 32A). After sectioning and staining, unfortunately, unspecific 
TdTomato expression in the hippocampus of oil treated mice at P55 was observed (Fig. 
32B), suggesting that the Sox2CreERT2::TdTomato transgenic mice was leaky and could 
not be further used for these experiments.  
Figure 31. EPO administration led to an increase in the number of Tdtomato labelled Sox2 
positive cells in the CA1 region of Sox2CreERT2::TdTomato mice. (A) Experimental 
schematic where 5 i.p. injections of tamoxifen were administered from P23-P27, followed 
by 11 i.p. injections of either placebo or EPO (on alternate days) from P28-P48 in 
Sox2CreERT2::TdTomato mice. Mice were then sacrificed at P55. (B) Representative images 
of the hippocampus at P55 of placebo or EPO treated Sox2CreERT2::TdTomato mice, 
showing positive signal for TdTomato (red) in the CA1 region of the hippocampus. (C) 
Quantification of TdTomato labelled Sox2 positive cells in the CA1 region at P55 of placebo 
(black) and EPO (red) treated hippocampi of Sox2CreERT2::TdTomato mice. Data 
represents average number of cells ± SEM. Quantification performed from 5-6 independent 
mice and p-values presented via unpaired Student’s t-test. (D) Representative images of the 
hippocampus at P55 of EPO treated Sox2CreERT2::TdTomato mice, showing positive signal 
for TdTomato (red) and neuronal marker NeuN (green) in the CA1 region of the 
hippocampus. Nuclei were counterstained using DAPI (blue). Scale bar: 100µm.  
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Many transgenic mice have known to show a variable degree of leaky expression, 
although it is not always documented. However, the number of unspecific TdTomato 
positive cells obtained after corn oil treatment were still quantified (Fig. 32C) and 
subtracted from the number of TdTomato positive cells obtained after placebo or EPO 
treatment (Fig. 32D). In this case, a similar increase trend in the number of Sox2 
positive cells after EPO treatment was observed as compared to the placebo treated 
mice (Fig. 32D). This data, however, cannot provide concrete evidence that EPO 
treatment leads to an increase in the number of pyramidal neurons mediated via Sox2 
positive precursors. 
Taking results and interpretations from all the three mouse lines used so far and the 
Doublecortin (Dcx) mouse line used in the past, this thesis can conclude that neuronal 
lineage commitment is comparatively more complex than the oligodendrocyte lineage 
Figure 32. Unspecific TdTomato expression observed in Oil injected control 
Sox2CreERT2::TdTomato mice. (A) Experimental schematic where corn oil was 
administered (i.p.) at P23-P27 in Sox2CreERT2::TdTomato mice and then sacrificed at P55. 
(B) Representative image of the hippocampus of corn oil treated Sox2CreERT2::TdTomato 
mice at P55, showing unspecific signal for TdTomato (red). Nuclei were counterstained 
using DAPI (blue). Scale bar: 100µm. (C) Quantification of TdTomato positive cells in the CA1 
region at P55 of corn oil treated hippocampi of Sox2CreERT2::TdTomato mice. (D) 
Quantification of Sox2 positive cells obtained in Placebo (black) or EPO (red) treated mice 
after subtracting the number of unspecific positive cells observed in corn oil treated mice at 
the same time point. Data represents average number of cells ± SEM. Quantification 
performed from 9 independent mice and p-values presented via unpaired Student’s t-test.  
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commitment (as shown by Hassouna et al., 2016). Various precursors, known or 
unknown, could differentiate, alone or synergistically, to contribute to the increased 
pyramidal neuronal number upon EPO administration. Interestingly, multiple studies 
have demonstrated that hematopoietic stem cells (HSCs) and multipotent precursors 
(MPPs) can circumvent distinct intermediate stages (Haas et al., 2005; Pietras et al., 
2015; Sanjuan-Pla et al., 2013; Yamamoto et al., 2013). Therefore, drawing parallels 
from the effect of EPO on the hematopoietic system, the present work could suggest 
that EPO could drive the neuro-differentiation without proliferation, possibly also 
skipping the intermediate stages. However, the data gathered so far from several 
experiments with different precursor makers like Sox9, Pax6, DCX (Hassouna et al., 
2016), Sox2 and from transgenic mouse lines for DCX, Nestin, Gli and Sox2, this thesis 
could suggest that EPO works on multiple precursors (Pax6, DCX, Sox2) in the brain to 
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4.2. Effect of EPO on pyramidal neurons. 
 
4.2.1. Substantial generation of pyramidal neurons in the CA1 of adult mice and its 
amplification by EPO. 
 
An increase (>20%) in pyramidal neurons upon 3-week treatment of juvenile mice (P55) 
with EPO, without evidence of proliferation or anti-apoptosis was recently 
demonstrated (Hassouna et al., 2016). Due to the absence of any suitable reporter line 
(Fig. 24 – Fig. 32), which allowed us to fate map the importance of a single neuronal 
precursor, the above-mentioned observation remained difficult to corroborate. Several 
reports, fate-mapping neurons using additive labelling of progenitors and their 
progenies, have provided variable results (Sun, 2014). Therefore, these type of studies 
are still in their infancy to provide reliable answer to the question of adult 
neurogenesis. Taking this into account, a subtractive approach was hypothesized that 
could enable us to elucidate the influence of EPO on adult neurogenesis. The idea 
behind this subtractive approach was to completely label embryonic born neurons in 
juvenile mice, which then could be distinguished from newly generated neurons. Using 
a novel approach to consolidate the finding (Hassouna et al., 2016), almost all mature 
CA1 pyramidal neurons present at P27 were permanently pre-labeled with a tamoxifen 
inducible reporter TdTomato. This was performed by crossing a NexCreERT2 (Agarwal 
et al., 2012) with a inducible TdTomato; R26R-TdTomato (Madisen et al., 2010) 
transgenic mouse line. These NexCreERT2::TdTomato transgenic mice were treated 
with 5 or 10 i.p. injections of tamoxifen to completely label embryonic born neurons in 
juvenile mice and adult mice respectively (Fig. 33A). All neurons differentiating and 
maturing thereafter (i.e. start Nex/NeuroD6 expression) would not carry the TdTomato 
label, thereby enabling us to distinguish between pre-existing TdTomato labeled 
neurons and the newly generated neurons marked by a pyramidal neuronal marker 
Ctip2 (Chicken ovalbumin upstream promoter transcription factor-interacting protein 
2). As a control experiment, a co-staining of TdTomato with Ctip2 was performed and 
approximately <3% of Ctip2 positive neurons were found (data not shown) to be not 
labelled with TdTomato (TdTomato-, Ctip2+). EPO or placebo treatment was initiated at 
P28, according to the previous injection scheme (5000U/kg, on alternate days from 
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P28-P48, followed by a treatment free week; Hassouna et al., 2016). The mice were 
then sacrificed at P55. Upon sectioning and staining (Fig. 33B), a significant increase in 
the number of newly generated neurons (TdTomato-, Ctip2+) in the CA1 after EPO 









As previously reported (Hassouna et al., 2016), these differentiated neurons did not 
show any evidence of recent generation from proliferating precursors (All EdU-). 
Interestingly, using the same treatment schedule in adult mice, where the mice would 
Figure 33. EPO increases number of pyramidal neurons in the CA1 region of the 
hippocampus. (A) Experimental schematic to determine the effect of EPO on neuron 
number in NexCreERT2::TdTomato mice (starting at age P23 or month 3), where tamoxifen 
was administered either  for 5 i.p. injections either in juvenile (P23) or 10x i.p. injections 
adult (Month 3) mice, followed by either placebo or EPO (11 i.p; on alternate days) for three 
weeks. Mice were then sacrificed at P55 or at approx. Month 4.2. (B) Representative images 
of the hippocampus at P55 of placebo or EPO treated NexCreERT2::TdTomato mice, 
showing positive signal for TdTomato (red) and excitatory neuronal marker Ctip2 (green) in 
the CA1 region of the hippocampus. White arrows indicate newly generated neurons. Scale 
bar: 50µm. (C-D) Quantification of newly generated Ctip2+/TdTomato- neurons at P55 (C; 
juvenile) and at Month 4 (D; adult) in the CA1 of placebo (black) and EPO (red) treated 
hippocampi of NexCreERT2::TdTomato mice. Data represents average number of cells ± 
SEM. Quantification performed from 6 independent mice and p-values presented via 
unpaired Student’s t-test.  
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receive EPO or placebo starting at month 3 (Fig. 33A), a comparable increase in newly 
generated pyramidal neurons (TdTomato-, Ctip2+) upon EPO treatment (Fig. 33D) was 
recorded. Taken together, these data indicate that EPO induced substantial generation 
of pyramidal neurons not only in early developmental stages (juvenile mice), but also 
in adulthood. This, interestingly, represents a previously overlooked novel aspect of 
adult neurogenesis uncovered by the serendipity and validated with the subtractive 
approach in our EPO studies.  
4.2.2. EPO leads to an increase in the dendrites and spine density of pyramidal 
neurons in the CA1. 
 
Not only neuronal numbers, but also an increase in neuropil can theoretically 
contribute to enlargement of brain regions and cognitive improvements as previously 
observed under the influence of EPO (Wüstenberg et al., 2011; Hassouna et al., 2016). 
A Thy1-EGFP transgenic mice (Feng et al., 2010; Porrero et al., 2010) was employed, 
where dendrites of pyramidal neurons are labelled with EGFP reporter. Following 
similar treatment regime (Hassouna et al., 2016), Thy1-EGFP juvenile mice or Month 3 
old adult mice were treated with placebo or EPO (11 i.p. injections, on alternate days) 
(Fig. 34A). Brain sections were stained with a dendritic marker Map2 (Fig. 34B-C) to 
determine the dendritic density after placebo or EPO treatment. Upon quantification, 
a significant increase in the dendritic density in juvenile (P55) and adult (4 months) 
mice after EPO treatment was quantified as compared to the placebo treated mice (Fig. 
34D). 
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Figure 34. EPO increases the dendritic and total spine density in the CA1 region of the 
hippocampus. (A) Experimental schematic where Thy1-EYFP juvenile (P23) or adult (Month 
3) mice were treated with either placebo or EPO (11 i.p; on alternate days) for three weeks. 
Mice were then sacrificed at P55 or at approx. Month 4.2. (B) Representative overview 
image of the quantification method employed for determining the density of dendrites 
using dendritic marker MAP2 (red) in CA1 stratum radiatum (SR).White boxes denote areas 
of measurements. Scale bar: 20µm. (C) Representative images at P55 of the dendrites of 
pyramidal neurons of placebo or EPO treated Thy1-EGFP mice, showing positive signal for 
dendritic marker MAP2 (red) in the CA1 region of the hippocampus. Scale bar: 10µm (D) 
Quantification of total number of MAP2 positive dendrites of pyramidal neurons in the CA1 
at P55 and at Month 4 of placebo (black) and EPO (red) treated hippocampi of Thy1-EGFP 
mice. Data represents average number of Map2 positive dendrites/µm2 ± SEM. (E) 
Representative images of EYFP (green) expression in principal apical dendrites in CA1 of 
placebo or EPO treated Thy1-EYFP mice. Scale bar: 10µm. (F) Quantification of total number 
of apical dendritic spines at P55 (juvenile) or at Month 4 (adult) in placebo (black) or EPO 
(red) treated Thy1-EGFP mice hippocampus. Data represents average number of dendritic 
spines/µm ± SEM. (G-H) Line graphs depict the total number of spines mice at P55 (G; 
juvenile) or at Month 4 (H; adult) presenting their respective distance from the soma in 
placebo (black) or EPO (red) treated. Data represents average number of total dendritic 
spines/µm ± SEM in correlation with their respective distance from the soma (µm). 
Quantification performed from 5-6 independent mice and p-values presented via unpaired 
Student’s t-test. This data was generated in collaboration with Yasmina Curto. 
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Next, the total dendritic spine density of pyramidal neurons (labelled by EGFP) in 
placebo or EPO treated juvenile and adult mice was determined (Fig. 34E) and was 
observed to be enhanced after EPO treatment at both P55 and 4 months of age (Fig. 
34F). Correlating the number of dendritic spines with their distance from the respective 
cell soma, a significantly higher number of spines located closer to their respective cell 
somas (Fig. 34G) after EPO treatment in juvenile mice was observed, whereas in adult 
mice, significantly higher number of spines were located further away from their 
respective cell somas (Fig. 34H). Taken together, this data suggests that EPO induces 
an increase in dendritic density as well as dendritic spine density in both juvenile mice 
(P55) and adult mice (4 months).  
Previous reports have suggested that maturity of dendritic spines can be determined 
by observing their morphology (Kasai et al., 2011). Therefore, following similar placebo 
or EPO treatment regime in Thy1-EGFP juvenile and adult mice (Fig. 35A), the 







Figure 35. EPO increases the density of immature stubby spine type in the CA1 region of 
the hippocampus. (A) Experimental schematic where Thy1-EYFP juvenile (P23) or adult 
(Month 3) mice were treated with either placebo or EPO (11 i.p; on alternate days) for three 
weeks. Mice were then sacrificed at P55 or at approx. Month 4.2. (B-D) Quantification of 
EYFP positive principal apical dendritic in the CA1 region of the hippocampus at P55 (C-E; 
juvenile) and at Month 4 (C-E; adult) based on their morphology as illustrated in (B) showing 
thin (C), stubby (D) or mushroom (E) morphology in placebo (black) and EPO (red) treated 
Thy1-EGFP mice. Data represents average number of dendritic spines/µm ± SEM. 
Quantification performed from 5-7 independent mice and p-values presented via unpaired 
Student’s t-test. This data was generated in collaboration with Yasmina Curto. 
 
 RESULTS – EFFECT OF EPO ON PYRAMIDAL NEURONS 
 
  
DEBIA WAKHLOO 92 
 
Upon quantification, a significant increase in stubby immature spines and a trend 
towards more of the mature mushroom spines upon EPO treatment (Fig. 35C-E) was 
measured. These findings indicate that in addition to more newly generated pyramidal 
neurons, other important aspects of neuroplasticity, supporting functional neuronal 
network complexity, are efficiently augmented by EPO. 
4.2.3. EPO mediated increase in neurons is accompanied by changes in other cell 
types in the CA1.  
 
After confirming a substantial increase in the number of pyramidal neurons in the CA1 
upon EPO treatment, it was imperative to determine whether EPO mediated an 
interplay between other cell types present in the CA1 region of the hippocampus. In 
our previously published report, EPO has been demonstrated to play a crucial role in 
the myelination of the newly formed neurons as well as significantly increased 
oligodendrocyte differentiation (Hassouna et al., 2016). Therefore, the present work 
extended this to other cells present in the CA1, mainly microglia and astrocytes. To 
accomplish this, a staining for Iba1, a marker of microglia in the same mice was 
performed, which were subjected to 3-week EPO treatment (Fig. 36A-B).  
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Upon quantification, a significant decrease in the number of microglia (Iba1+) at P55 
after EPO treatment was observed as compared to the placebo treated mice (Fig. 36C). 
This EPO induced decrease of microglia was no longer observed in adult mice (Fig. 36D) 
at the age of 4 months, implicating the role of EPO on microglia specifically at early 
developmental stages. In parallel, staining sections of hippocampi from juvenile as well 
as adult mice for s100β, which is a marker of mature astrocytes (Fig. 36E) did not reveal 
a significant change in the number of mature astrocytes, however, only a trend towards 
an increase in juvenile mice (Fig. 36F). This could implicate that some of the Gli 
precursors (demonstrated in Fig. 26 – Fig. 29), which gave rise to astrocytes upon EPO 
treatment. However, this effect was not observed in EPO treated adult mice (Fig. 36G), 
suggesting that EPO does influence microglia and astrocytes during development or 
adulthood.  
The underlying mechanism explaining the effect of EPO on other cell types is still 
unknown. Therefore, to elucidate whether EPO mediated changes in the above-
mentioned cell types occur via EPO-receptor (EPOR), it was imperative to determine 
whether EPOR is present on these cells. To achieve this, a collaboration with Synaptic 
Systems (SySy) was established to generate monoclonal and polyclonal antibodies 
Figure 36. EPO decreases the number of Iba1 positive microglia in juvenile mice in the CA1 
region of the hippocampus. (A) Experimental schematic to determine the effect of EPO on 
neuron numbers in 2 cohorts of NexCreERT2::TdTomato mice (starting at age P23 or 
month3), where tamoxifen was administered either for 5 i.p. injections in juvenile (P23) or 
10x i.p. injections in adult (Month 3) mice, followed by either placebo or EPO (11 i.p; on 
alternate days) for three weeks. Mice were then sacrificed at P55 or at approx. Month 4.2. 
(B) Representative images of the hippocampus at P55 of placebo or EPO treated 
NexCreERT2::TdTomato mice, showing positive signal for microglial marker Iba1 (red) in the 
CA1 and CA3 region of the hippocampus. (C-D) Quantification of Iba1 positive microglia at 
P55 (C; juvenile) and at Month 4 (D; adult) in the CA1 and CA3 of placebo (black) and EPO 
(red) treated hippocampi of NexCreERT2::TdTomato mice. (E) Representative images of the 
hippocampus at P55 of placebo or EPO treated NexCreERT2::TdTomato mice, showing 
positive signal for astrocyte marker s100β (cyan) in the CA1 and CA3 region of the 
hippocampus. Nuclei were counterstained with DAPI (blue). Scale bar: 100µm. (F-G) 
Quantification of s100β positive astrocytes at P55 (F; juvenile) and at Month 4 (G; adult) in 
the CA1 and CA3 of placebo (black) and EPO (red) treated hippocampi of 
NexCreERT2::TdTomato mice. Data represents average number of cells ± SEM per mm2. 
Quantification performed from 5-6 independent mice and p-values presented via unpaired 
Student’s t-test.  
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against EPOR. After several standardizing experiments, none of the generated 
antibodies gave reproducible results upon staining mouse brain sections with anti-
EPOR antibody (data not shown). Although the expression of EPOR on different cell 
types in vivo was not demonstrated, in vitro primary cell cultures of neurons, microglia, 
astrocytes and oligodendrocytes were performed. The presence of EPOR mRNA in cell 
cultures at different time points of development could be determined using 
quantitative real time PCR. To accomplish this, primary hippocampal neurons were 
cultured from E17 mice embryo brains (Fig. 37A) and primary microglia, astrocytes and 







In all cultures, the cells were lysed and RNA was extracted at DIV 2, DIV 4 and DIV 6 
(Fig. 37A-B). Upon performing qRT-PCR with a specific EPOR primers, endogenous 
mRNA levels of EPOR in primary cultured hippocampal neurons (Fig. 37C), microglia 
(Fig. 37D), astrocytes (Fig. 37E) and oligodendrocytes (Fig. 37E) was observed. 
Expression of EPOR mRNA levels were normalized to GAPDH, which was used as a 
housekeeping gene. Interestingly, higher changes in the basal levels of EPOR mRNA in 
Figure 37. Endogenous mRNA levels of EPOR in cultured neurons, microglia, astrocytes 
and oligodendrocytes. (A) Experimental schematic where E17 mice embryos derived 
hippocampal neurons were cultured for DIV 2, DIV 4 and DIV 6. Cells were lysed and RNA 
was collected at these time points. (B) Experimental schematic where P1 post-natal pup 
brain derived microglia, astrocytes or oligodendrocytes were cultured for DIV 2, DIV 4 and 
DIV 6. Cells were lysed and RNA was collected at these time points. (C-F) Quantification of 
endogenous mRNA levels of EPOR in cultured neurons (C), microglia (D), astrocytes (E) or 
oligodendrocytes (F) at DIV 2, DIV 4 and DIV 6 by qRT-PCR. Expression of EPOR mRNA was 
normalized to GAPDH, which is used as a housekeeping gene.  
 
 RESULTS – EFFECT OF EPO ON PYRAMIDAL NEURONS 
 
  
DEBIA WAKHLOO 96 
 
cultured microglia and oligodendrocytes were quantified, but not in cultured neurons 
and astrocytes during the time course studied. Taken together, this data could indicate 
the role of EPO due to the presence of EPOR on these cells.  
4.2.4. Drop-sequencing analysis demonstrates increase in the number of immature 
glutamatergic neurons after EPO treatment. 
 
Since EPOR mRNA expression was observed in various cell types by qRT-PCR, which 
determines the expression of known genes with the help of specific primers, a state-
of-art comprehensive approach was employed to determine the effect of EPO on the 
cellular heterogeneity of the CA1 region. Using this approach, the population of cells, 
which respond to EPO could be determined, which could not be addressed by qRT-PCR. 
Therefore, single cell transcriptome analysis (scRNA-Seq) was employed to explore the 
immediate response of EPO on the cells in the CA1 (Fig. 38A). Based on expression of 
previously known and well characterized cell-type markers (Fig. 38B; Wu et al. 2017), 
six main cell types were identified in the CA1, namely, neurons, astrocytes, microglia, 
oligodendrocyte precursor cells (OPCs), oligodendrocytes, and vascular endothelial 
cells. Feature plots marked the identity of each cluster with a specific marker. Markers 
that characterize each cluster are as follows: glutamatergic neurons: Camk2a (Fig. 38C) 
and Kif5c (Fig. 38C); GABAergic neurons: Gad1 (Fig. 38D) and Gad2 (Fig. 38D); 
astrocytes: Slc7a10 (Fig. 38E) and Lfng (Fig. 38E); microglia: Tmem119 (Fig. 38F) and 
C1qc (Fig. 38F); oligodendrocyte precursor cells: Pdgfra (Fig. 38G) and Gpr17 (Fig. 38G); 
mature oligodendrocytes: Mog (Fig. 38H) and Opalin (Fig. 38H); and endothelial cells: 
Flt1 (Fig. 38I) and Ly6c1 (Fig. 38I).  
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Next, juvenile mice were treated with one injection of either placebo or EPO 
(5000U/kg) and dissected CA1 after 6 hours of treatment. The dissected CA1 was 
dissociated to obtain single cell suspension and was further analyzed by Drop-Seq. This 
experiment revealed alterations in the cell cluster composition (visualization of 
hippocampal CA1 cell clusters using t-distributed stochastic neighbor embedding, 
tSNE) as defined by gene expression profiles (Fig. 39A). From acutely micro-dissected 
and dissociated CA1 of juvenile mice, 390 and 583 single-cell transcriptomes for 
placebo and EPO treated mice (3 animals per group) respectively were acquired (Fig. 
39B). Using principle component analysis (PCA), dimensionality reduction by t-
distributed stochastic neighbor embedding (tSNE) and clustering, all the cells were 
unbiasedly grouped into multiple distinct clusters (Fig. 39A-B).  
Figure 38. Determination of major hippocampal cell types and cell type-specific gene 
markers. (A) Experimental schematic where P28 C57Bl6 WT mice were treated with 1x i.p. 
injection of placebo or EPO and CA1 was isolated 6 hours later. The CA1 region was then 
triturated into single cell suspension and processed for Drop-Seq analysis. (B) Boxplots 
showing representative major cell-type of known marker genes across different cell types 
(Wu et al., 2017) (C-I) t-SNE plot showing cell cluster specific expression (darker signal 
correlates to higher expression) of known markers. Each dot is a specific cell. Known 
markers genes specific to mature neurons (C), GABAergic neurons (D), Astrocytes (E), 
Microglia (F), Oligodendrocyte precursors (G), Oligodendrocytes (H) and Endothelial cells 
(I). This analysis confirms that each cluster captures a particular cell. This data was 
generated in collaboration with Stefan Bonn’s lab. 
type. 
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Figure 39. Drop-Sequencing analysis demonstrates increase in the number of immature 
glutamatergic neurons after EPO treatment. (A) Visualization of hippocampal CA1 cell 
clusters using t-distributed stochastic neighbor embedding (tSNE). Each color represents a 
cluster of specific cells, characterized by a defined gene expression profile. (B) Based on the 
clusters defined in (A), individual cells derived from either placebo (black) or EPO (red) 
treated mice are denoted. (C) Taking the absolute number of cells (given in C) from EPO 
(n=583) or placebo (n=390) treated mice into account, bar graphs represents the percentage 
of glutamatergic clusters under each treatment condition. (D) For the immature 
glutamatergic cluster, significantly increased under EPO, the most relevant gene ontology 
terms are listed. The X-axis represents the -log10 FDR (false discovery rate adjusted p value). 
(E) The percentage of other cell types present in the CA1 under each treatment condition 
placebo (black) or EPO (red). Data represents the percentage of cells under each treatment 
conditions. Quantification performed from 3 independent mice per group and p-values 
presented via 2-tailed Fisher’s exact test. Oligo: Oligodendrocytes; Astro: Astrocytes; Endo: 
Endothelial; GABA: GABAergic; Micro: Microglia; OPCs: Oligodendrocyte precursors.  
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All the clusters obtained after the initial clustering and after further sub-clustering were 
further studied. No significant changes in the non-neuronal cell types such as 
astrocytes, oligodendrocytes, OPCs and endothelial cells were observed with a slight 
trend in the GABAergic neuronal cluster (Fig. 39C). A significant reduction in the 
number of microglia after EPO treatment was observed, but no effect of EPO on other 
cell types after 6 hours (Fig. 39C). A significant reduction in the number of microglia 
suggested the importance of microglia and neuron interaction at an earlier 
developmental time (as depicted in vivo in Fig. 36C).  
Initial clustering of glutamatergic neurons resulted in a single cluster; however, further 
sub-clustering revealed multiple subpopulations, suggesting that the glutamatergic 
neuronal cluster does not represent homogeneous population of mature neurons but 
rather cells at different development stages. The clusters obtained after unbiased sub-
clustering were classified as follows: (i) Glut1: Mature glutamatergic 1 expressing 
mature neuronal and glutamatergic signaling markers; (ii) Glut2: Mature glutamatergic 
2 expressing mature neuron markers involved in processes like cytoskeleton and 
metabolic modifications; (iii) Glut3: Mature glutamatergic 3 involved in pre-synaptic 
transmission in processes like dendritic spine modification. Strikingly, along with these 
mature glutamatergic clusters, which did not show significant differences between EPO 
and placebo treatments (Fig. 39D), I observed a tiny cluster of cells, which expressed 
markers of immature neurons and were involved in processes of neuron 
differentiation. A significantly higher number of cells in the immature glutamatergic 
differentiation cluster after EPO treatment was observed as compared to the placebo 
treated CA1 (Fig. 39D). Gene Ontology (GO-terms) analysis revealed the biological 
relevance of transcripts involved in neuron differentiation, axon development and 
synapse organization for the immature glutamatergic neuronal cell cluster (Fig. 39E).   
4.2.5. EPO drives maturation of immature neurons as revealed by Monocle analysis. 
 
In order to describe the transcriptional signature that defines the immature 
glutamatergic vs mature glutamatergic 1 cluster, the expression of two immature 
neuronal markers (Tbr1 and Tle4) in combination with a known mature neuronal 
marker (Camkk2) was studied in our dataset. The immature glutamatergic cluster was 
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found to be highly specific for immature neuronal markers Tbr1 and Tle4, whereas the 
mature glutamatergic 1 cluster expressed the mature neuronal marker Camkk2 (Fig. 
40A-C). In order to strengthen the fact that the cluster of cells, which showed an 
immediate response to EPO was indeed not as mature as other glutamatergic neuronal 
cluster, their differentiation trajectory on cells in the immature glutamatergic cluster 
and its neighboring cluster, mature glutamatergic 1 was determined in Monocle. To 
accomplish this, monocle analysis was performed wherein the single cells were ordered 
on a pseudo-temporal axis. The principle by which Monocle works is that, instead of 
tracking changes in expression as a function of time, Monocle tracks the changes as a 
function along the trajectory, which is termed as ‘Pseudotime’. This could be defined 
as an abstract unit of progress, which measures the distance between a cell and the 
start of the trajectory. The total length of the trajectory is defined in terms of the total 
amount of transcription change that a particular cell undergoes when it moves from 
the starting state to the final state. The analysis confirmed the immature identity of 
cells in the immature glutamatergic cluster, reflected by a homogeneously low 
pseudotime of almost all cells in this cluster, which was significantly lower as compared 
to cells in the mature glutamatergic1 cluster (Fig. 40C-D). Importantly, a generally 
lower pseudotime upon EPO was observed, independent of cluster assignment, further 
supporting our observation of an increase in immature cells irrespective of clustering 
(Fig. 40E).  
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Figure 40. Trajectory analysis (Monocle) demonstrates EPO induced maturation of 
immature glutamatergic neurons. (A) Visualization of hippocampal CA1 cell clusters using 
t-distributed stochastic neighbor embedding (tSNE). Each color represents a cluster of 
specific cells, characterized by a defined gene expression profile. (B-C) t-SNE plot showing 
bulk expression of Tbr1 (B), Tle4 (C) and Camkk2 (B-C) genes in all cell clusters of the CA1 
(B-C; darker signal correlates to significant expression), where each cell is represented by a 
dot. Red dot represents cell, which shows the expression of Tbr1 (B) or Tle4 (C), whereas 
blue dot represents cell, which shows the expression of Camkk2 (B-C). In both cases, green 
dot represents cell, which express both Tbr1 and Camkk2 (B) or Tle4 and Camkk2 (C). (D) 
Trajectory analysis in Monocle 2 of cells in the ‘Mature Glutamatergic1’ and the ‘Immature 
Glutamatergic’ cluster colored by pseudotime (the darker the more mature). (E) Trajectory 
colored by cell identity. Bar graph indicates average pseudotime of the respective clusters. 
(F) Trajectory colored and split by placebo (black; left) versus EPO treatment (red; right). 
Bar graph shows average pseudotime of cells in the respective treatment groups. Data 
represents mean ± SEM. Quantification performed from 3 independent mice and p-values 
presented via 2-tailed Mann–Whitney U test. This data was generated in collaboration with 
Agnes Steixner. 
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These results suggest that under the influence of EPO, enhanced neuro-differentiation 
occurs and neurons are present in a continuum, in which immature neurons 
progressively proceed towards neuronal maturation. This progression is characterized 
by expression of specific immature neuronal markers such as doublecortin (Dcx), 
transducin-like enhancer family member4 (Tle4), T-box brain1 (Tbr1), 
rhabdomyosarcoma 2-associated transcript (Rmst), SRY-Box5 (Sox5) and Stabilin1 
(Satb1). 
4.2.6. EPO increases the expression of immature neuronal markers such as Tbr1 and 
Tle4. 
 
Certain immature neuronal markers such as Tbr1 and Tle4 were further analyzed. Tbr1 
is a transcription factor expressed in the developing cerebral cortex, hippocampus and 
olfactory bulb (Bulfone et al. 1995; Puelles, 2017). Méndez-Gómez and co-workers 
reported that overexpression of Tbr1 promotes generation of glutamatergic neurons 
without enhancing proliferation (Méndez-Gómez et al., 2011). Several reports have 
demonstrated Tbr1 to be a conserved pallial cell type (Luzzati, 2015; Puelles, 2017) as 
well as Tbr1 expressing cells regarded as conserved endogenous reserve of plastic cells 
(Piumatti et al., 2018), which mature slowly. Using principle component analysis (PCA), 
dimensionality reduction by t-distributed stochastic neighbor embedding (tSNE) and 
clustering, the presence of Tbr1 specifically in immature glutamatergic neuronal cluster 
was observed as depicted by the feature plot (Fig. 41A). There was an increase in the 
number of Tbr1 expressing cells in the dissected CA1 upon EPO treatment as compared 
to the placebo treated CA1 as depicted by the violin plots in the bulk clustering (Fig. 
41B) and in immature glutamatergic cluster (Fig. 41C).  
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The expression of Tbr1 was further confirmed by immunohistochemistry in 
GliCreERT2::TdTomato mice after a single injection of EPO at P28 (Fig. 41D). Upon 
sectioning and staining with a Tbr1 specific antibody (Fig. 41E), a significant increase in 
the number of Tbr1 positive cells present in the CA1 region of the hippocampus of EPO 
treated mice was observed as compared to the control placebo treated mice (Fig. 41F).  
Another differentially regulated gene in the immature cluster was Tle4. Reports have 
also demonstrated that Grouncho/Tle4 family, acts in conjunction with sequence 
specific DNA binding proteins like TCF3, Nanog, Oct4 and Sox2, to repress the 
embryonic stem cells (ESCs) transcription factor network in order to mediate 
Figure 41. EPO treatment increases the expression of immature neuronal marker gene 
Tbr1. (A) t-SNE plot showing bulk expression of Tbr1 gene in all cell clusters of the CA1 (A; 
darker signal correlates to significant expression), where each cell is represented by a dot. 
(B-C) Violin plot depicting the bulk expression of Tbr1 in control and EPO treatment in all 
cell clusters (B) and in the immature glutamatergic cell cluster (C). Data generated from 3 
mice per group. (D) Experimental schematic where 5 i.p. injections of tamoxifen were 
administered in juvenile (P23) mice from P23-P27, followed by either placebo or EPO (1 i.p.) 
injection. Mice were then sacrificed at P29. (E) Representative image of the hippocampus 
at P29 of EPO treated GliCreERT2::TdTomato mice, showing positive signal for immature 
neuronal marker Tbr1 (green). Nuclei were counterstained with DAPI (blue). Insert 
represents the magnified image of the CA1 region of EPO treated mice, where arrows 
indicate positive cells. Scale bar: 100µm. (F) Quantification of Tbr1 positive cells/mm2 at 
P29 in the CA1 of placebo (black) and EPO (red) treated hippocampi of 
GliCreERT2::TdTomato mice. Data represents average number of cells/mm2 ± SEM. 
Quantification performed from 6 independent mice and p-values presented via unpaired 
Student’s t-test. 
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differentiation towards multiple lineages (Laing et al., 2016). Feature plot depicted the 
expression of Tle4 in all cell clusters (Fig. 42A), and these cells were increased in the 
dissected CA1 region upon EPO treatment as depicted by the violin plots in the bulk 










Similar treatment scheme was followed for Tle4 quantification (Fig. 42D), and sections 
were stained using a Tle4 specific antibody (Fig. 42E). Here, a significant increase in the 
number of Tle4 positive cells in the CA1 of EPO treated mice was observed as compared 
to the placebo treated mice (Fig. 42F).  
Figure 42. EPO treatment increases the expression of immature neuronal marker gene 
Tle4. (A) t-SNE plot showing bulk expression of Tle4 gene in all cell clusters of the CA1 (A; 
darker signal correlates to significant expression), where each cell is represented by a dot. 
(B-C) Violin plot depicting the bulk expression of Tle4 in control and EPO treatment in all cell 
clusters (B) and in the immature glutamatergic cell cluster (C). Data generated from 3 mice 
per group. (D) Experimental schematic where 5 i.p. injections of tamoxifen were 
administered in juvenile (P23) mice from P23-P27, followed by either placebo or EPO (1 i.p.) 
injection. Mice were then sacrificed at P29. (E) Representative image of the hippocampus 
at P29 of EPO treated GliCreERT2::TdTomato mice, showing positive signal for immature 
neuronal marker Tle4 (green). Nuclei were counterstained with DAPI (blue). Insert 
represents the magnified image of the CA1 region of EPO treated mice, where arrows 
indicate positive cells. Scale bar: 100µm. (F) Quantification of Tle4 positive cells/mm2 at P29 
in the CA1 of placebo (black) and EPO (red) treated hippocampi of GliCreERT2::TdTomato 
mice. Data represents average number of cells/mm2 ± SEM. Quantification performed from 
6 independent mice and p-values presented via unpaired Student’s t-test. 
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4.2.7. EPO increases the expression of Lnc-RNA ‘RMST’ in immature glutamatergic 
neuronal cluster. 
 
As reported by Hsieh and Gage, 2005 and Yao et al., 2016, a tight regulation of the 
transcriptional and epigenetic program appears to be an important player in 
maintaining NPCs. Moreover, transcription factors such as Sox2, Pax6, Tlx1 and REST 
are identified to cooperate with stage specific cofactors to induce cell fate commitment 
and specification. More importantly, Sox2 cooperation with various cofactors depends 
on the stage of that particular cell. Lodato and colleagues demonstrated that Sox2 
cooperates with Oct4 in embryonic stem cells (Lodato et al., 2013) as well as a long 
non-coding RNA (lncRNAs) `RMST` to control transcriptional programs in stem cells to 
induce neuro-differentiation (Ng et al., 2013). These publications, thereby, provide 
insight on relationship between Sox2 and its partners in a specifying cell state.  
Using a genome-wide approach to screen for neurogenic lncRNAs, rhabdomyosarcoma 
2-associated transcript (RMST) as a lncRNA required for neuronal differentiation was 
previously identified (Ng & Stanton, 2013). RMST associated with Sox2 (Ng et al., 2013), 
which is one of the important transcription factors controlling the fate of neural stem 
cells (NSCs). Therefore, this study decided to elucidate the role of RMST in modulating 
neurogenesis under the influence of EPO.  To achieve this, similar clustering for RMST 
expressing cells was performed (Fig. 43A), and observed that these cells were increased 
in the dissected CA1 region upon EPO treatment as depicted by violin plots in the bulk 
clustering (Fig. 43B) and immature glutamatergic cluster (Fig. 43C), highlighting a 
central role for concerted Sox2-partner relationships in specifying cell state. 
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As RMST is a long noncoding RNA, there are no antibodies available for 
immunohistochemical analysis, this study decided to determine the effect of EPO on 
Sox2 positive cells at a similar time (i.e. after 6 hours). Similar treatment scheme (Fig. 
43D) was followed, and sections were stained using a Sox2 specific antibody. Upon 
quantification, a trend in decrease in the number of Sox2 positive cells in the CA1 of 
EPO treated mice was quantified as compared to the placebo treated mice (Fig. 43E). 
This is intriguing as RMST is known to interact with Sox2 and this RNA-protein complex 
activates the promoter of other neurogenic genes (Ng et al., 2013; Fig. 43F). 
Other interesting markers for this study were Doublecortin (DCX), Special AT-rich DNA 
binding protein 1 (Satb1) and SRY-Box5 (Sox5). Dcx, facilitates microtubule 
Figure 43. EPO treatment increases the expression of long noncoding RNA `RMST`.  
(A) t-SNE plot showing expression of RMST in the cell clusters of the CA1 (A; darker signal 
correlates to significant expression), where each cell is represented by a dot. (B-C) Violin plot 
depicting the expression of RMST in control and EPO treatment in all cell clusters (B) and in 
the immature glutamatergic cell cluster (C). Data generated from 3 mice per group. (D) 
Experimental schematic where 5 i.p. injections of Tamoxifen were administered in juvenile 
(P23) mice from P23-P27, followed by either placebo or EPO (1 i.p.) injection. Mice were 
then sacrificed 6 hours later at P29. (E) Quantification of Sox2 positive cells/mm2 at P29 in 
the CA1 of placebo (black) and EPO (red) treated hippocampi of GliCreERT2::TdTomato 
mice. Data represents average number of cells/mm2 ± SEM. Quantification performed from 
4-5 independent mice and p-values presented via unpaired Student’s t-test. (F) 
Representative schematics demonstrating the association of RMST and Sox2 (adapted and 
modified from Ng et al, 2013).  
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polymerization and is expressed in migrating neuroblasts and immature neurons 
(Brown et al., 2003). Satb1 forms a positive regulatory loop with HuD, activating 
NeuroD1 transcription and thereby promoting neuronal differentiation (Wang et al., 
2015). Moreover, Sox5 cooperates with Tbr1 to regulate early born neurons during 
embryonic development and form a part of the same transcriptional network (Bedogni 
et al., 2010).  Other markers like DCX (Fig. 44A), Satb1 (Fig. 44D) and Sox5 (Fig. 44G) 
revealed that these markers were present in most of the cell clusters (Fig. 44B; 44E; 
44H), with specifically more expression in immature glutamatergic cell cluster (Fig. 44C; 






Figure 44. EPO treatment increases the expression of immature neuronal marker gene 
Dcx, Satb1 and Sox5. (A; D; G) t-SNE plot showing bulk expression of Dcx (A), Satb1 (D) and 
Sox5 (G) genes in all cell clusters of the CA1 (A, D, G; darker signal correlates to significant 
expression), where each cell is represented by a dot. (B-C; E-F; H-I) Violin plot depicting the 
bulk expression of Dcx (B-C), Stab1 (E-F) and Sox5 (H-I) in control and EPO treatment in all 
cell clusters (B, E, H) and in the immature glutamatergic cell cluster (C, F, I). Data generated 
from 3 mice per group. 
 RESULTS – EFFECT OF EPO ON PYRAMIDAL NEURONS 
 
  
DEBIA WAKHLOO 109 
 
Drop-Seq data largely corresponded with the proportion of different cell types revealed 
by staining. Taken together, this data provides supportive evidence of an immediate 
effect of EPO on pre-existing precursors to instantaneously initiate neuronal 
differentiation, thereby rapidly increasing the number of immature glutamatergic 
neurons in the CA1 region of the hippocampus. EPO and EPOR were not detected by 
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4.3. Effect of EPO and Hypoxia on cognitive learning. 
4.3.1. Elevated expression of EPO and EPOR in pyramidal neurons upon Complex 
Running Wheel (CRW). 
Drop-Sequencing analysis is known to have dropout effects if a certain transcript is 
expressed in low amounts. This could be the reason why the expression of EPO and 
EPOR could not be detected. Therefore, an older yet highly sensitive approach of mRNA 
detection i.e. in-situ hybridization was employed. Based on the previous results, 
exogenous EPO induced enhancement in cognition was observed and therefore, this 
present study decided to explore the physiological significance of this potent effect. As 
it is unlikely that an organism possesses receptors and downstream mechanisms just 
for exogenous compounds, our group wondered whether EPO and/or EPOR are 
expressed in pyramidal neurons. Moreover, this thesis also decided to explore if a 
learning task like Complex Running Wheel (CRW) could endogenously boost EPO 
and/or EPOR. This could possibly provide an explanation for the improved cognition 
upon physical training as suggested by several publications (Dustman et al., 1984; 
Gomez-Pinilla & Hillman, 2013; Kramer & Erickson, 2007; Lautenschlager & Almeida, 
2006; Voelcker-Rehage & Niemann, 2013). It has also been reported that physical 
training reduces the risk for memory deficits and dementia in older adults (Brown et 
al., 2013; de Bruijn et al., 2013; Larson et al., 2006; Rovio et al., 2005; van Gelder et al., 
2004). Results from rodent studies have shown that voluntary wheel running increases 
neurogenesis and cell proliferation in hippocampal dentate gyrus in elderly rats (Eadie 
et al., 2005; van Praag et al., 2005). However, the mechanisms responsible for the 
improvement in cognition has not been well delineated. As opposed to normal running 
wheels, complex running wheel (CRW) (Liebetanz & Merkler, 2006), are wheels 
wherein the bars are irregularly spaced and the running mice are required to learn the 
pattern on the wheel to perform better. Therefore, WT mice were employed at P55 and 
exposed them to either running on CRW or without running for 5 hours, 9 hours or 13 
hours (Fig. 45A). The mice were then sacrificed immediately after their running period. 
A highly sensitive in-situ hybridization method was used, which is capable of detecting 
even single mRNA molecules. The expression of EPO and EPOR mRNA was observed in 
pyramidal neurons of the CA1 region of the hippocampus (Fig. 45B).  
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The mRNA expression of EPO and EPOR is reported to be very high in kidney (Lacombe 
et al., 1988; Semenza et al., 1991) and heart (Ruifrok et al., 2008) and therefore, their 
sections were used as positive controls (Fig. 45B). Upon quantification, 5-9 hours of 
running significantly increased the number of EPO (Fig. 45C) and EPOR (Fig. 45D) 
transcripts in running mice as compared to the non-running mice. Interestingly, the 
overall abundance of positive EPO and EPOR spots was most prominent in the cornu 
ammonis and gyrus dentatus but much lower in cortex and other brain regions (data 
not shown). 
 
Figure 45. EPO increases the local expression of EPO/EPOR in pyramidal neurons in the 
CA1 region of the hippocampus. (A) Experimental schematic of wildtype C57Bl6 mice 
exposed to no running (NR) or voluntary running on CRW at P55 for 5h, 9h or 13h. Mice 
were sacrificed at the respective time points and in-situ hybridization was performed on 
CA1 regions. (B) Representative in-situ hybridization images of CA1 regions of non-runners 
(NR) and runners (CRW) showing EPO and EPOR mRNA expression in pyramidal neurons as 
indicated by the brown spots. As positive controls for EPO/EPOR mRNA expression, sections 
of kidney (P55) and heart (E14.5) from wildtype C57Bl6 mice are presented. Scale bars: 
10µm; for heart 5µm. (C-D) Quantification of total number of EPO (C) or EPOR (D) mRNA 
spots in CA1 of non-runners (NR) and runners (CRW), shown at 5h, 9h and 13h. Data 
represents average number of spots ± SEM. Quantification performed from 2 independent 
mice and p-values presented via two-way ANOVA. 
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4.3.2. Hypoxia inducible gene EPO and its EPOR are master regulators of enhanced 
learning. 
First evidence of an increase in the immature neuronal markers in the CA1 like Tbr1, 
Dcx after a single dose of EPO was observed by single cell sequencing (Fig. 41 – Fig. 43). 
These represented a continuum of maturing neurons as seen by the monocle analysis 
(Fig. 40). Continued EPO treatment for three weeks led to an increase in mature 
neuronal numbers (Fig. 33) and increase in synaptic plasticity (Fig. 34). Along with these 
results, complex learning tasks were able to induce the expression of EPO and EPOR 
(Fig. 45). Moving forward, the present work wanted to decipher if these potent effects 
would translate into improved learning in mice treated with EPO. To determine the 
potential of EPO to improve cognitive performance, juvenile WT and NexCre::EPOR-KO 
mice were treated according to our treatment regime (Fig. 46A) where placebo or EPO 
was administered intraperitoneally every other day for 3 weeks, followed by a 1-week 
break. After the break at P55, the running-naive mice were transferred to cages 
containing CRW (Fig. 46B). The description of the method of generation of 
NexCre::EPOR-KO mice is shown below in section 4.3.5. Briefly, there is a knockdown 
of EPOR specifically in mature pyramidal neurons of the CA1 region of the hippocampus 
in these mice. However after treated with EPO, a rise in performance of EPO treated 
mice was observed as compared to placebo treated mice (Fig. 46C). This rise in 
performance was followed by a significant enhanced endurance over the whole night. 
However, in NexCre::EPOR-KO, EPO treatment did not show any increase in the 
learning and performance (Fig. 46D) as compared to placebo treated mice. 
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The endurance shown by EPO treated mice remained superior to the placebo treated 
mice over several nights (data not shown). As presented in literature (Noakes et al., 
2005), the EPO induced increase in hematocrit, also known as `blood doping` could 
have contributed to the observed enhancement in performance of EPO treated mice. 
However, as seen by the pyramidal neuron specific knockout in Fig. 46D, this was not 
the case. 
4.3.3. Labelling of increased hypoxic neurons in the CA1 upon CRW. 
After discovering that CRW led to an increase in the endogenous EPO expression (Fig. 
45), the present work decided to gain further mechanistic insight into its physiological 
relevance. The present work decided to focus on EPO regulation, where the underlying 
mechanism responsible for the upregulation of EPO in pyramidal neurons upon CRW 
exposure was studied. EPO was the first target gene to be identified for hypoxia-
inducible factor-1 (HIF-1; Semenza and Wang, 1992) and is one of the best-
characterized genes activated by reduced oxygen levels (Wenger, 2002). Hypoxia, via 
hypoxia-inducible factor (HIF), has been reported to induce EPO expression in various 
cell types (Jelkmann, 2007; 2011; Kietzmann et al., 2016; Krantz, 1991; Noguchi et al., 
2008; Sargin et al., 2010; Sirén et al., 2009). A hypothesis was considered where 
cognitive challenge/learning of complex tasks would require more oxygen than 
provided steady state. This requirement of more oxygen could induce endogenous 
physiological hypoxia, which acts as the driving force for upregulating the endogenous 
EPO system in pyramidal neurons. Therefore, to prove this hypothesis, a transgenic 
mouse was employed, expressing a chimeric protein in which the oxygen-dependent 
degradation (ODD) domain of Hif-1α is fused to the tamoxifen-inducible CreERT2 
recombinase (Kimura et al., 2015). The CreERT2-ODD mice after crossing with R26R-
TdTomato reporter mice would label every cell undergoing or responsive to hypoxia. 
Figure 46. Learning improved upon EPO treatment. (A) Experimental schematic 
 to determine the effect of EPO on CRW learning. Wildtype or NexCre::EPOR-KO mice (at 
P28) were treated with placebo or EPO (11x i.p.) on alternate days for 3 weeks, and after 1 
week of break, exposed to CRW. (B) Schematic image of standard v/s Complex Running 
Wheel (CRW). (C-D) Total distance run by placebo (black) and EPO (red) treated Wildtype 
(C) and NexCre::EPOR-KO (D) mice over the first night. Data represents average mean ± 
SEM. Quantification performed from 6-8 independent mice and p-values presented via two-
way ANOVA. This data was generated in collaboration with Franziska Scharkowski. 
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These CAGCreERT2-ODD::TdTomato mice (at P55) were first treated with a single 
injection of Tamoxifen (100mg/kg) and exposed to either overnight running on CRW or 
no running as controls (Fig. 47A). The mice were then sacrificed. The brains were 
isolated and sectioned. Upon staining with a neuronal marker NeuN (white) and 
TdTomato (red; Fig. 47B), labelled pyramidal neurons were observed, for the first time, 








Upon quantification of these hypoxic pyramidal neurons, the complex wheel running 
over one night increased the number of 'ODD-labelled' pyramidal neurons in CA1, 
indicating more hypoxic neurons in animals subjected to learning of a new challenging 
task. (Fig. 47C). Moreover, CRW induced tendency in increased neuronal activity in the 
pyramidal layer (Fig. 47D) marked by the early neuronal activity marker C-Fos (cyan; 
Fig. 47B) was also observed.      
Figure 47. Voluntary running induces hypoxia in pyramidal neurons. (A) Experimental 
schematic to determine the effect of running on the induction of hypoxia in the pyramidal 
neurons of CA1 region. CAGCreERT2-ODD:TdTomato mice were administered tamoxifen at 
P55 of age and exposed to either no running (NR) or overnight voluntary running (CRW). (B) 
Representative images of neuronal marker NeuN (white), TdTomato (red; labeling hypoxia) 
and C-Fos (cyan) in non-runner (NR) and runner mice (CRW). Scale bars in (B): 100µm, 10µm. 
(C-D) Quantification of hypoxic neurons (TdTomato+) and active neurons (C-Fos+) in CA1 is 
presented for NR or CRW over one night. Data represents average number of cells ± SEM. 
Quantification performed from 7-8 independent mice and p-values presented via two-way 
ANOVA. This data was generated in collaboration with Umer Butt. 
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4.3.4. Exogenous mild hypoxia acts synergistically with CRW on generation of 
pyramidal neurons in the CA1. 
Learning to run on CRW led to relative endogenous hypoxia in pyramidal neurons as 
demonstrated by ODD-labeling (Fig. 47) along with upregulated EPO and EPOR mRNAs 
transcripts (Fig. 45) in the pyramidal neurons. Although, this short learning exposure 
was sufficient to cause relative endogenous hypoxia, it was not sufficient for long 
lasting plasticity as seen by a tendency in the C-Fos expression (Fig. 47). Therefore, 
whether CRW exposure for a few weeks (instead of EPO treatment) could lead to an 
increase in the number of pyramidal neurons, and whether sustained application of 
mild exogenous hypoxia in combination with running would result in similar or even 
synergistic effects, i.e. better learning performance together with increased neurons in 
the stratum pyramidale remained to be determined. To achieve this, 
NexCreERT2::TdTomato mice were employed and treated them with Tamoxifen 
(100mg/kg, P23-P25). From P28-P48, these mice were kept in cages with normoxic or 
hypoxic (12% O2) conditions (Fig. 48A). After 1-week break, these mice were exposed 
to either running on CRW or no running for 4 hours at the start of their night phase 
before sacrificing them. Immediately afterwards, the brains were processed for 
immunohistochemistry. Upon sectioning, staining and quantification, a significant 
increase in the newly formed neurons upon running was observed, which was further 
enhanced by exposure to mild hypoxia (Fig. 48B).  
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In parallel to understanding these effects, the WT mice were also monitored for their 
learning performance via CRW. Here, a significant improvement in motor 
learning/endurance in mice exposed to hypoxic conditions was observed as compared 
Figure 48. Voluntary running induced hypoxia gives rise to new pyramidal neurons in CA1 
region. (A) Experimental schematic to determine the effect of endogenous hypoxia on 
learning. NexCreERT2:TdTomato mice at P23 were injected with tamoxifen (5x i.p.) and then 
at P28 were exposed to NR or CRW under normoxia (21%O2) or hypoxia (12%O2) for 3 weeks. 
After 1 week of break, CRW mice were again exposed to voluntary CRW for 4h before being 
sacrificed at P55. (B) Quantification of newly formed neurons (Ctip2+/TdTomato-) in NR and 
CRW mice exposed to either normoxia or hypoxia. (C) Wildtype mice at P28 were exposed 
to the same experimental paradigm as shown in (A). Percent of distance run per night 
(normalized to mean distance run over first 3 nights) over 17 nights by WT mice exposed to 
either normoxia or hypoxia. (D) Representative images of active C-Fos+ neurons (cyan) in 
NR and CRW mice exposed to normoxia or hypoxia. Scale bars: 25µm. (E-F) Quantification 
of active neurons among pre-existing (F) neurons (cFos+/Ctip2+/tdTomato+) and among 
newly formed (E) neurons (cFos+/Ctip2+/tdTomato-) in CA1 region of the mice. (G) 
Presentation of the small percentage of pre-existing neurons among C-Fos+ neurons. Data 
represents the average number of cells ± SEM. Quantification performed from 3-8 
independent mice and p-values presented via 2-tailed student's t-test (E-F) or two-way 
repeated measures ANOVA (B-C).  
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to normoxic over three weeks (Fig. 48C). To determine the functionality of the newly 
differentiated/matured neurons following exposure to CRW cages with or without 
hypoxia for 3 weeks, the CA1 region of the hippocampus was stained with C-Fos (Fig. 
48D), which is used as a readout of neuronal activity (Morgan et al., 1987). A significant 
increase in the number of C-Fos positive neurons following running was observed, 
which was further enhanced by exposure to mild hypoxia (Fig. 48E). Unexpectedly, C-
Fos expression was primarily detected in recently differentiated neurons (Fig. 48E), 
whereas the fraction of pre-existing neurons expressing C-Fos was relatively smaller 
(Fig. 48F; 48G).  
4.3.5. Targeted deletion of EPO and EPOR in pyramidal neurons attenuates hypoxia-
induced motor learning and endurance.  
To pinpoint the importance of EPOR in pyramidal neurons for the enhanced motor 
learning and endurance, mice with targeted knockout of EPOR in pyramidal neurons 
were generated (NexCre::EPORfl/fl; as termed as EPOR-cKO). To generate this mouse 
model, the present work first validated whether the generated EPOR-cKO mice was 
indeed a functional knockout. Therefore, the female EPORfl/fl mice was cross-bred with 
male mice homozygous for the Cre-recombinase gene under the control of the 
adenovirus EllA-promoter, which was used as a deleter mice. EllA-regulated Cre-
recombinase was expressed in pre-implantation embryos leading to site specific 
deletion of LoxP flanked (fl) sequence in all tissues including the germ cells. This cross 
breeding generated the first familial generation (F1) of pups consisting of one EPOR 
allele with wild-type sequence (EPOR+/+) and one EPOR deleted allele (EPOR+/del). Since 
the EPOR+/del allele was present in the germ cells, a F2 cross resulted in pups possessing 
all possible genotypes (EPOR+/+; EPOR+/del and EPORdel/del). Interbreeding of these first 
generation progenies resulted in efficient germ line transmission of the deletion to 
subsequent generations. The presence of deleted alleles were determined by PCR 
based genotyping using specific primers as listed in Methods (Fig. 49B). As global 
deletion of EPOR is known to be lethal by E13.5 (Lin et al., 1996; Wu et al., 1995), the 
global EPOR-cKO embryos at E12.5 were observed to be smaller and without 
vasculature due to the global knockout as compared to their WT littermates (Fig. 49A). 
A global EPOR-cKO was observed at E12.5, thereby validating the functionality of the 
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generated EPOR-cKO mice. After validation, the EPORfl/fl mice were cross-bred with a 
Cre-recombinase mouse under the control of Nex promoter. This cross breeding 
resulted in a conditional deletion of EPOR specifically in mature pyramidal neurons. 
Since previously, an improved learning performance of WT mice on CRW was observed, 
this thesis considered a hypothesis whether this effect is attenuated with the 
conditional knockout of EPOR in pyramidal neurons. To achieve this, NexCre::EPOR-KO 
mice were exposed to CRW in normoxic or hypoxic conditions from P28-P48 followed 
by 1-week break (Fig. 49C; 49H). 
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A significant reduction in the number of neurons (normalized to their respective NR 
controls) in the CA1 of NexCre::EPOR-KO mice was quantified as compared to wild-type 
mice exposed to either normoxic (Fig. 49D) or hypoxic conditions (Fig. 49F). 
Subsequently, lack of EPOR in pyramidal neurons resulted in a distinct and significant 
reduction of the learning curve slope over time in normoxic (Fig. 49E) as well as hypoxic 
conditions (Fig. 49G) compared to the respective WT controls. To further pinpoint that 
this enhanced learning is due to the EPO present within pyramidal neurons, 
NexCRE::EPO-KO mice were generated. These mice consisted of knockout of EPO 
specifically in pyramidal neurons. These mice along with control wild-type were 
subjected to endogenous hypoxia via complex running wheel. Similar to results 
observed in NexCre::EPOR-KO mice, significant defects in learning in NexCre::EPO-KO 
mice (Fig. 49I) were observed as compared to the wild-type mice. Together, these data 
suggests the importance of EPO and EPOR expression in pyramidal neurons to enhance 
learning in mice.
Figure 49. Voluntary running induced learning is mediated by EPOR. (A) Representative 
pictures of Wildtype and E2A-Cre global KO in e12.5 embryos. Scale bars: 25µm. (B) 
Genotyping results depicts the functional KO using specific primers. (C) Experimental 
schematic to determine the effect of endogenous hypoxia on learning. WT and 
NexCre::EPOR-KO mice (at P28) were exposed to NR or CRW under normoxia (21%O2) or 
hypoxia (12%O2) for 3 weeks. After 1 week of break, CRW mice were again exposed to 
voluntary CRW for 4h before being sacrificed at P55. (D; F) Quantification of Ctip2 positive 
neurons (normalized to their respective NR controls) present in the CA1 region of the 
hippocampus of runner (CRW) exposed to either normoxic (D) or hypoxic (F) condition. Data 
represents average number of cells ± SEM per mm2. Quantification performed from 3-8 
independent mice and p-values presented via unpaired Student’s t-test. (E; G) Percent of 
distance run per night (normalized to mean distance run over the first 3 nights) over 17 
nights by WT and NexCre::EPOR-KO (in collaboration with Franziska Scharkowski) mice 
exposed to normoxia or hypoxia. Data presented as mean ± SEM. Quantification performed 
from 7-16 independent mice and p-values presented via 2-way repeated measures ANOVA. 
(H) Experimental schematic to determine the effect of endogenous hypoxia on learning. WT 
and NexCre::EPO-KO mice (at P28) were exposed to CRW for 3 weeks. After 1 week of break, 
the mice were sacrificed at P55. (I) Percent of distance run per night (normalized to mean 
distance run over the first 3 nights) over 17 nights by WT and NexCre::EPO-KO mice. Data 
presented as mean ± SEM. Quantification performed from 5-7 independent mice and p-
values presented via 2-way repeated measures ANOVA.  
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5. Discussion.  
 
Although several reports have provided individual facets of the brain EPO system, the 
overall view was lacking. This work contributes to the broader view by providing 
evidence of a novel role of EPO as a potent growth factor, which acts as a local mediator 
of neuronal adaptation, presumably in response to increased network activity. A new 
working model is proposed where cognitive challenge leads to physiological hypoxia 
which upregulates EPO expression in the pyramidal neurons. This induced endogenous 
hypoxia leads to enhanced dendritic spine growth and precursors to differentiate into 
neurons. This observation of substantial numbers of newly generated pyramidal 
neurons without proliferation may change our present concepts of adult hippocampal 
neurogenesis. 
5.1. Role of EPO on neuronal precursors situated in adult hippocampus. 
 
After reports from our group demonstrating the positive effect of EPO on improved 
cognition in man (Ehrenreich et al., 2004; Ehrenreich et al., 2002) and mouse (Hassouna 
et al., 2016), our group tapped by serendipity into EPO mediated neuronal 
differentiation. This provided evidence that EPO treatment induced an increase in the 
number of pyramidal neurons and oligodendrocytes in the CA1 region of the 
hippocampus. Lineage tracing of newly differentiated oligodendrocytes enabled us to 
pinpoint the effect of EPO on NG2 positive precursors leading to their differentiation 
(Hassouna et al., 2016). Therefore, the obvious question was to determine which 
neuronal precursors could give rise to EPO mediated neuronal differentiation. 
Although the genetic identity of EPO responsive precursors is an important aspect, the 
complex nature of the neuronal lineage (Fig. 50; Rushing & Ihrie, 2016) and the 
technical pitfalls precludes this thesis to make a strong conclusion. In the past, multiple 
transgenic mouse models of known marker proteins/genes have been developed to 








Puelles and colleagues demonstrated that evolutionarily, Doublecortin (Dcx) positive 
cells are present in the pallial derivatives (homologous to the amygdala) of reptiles 
(Puelles, 2017). These results were in congruence with the proposal put forth by Luzzati 
and colleagues regarding the presence of a phylogenetically conserved pallial cell type, 
indicating the possibility of a population of slowly maturing Dcx positive cells shared by 
multiple domains, which also remains conserved during evolution (Luzzati, 2015). Our 
previous confirmatory results of EPO induced decrease in the number of transit 
amplifying progenitor Dcx positive cells in the CA1 region led us to consider these NSCs 
could give rise to pyramidal neurons. One explanation that is in line with the reports 
that immature Dcx positive neuronal precursors migrate through subcortical white 
matter tracts (Gould et al., 1999; Gould et al., 2001; Nacher et al., 2001; Bernier et al., 
2002; Luzzati et al., 2003), suggesting that some neurons generated in the adult SVZ 
may incorporate into a region(s) other than the olfactory bulb. Despite of the observed 
neurons using a DcxCreERT2 mouse line, the Cre background activity without 
tamoxifen induction limits us from conclusively labelling it as one of the EPO responsive 
precursor. Moreover, in addition expression of Dcx within our ‘immature 
glutamatergic’ neuronal cluster after EPO treatment was also observed by Drop-
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Sequencing, thereby providing resistance for completely ruling out the possibility that 
EPO could mediate neuronal differentiation via Dcx positive precursors. However, six 
hours is a relatively short time for these precursors to migrate from the known 
neurogenic zones. The more plausible explanation is that these cells are generated 
during early development (Luzzati et al., 2009; Bonfanti and Nacher, 2012) and 
undergo slow yet delayed postnatal differentiation, which could be enhanced in need 
or in the presence of an EPO like factor.  
Another widely accepted marker for neuronal precursor cells is Nestin. Taking hints 
from the literature present and employing a specific transgenic mouse line i.e. 
NestinCreERT2::TdTomato, which labels Nestin-expressing precursors with a TdTomato 
reporter, the presence of these precursors or its progeny in the CA1 region of EPO 
treated mice was not detected. Surprisingly, EPO had an effect on the Nestin positive 
precursors in the SGZ of hippocampus. This is in congruence with reports from 
Bonaguidi et al., 2011, where the authors concluded that the Nestin NSCs present in 
the SGZ have the ability to proliferate as well as differentiate into multi-lineage 
progeny. Our results are suggestive that EPO could drive these precursors to 
differentiate to a different progeny in other regions of the brain. However, the 
evidence for this hypothesis still remains to be determined and was not further 
explored, as it would have been outside the scope of my thesis. More than eight Nestin 
transgenic mouse lines have been developed. Controversial conclusions using these 
Nestin transgenic mouse lines revealed variations in their targets, depending on the 
genomic element used to drive the transgene expression (Semerci & Maletic-Savatic, 
2016). Using the same inducible mouse line resulted in contradictory conclusions in 
two different studies. Encinas and collaborators used BrdU and its analogs to suggest 
that these Nestin positive NSCs are disposable (Encinas et al., 2011). On the other hand, 
Bonaguidi and colleagues used an induction protocol to activate Cre in spare, individual 
NSCs thereby tracing their respective lineages and claimed the indisposable nature of 
Nestin positive NSCs. Another NestinCreERT2 mouse line led to results that suggested 
external factors like social isolation or enriched environment affect these NSCs 
(Dranovsky et al., 2011). Therefore, Nestin dependent inducible lines are a perfect 
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transgenic inducible line used in this thesis is one of many that have been developed 
over the years and appears to be active mainly in type-2 progenitors. Both type-1 radial 
glial cells and type-2a and 2b neural precursor cells express endogenous Nestin protein 
(Encinas et al., 2011; Kronenberg et al., 2003). A critical point in lineage tracing 
approaches is to determine the exact progenitor stage where CreERT2 is active and the 
efficiency with which it induces the reporter expression. Thus, this thesis could also not 
completely exclude Nestin as an EPO responsive precursor, since it could be possible 
that EPO does not mediate an increase in the number of neurons via Type-2 precursors 
in the CA1.  
Sonic hedgehog (SHH) responsive NSCs have been reported to possess the ability of 
proliferation and differentiation into neurons, thereby increasing the NSC number as 
well as generating more neurons (Ahn & Joyner, 2005). Gli1 is a transcription factor, 
which is activated by SHH signaling pathway (Lai et al., 2003; Machold et al., 2003). 
These Gli positive precursors located in the SGZ of the hippocampus are implicated in 
adult neurogenesis (Ahn et al., 2005). Fate mapping using GliCreERT2 inducible line, 
the number of Gli positive precursors significantly increased in the stratum radiatum 
(SR), Alveus (ALV) as well as a trend in increase in the SGZ region of the hippocampus. 
Surprisingly, this increase was not observed in EdU positive proliferating cells, which 
partially is in agreement with results previously published from Encinas et al., 2011, 
where the authors demonstrate that Gli positive NSCs are quiescent in nature, which 
could undergo asymmetric (direct) division to give rise to amplifying NSCs.  
However, similar to the Nestin positive precursors, the presence of Gli positive 
precursors or their progenies in the CA1 region of the hippocampus was not detected. 
Interestingly, the Gli positive precursors in the SR region of EPO treated mice also 
showed co-expression of astrocyte marker GFAP. Surprisingly, a marker of mature 
astrocytes S100β was significantly reduced in the same region of the hippocampus. This 
finding points us in the direction that various reports have enlisted i.e. the ability of 
mature astrocytes to undergo dedifferentiation or transdifferentiation into other cell 
types in case of need such as injury (Gotz et al., 2015; Michelucci et al., 2016; Wang et 
al., 2015; Yang et al., 2012). In conclusion, EPO seems to have an effect on SHH 
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demonstrated EPO induces SHH mediated enhanced proliferation and differentiation 
of adult neural progenitor cells (Wang et al., 2007). Although it is undefined whether 
EPO induces a similar need for these mature astrocytes to dedifferentiate, this thesis 
could at least emphasize on the effect of EPO to regulate astrocytic differentiation via 
Gli positive precursors.  
Yet another promising candidate is the transcription factor Sox2, which has been 
characterized for the generation of induced pluripotent stem cells (Takahashi & 
Yamanaka, 2006). Since, Sox2 is an important player in maintaining stemness; the 
present work decided to decipher the effect of EPO on this particular precursor. Using 
Sox2CreERT2::TdTomato inducible mouse line, the pyramidal neurons carrying 
TdTomato reporter in the CA1 region was observed after using EPO as a potent 
molecule. The observation of Sox2 positive cells giving rise to new neurons is in 
accordance with multiple previous reports (Ahlfeld et al., 2017; Suh et al., 2007). For 
instance, viral vector mediated expression of exogenous Sox2 in resident astrocytes in 
the adult mouse reprograms them into proliferating neuroblasts in the striatum and 
spinal cord, which are the regions outside canonical neurogenic niches (Niu et al., 2013; 
Su et al., 2014). The observation that pyramidal neurons could carry over the TdTomato 
reporter from Sox2 labelled precursors after EPO induced differentiation interested us 
immensely. Unfortunately, these mice showed unspecific TdTomato signal in non-
tamoxifen treated mice, thereby yet again, inhibiting us to conclusively determine 
whether EPO mediated increase in pyramidal neurons is via Sox2 positive precursors. 
However, reports suggest that Sox2 interacts with a long noncoding RNA ‘RMST’ to 
form a RNA-protein complex, which activates the promoters of various neurogenic 
genes (Ng et al., 2013). The presence of RMST in the ‘immature glutamatergic’ 
neuronal cluster was observed upon EPO treatment using Drop-Sequencing, further 
strengthening the possibility of EPO mediated neuronal differentiation of Sox2 positive 
precursors. It remains to be elucidated whether RMST associates with Sox2 under the 
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5.2. EPO acts on multiple precursors analogous to the hematopoietic system. 
 
Growing evidence and our own work suggested that the neuronal lineage would be 
difficult to trace using transgenic mouse models. Several of these marker genes are 
unspecific to quiescent or amplifying progenitors, which greatly restricts their utility for 
such fate mapping experiments (Hochgerner et al., 2018). Therefore, there is no 
convincing data set at present that could define EPO responsive neuronal progenitor(s) 
by the expression of ‘unique proteins’ and it remains uncertain whether such a unique 
marker gene exists at all. Alternatively, the molecular profile of these cells is defined 
by the expression level of multiple genes, as it is the case for a number of other neural 
cell types and their precursors, which are increasingly recognized by single cell RNA 
Sequencing (Hochgerner et al., 2018; Marques et al., 2018; Zeisel et al., 2015). Using 
this approach, the known targets like Dcx, Dclk and Pax6 along with other targets like 
immature neuronal markers Tbr1, Tle4, Sox5, Satb1 and epigenetic players like long 
noncoding RNA ‘RMST’ were detected, all of which were present in the ‘immature 
glutamatergic’ neuronal cluster after EPO treatment. ScRNA-Sequecing has been able 
to reveal more markers and support a continuum of neural stem cells throughout 
development and adulthood as they share similar transcriptional trajectories 
(Hochgerner et al., 2018; Marques et al., 2018; Zeisel et al., 2015).  
So far, with the battery of potential markers, EPO could directly or indirectly influence 
the proliferation or differentiation of transit amplifying cells or neuroblasts (Dcx) and 
radial glial cells (Sox2 and Pax6). This thesis could partially exclude Nestin and Gli 
positive precursors as EPO responsive precursors that increase the number of 
pyramidal neurons. More importantly, using our approach, this thesis cannot exclude 
endothelial and astroglial cells as potential candidates. Due to the technical difficulties 
with the unspecific signal observed in control untreated mice, the present work cannot 
demonstrate with certainty that EPO has an effect on pyramidal neuronal number via 
particular type of precursor cell.  
Moreover, this thesis also does not exclude the hypothesis that various precursors, 
known or unknown, could differentiate, alone or synergistically, to contribute to the 
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difficulties, this work cannot unequivocally pinpoint these precursors, which are 
influenced by EPO. Moreover, this thesis could neither exclude the possibility that EPO 
could work on multiple precursors (Pax6, Dcx, and Sox2) in the brain to differentiate 
into pyramidal neurons, which reside in the CA1 region of the hippocampus nor exclude 
the infiltration of other resident precursors from the neighboring region. The effect of 
EPO on multiple progenitor cells bare similar resemblance with the differentiation 
observed with hematopoietic stem cells, where these cells can circumvent distinct 
intermediate stages and are capable of trans-differentiation. Previously, authors had 
proposed a continuum like view of the lineages for the hematopoietic stem cells (HSCs), 
where each HSC could proliferate or chooses from a spectrum of all cell fates to 
‘merely’ differentiate. After selecting a specific cell lineage, the HSC could still ‘step 
sideways’ to an alternative, albeit closely related cell fate, suggesting that HSCs and 
their progenies remain versatile (Haas et al., 2005; Pietras et al., 2015; Sanjuan-Pla et 
al., 2013; Yamamoto et al., 2013). Considering the similarities with the hematopoietic 
system, one could hypothesize that EPO drives neuronal differentiation without 
proliferation, possibly by skipping the intermediate stages of differentiation. Bernstein 
and colleagues provided further support to this hypothesis, where they proposed 
domain silence genes in embryonic stem cells, which are still ‘poised’ and readily 
activated (Bernstein et al., 2006). The triggers, which induces differentiation in these 
cells, could be injury or factors like EPO. If at all, this holds true, needs to be 
determined.   
5.3. EPO mediates neurogenesis in the hippocampus. 
 
Fate mapping neurons using additive labelling of progenitors along with their progenies 
have provided variable results, which might all contribute to different findings despite 
the use of the ‘same’ transgenic mouse line (Sun et al., 2014). Employing inducible 
transgenic lines to label different precursors, the present work fails to confirm the role 
of EPO on either a specific type of precursor or multiple precursors present in the CA1 
region of the hippocampus. This was unfortunately due to the technical difficulties and 
the absence of a suitable reporter line, which allowed us to fate map the newly 
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additive method, a novel subtractive approach was employed (wherein creERT2 is not 
expressed by progenitors but by mature neurons) to elucidate the influence of EPO on 
adult neurogenesis. Suh and colleagues have previously proposed the intellectual 
basics to this theory giving an example of a use for CaMKIIa-CreERT2 transgenic mice 
(Sun et al., 2014). In keeping with this theory, for the first time, all embryonically born 
pyramidal neurons are labelled using NexCreERT2::TdTomato inducible mice both in 
juvenile and adult stage. The use of excitatory neuronal antibody marker like Ctip2 
enabled us to distinguish the newly generated neurons obtained after EPO 
administration. These newly generated neurons were positive for pyramidal neuronal 
marker Ctip2, but were negative for TdTomato reporter as EPO treatment followed the 
tamoxifen administration (Fig. 51). This method does contain some limitations, like all 
other fate mapping approaches. The labelling efficiency upon tamoxifen induction is 
hardly ever 100% because some cells escape recombination. To overcome this pitfall, 
the percentage of unlabeled cells immediately after tamoxifen induction was 
estimated to be approximately 3% of cells of the total number of cells. Previous results 
from our group (Hassouna et al., 2016) have demonstrated that an increase in 
pyramidal neurons upon EPO treatment in the CA1 of juvenile mice occurs without an 
increase in proliferation. This could suggest that EPO induces asymmetric (direct) 
division of neural precursors to generate more pyramidal neurons on demand. EPO 
mediated an increase in the number of unlabeled neurons in the pyramidal layer 
without proliferation was demonstrated for the first time. Importantly, increased – 
albeit lower – numbers of newly differentiated neurons were found under these 
conditions even in placebo treated animals. This observation provides evidence of 
physiological neurogenesis throughout life outside the known neurogenic niches. 
Similar reports of constitutive neurogenesis in various other regions of the brain of 
primates and rodents have been demonstrated in neocortex (Dayer et al., 2005; Gould 
et al., 1999; Gould & Kamnasaran, 2011; Kaplan, 1981), piriform cortex (Bonfanti & 
Nacher, 2012; Rotheneichner et al., 2018), brain stem (Bauer et al., 2005) and spinal 
cord (Yamamoto et al., 2001). Other regions of the brain where constitutive 
neurogenesis occurs are the substantia nigra (Zhao et al., 2003), the amygdala (Bernier 
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mechanism of adult neurogenesis without proliferation has been previously 
overlooked, but is relevant for the steady state adjustment to demand and 
regenerative processes in the brain. It further adds a novel perspective to the pivotal 
work performed by many groups who discovered adult neurogenesis in multiple 
regions of the brain, based on labeling the proliferating cells via integration of 
nucleoside analogues (Aimone & Gage, 2011; Altman & Das, 1965; Doetsch, 2003; 
Gould, 2007; Kaplan, 1981; Rakic, 1985; Sanai et al., 2004). 
 
 
5.4. EPO supports a continuum view for neuronal lineage. 
 
Since the hypothesis was considered that EPO could act on multiple precursors at 
different stages of differentiation, this thesis argued if the continuum like view of HSCs 
holds true for the neuronal lineage. Firstly, the EPO mediated increase in pyramidal 
neurons was also confirmed on a transcriptome level, where a single dose of EPO 
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induced an immediate increase in the number of cells in the CA1 specifically in the 
‘immature glutamatergic’ cluster. Secondly, questions arose about the transcript 
signature of this cluster. How does one define this cluster as a progenitor, neuroblasts 
or an immature glutamatergic cluster? In our data set, progenitor markers such as 
Nestin and Sox2 were not elevated, but an increase in immature neuronal markers such 
as Dcx, Tbr1 and Tle4 was observed (Hochgerner et al., 2018; Piumatti et al., 2018). In 
accordance, similar marker expressions were observed to be further elevated upon 
EPO treatment, thereby defining this cluster as immature glutamatergic cluster. 
Thirdly, the immaturity of the cluster was further strengthened when Monocle analysis 
between immature and its neighboring mature glutamatergic cluster revealed a much 
lower pseudo time for the cells which were classified as immature. Lastly, to support 
the continuum-like view of HSCs as previously proposed (Brown and Ceredig, 2019), a 
homogenously lower pseudotime after EPO treatment was observed where neurons 
are present in a continuum, in which immature neurons progressively proceed towards 
neuronal maturation. The presence of such a physiological neuronal continuum-like 
view has also been substantiated in recent reports, where the authors demonstrated 
that adult hippocampal neurogenesis may represent a life-long extension of 
development that maintains heightened plasticity (Berg et al., 2019). The scRNA-Seq 
analysis provided sufficient evidence of an immediate effect of EPO on existing 
precursors to instantaneously initiate neuronal differentiation. As the expression levels 
of EPO and EPOR was low, they were not detected by scRNA-Seq, which is a known 
dropout effect.  
5.5. EPO mediated enhancement in synaptic plasticity. 
 
Several reports have successfully demonstrated enhanced neurogenesis in the 
hippocampus due to various factors such as VEGF, NT-3, Notch ligand Delta-like 1, IL-
1b, IL-6, FGF-2 (Barkho et al., 2006; Delgado et al., 2014; Faigle & Song, 2013; Kang & 
Hebert, 2015; Kawaguchi et al., 2013). However, the critical question often raised in 
the field consists of doubting the extent of positive effect of a few newly generated 
neurons on functional consequences. Many have reported that a small number of 
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single pyramidal neurons in the rat motor cortex. These newly generated neurons 
could also induce whisker movements (Brecht et al., 2004; Shadlen et al., 1996).  
Enhanced neurogenesis and synaptic integration together could contribute to positive 
effects observed at functional or behavioral level. Unstimulated neurogenesis is 
followed by an early survival phase, where the newly generated neurons show 
dramatic decline in their numbers within the first few days (Biebl et al., 2000; Kuhn et 
al., 2005). During this phase, majority of the cells are eliminated well before they could 
make functional connections in the target regions of the hippocampus (Kempermann 
et al., 2015). However, it is essential that the surviving neurons integrate into the 
existing architecture of the hippocampus by the formation of synaptic connections with 
the pre-existing neurons. The initiation of dendrite and spine development generally 
follows the process of axonal elongation (Sun et al., 2013). Once both these processes 
are underway, the newly generated neurons are said to be integrated and functional 
active. During normal neurogenesis in a healthy brain, a large proportion of neural 
progenitors undergo apoptosis within their first days. By rapidly removing cell debris, 
the scavenging properties of microglia could have an important regulatory role at early 
stages of neurogenesis (Sierra et al., 2010). However, it is not completely understood 
whether the phagocytosis is beneficial for the surrounding newborn neurons by 
reducing pro-inflammatory mediators, or whether they are detrimental by further 
inducing apoptotic neuronal death (Magnus et al., 2001; Neher et al., 2011). 
Using transgenic mouse line (Thy1-YFP), which specifically labels dendrites and spines 
of pyramidal neurons, a significant increase in the density of dendrites as well as spines 
was observed. This result could serve as another mechanism of augmented network 
function and therefore strengthen the evidence of cognitive improvement upon EPO 
administration. This observation is in accordance with reports suggesting increase in 
dendritic length and complexity appears to be mediated by a cell autonomous, 
autocrine action of another neurotrophic factor BDNF (Wang et al., 2015). In our 
findings, based on their morphology, the increase in the density of spines is constituted 
by an increase in stubby spines, which are immature in nature. The increase in 
immature stubby spines supports the hypothesis that the newly generated neurons 
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observed with trajectory analysis in neurons, which demonstrated that these neurons 
are present in continuum, and are driven to maturity upon EPO administration. It is 
very likely, that upon appropriate cognitive stimulation, these immature stubby spines 
would mature into stable mushroom spines. However, evidence that this is the case, is 
currently the ongoing work. 
Though likely, it is not established how finely tuned cross talk between microglia and 
adult born neurons would function and how it leads to any changes upon microglia 
activation. Previous work from our group also has hinted to the effect of EPO, where 
EPO treatment was shown to dampen microglial activity (Mitkovski et al., 2015). In our 
present results, along with neuronal and dendritic spine increase, a reduction in the 
number of microglia upon EPO treatment was observed. This decrease in microglia was 
also corroborated by single cell RNA-Sequencing. These results together point towards 
enhanced neurogenesis and maybe the newly differentiated neurons do not require 
excessive pruning as they begin to form synaptic connections. Our findings are in 
accordance with Paolicelli and colleagues, where they observed a transient decrease in 
microglia in the first to fourth postnatal week in CXCR1 knockout mice and a 
corresponding increase in the dendritic spine density (Paolicelli et al., 2011). An 
explanation could be attributed to the previously stated concept of ‘pro-neurogenic’ 
function of microglia. Disruption of the microglia expressed receptor CX3CR1 pathway 
in young rodents’ decreased survival and proliferation of hippocampal neural 
progenitor cells (Bachstetter et al., 2011). The other hypothetical reasoning could be 
that the microglia in the presence of EPO transdifferentiate and give rise to some newly 
generated neurons in the CA1. The microglial transdifferentiation as compared to the 
astrocytic transdifferentiation has not been extensively studied; however, some 
reports demonstrate that using 70% fetal bovine serum upregulates Sox2 in microglia, 
which transforms them into Map2 positive neurons (Nonaka et al., 2008; Zhang et al., 
2013). Our current ongoing work will attempt to shed light on this matter. On a rodent 
behavioral level, the increase in the number of neurons and their synaptic connections 
might contribute to the brain function via alteration in the structural properties of the 
circuitry. Enhanced synaptic plasticity is also essential for mediating pattern separation 
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et al., 2011). However, on an over-arching human level, these results may provide 
explanation of the MRI-documentable increase in the dimensions of certain brain areas 
(Hassouna et al., 2016) or the reduction of brain matter loss upon EPO treatment in 
mental illness (Miskowiak et al., 2015; Wustenberg et al., 2011). 
5.6. Mechanism of EPO action – Activity mediated adult hippocampal neurogenesis. 
 
Adult hippocampal neurogenesis is a complex and an activity dependent process 
(Kempermann et al., 2015). A decline in neurogenesis is observed in mice when they 
were not challenged to lead an active life (Encinas et al., 2011). This result indicated 
the importance of ‘use it or lose it’ as a consequence of negligence (Kempermann et 
al., 2015; Ott et al., 2015). This activity could be either physical exercise or cognitive 
stimulus. Ehrenreich and colleagues over the past several years have extensively 
demonstrated the effects of EPO on improved cognition in humans. Now these findings 
of increased neurodifferentiation and neuroplasticity in rodents further strengthen 
these claims. Here, for the first time, an endogenous mechanism of EPO mediated 
action on improved learning was proved. The pyramidal neurons, upon undergoing a 
learning task such as complex running wheel, upregulates the expression of EPO and 
EPOR mRNA as observed by in situ hybridization. There have been similar reports on 
other molecules such as Vascular Endothelial Growth Factor (VEGF). For example, on a 
molecular level, exercise is shown to increase the levels of insulin-like growth factor 1 
(IGF-1) and VEGF, whereas inhibiting these factors led to a decrease in exercise induced 
adult hippocampal neurogenesis (Fabel et al., 2003; Trejo et al., 2001). Subsequently, 
EPO treatment has shown to significantly upregulate the expression of VEGF and 
downstream JAK-STAT, PI3K/AKT and ERK1/2 signaling pathway in neural precursors in 
vitro (Wang et al., 2007). Based on the evidence present in the literature and our 
previous work on signaling pathways, this thesis can speculate that EPO administration 
induces the generation of pyramidal neurons in the CA1 via upregulating certain 
signaling pathways in neural precursors.  
Interestingly, EPO was able to increase the generation of pyramidal neurons in adult 
mice at almost 4 months of age. The effect of EPO in relation to aging (10 months of 
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of this novel mechanism of rapid local generation of neurons on demand. Adult 
hippocampal neurogenesis is demonstrated to decline with age in rodents (Kuhn et al., 
1996; Seki & Arai, 1995) and in humans (Eriksson et al., 1998). This decline in 
hippocampal neurogenesis is attributed to the reduced number of precursors as well 
as decline in their proliferation (Garcia et al., 2004; Luo et al., 2006; Seki, 2002). It is 
still unclear whether EPO induces asymmetric division of neural precursors to generate 
pyramidal neurons in adult mice, thereby reducing the NSCs pool available for a later 
time point.  
5.7. EPO/EPOR system central to physiological hypoxia induced hippocampal 
neurogenesis. 
 
Another factor, shown to promote adult hippocampal neurogenesis, is hypoxia.  
Exposure to intermittent or chronic hypoxia has been demonstrated to increase 
neurogenesis in hippocampus (Zhu et al., 2010) by the activation of Wnt/β-catenin 
signaling (Varela-Nallar et al., 2014). Moreover, localized hypoxia with the SGZ of the 
hippocampus has also shown to contribute to early survival of newly differentiated 
neurons in the adult hippocampus (Chatzi et al., 2015). Similarly, hypoxia has also 
shown to increase neurogenesis of NSCs in vitro (Jin et al., 2002; Shingo et al., 2001). 
Since EPO is a hypoxia inducible gene (Semenza & Wang, 1992),  a hypothesis was 
considered whether the pyramidal neurons upon a learning challenge undergo hypoxia 
and therefore release more EPO in vivo. This was proved using a transgenic mouse, 
expressing a chimeric protein in which the oxygen-dependent degradation (ODD) 
domain of HIF-1α is fused to the tamoxifen inducible CreERT2 recombinase (Kimura et 
al., 2015). Upon exposure to overnight running on CRW, the labelled pyramidal 
neurons are present in a physiological hypoxic condition. Moreover, as mentioned 
above, an upregulation of EPO and EPOR mRNA levels in pyramidal neurons upon CRW 
was observed by insitu hybridization, thereby indicating that a cognitive challenge can 
increase the number of hypoxic neurons and upregulate the expression of EPO and 
EPOR. 
Multiple reports have demonstrated the presence of EPO (Tan & Ratcliffe, 1992) and 
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Interestingly, EPO mRNA expression was observed in astrocyte (Masuda et al., 1994), 
neuronal (Bernaudin et al., 1999) and oligodendrocyte (Sugawa et al., 2002) cultures. 
However, it is unlikely that the organism holds receptors and downstream mechanisms 
just for exogenous compounds, the present work hypothesized that EPOR must hold a 
functional relevance in the brain. Based on our findings, the present work 
demonstrates that the endogenous EPO system contributes to an adaptive increase in 
performance as shown by complex wheel running or by mild exogenous hypoxia over 
3 weeks. However, to prove functional relevance of EPOR in this ‘cognitive challenge 
or hypoxia’ enhanced learning, a transgenic mouse line was employed where specific 
knockout EPOR in pyramidal neurons of the CA1 would enable us to understand a 
mechanism that is independent of the peripheral hematopoietic system. Interestingly, 
the increased learning is attenuated in the mice carrying EPOR deletion in pyramidal 
neurons. This decline in learning was not rescued even after the mice were treated 
with exogenous EPO. Moreover, a specific EPO deletion in pyramidal neurons led these 
transgenic mice to perform significantly worse as compared to the controls, indicating 
that the learning induced hypoxia and the regulation of its target gene EPO/EPOR is the 
central theme in the CNS by which EPO mediates its pro-cognitive effects. 
Contrary to the more popular viewpoint that hypoxia in general is rather detrimental, 
recent reviews also consider that hypoxia may have beneficial effects and even a role 
in protecting against cognitive dysfunction (Dale et al., 2014; Mateika et al., 2015; 
Watts et al., 2018; Zhang et al., 2011). Nevertheless, up to now, cognitive challenge 
has never been shown to lead to mild relative hypoxia in functionally engaged neuron 
populations. Along with recording increased neurodifferentiation as well as improved 
learning, this thesis is able to pin these effects primarily to the newly generated 
neurons as observed by the expression of neuronal activity marker C-Fos. This result 
set the basis for studying the electrophysiological properties of these newly generated 
neurons, which is currently in progress. Preclinical and clinical studies, however, 
demonstrated that the performance of sensory systems in the cerebral cortex can be 
substantially improved through intensive learning and practice and that these 
improvements are mediated by plastic changes in key neural networks (Buonomano & 




DEBIA WAKHLOO 137 
 
may act as the driving force of neuronal adaptation to increased demand. Production 
of EPO/EPOR in neurons likely constitutes a cell-autonomous auto/paracrine 
mechanism, probably in concert with other hypoxia-inducible genes, like vascular 
endothelial growth factor (VEGF), which has previously also been reported to enhance 








In conclusion, my doctoral work provided first evidence that functional challenge via 
learning of new complex tasks induces physiological hypoxia in pyramidal neurons of 
the CA1. This induced hypoxia upregulates neuronal production/release of EPO, which 
regulates various precursors to act alone or synergistically to generate new pyramidal 
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neurons. Neuronal produced EPO may bind in an auto/paracrine manner to EPOR 
present on the pyramidal neurons leading to an increase in immature dendritic spines 
and thereby enhancing synaptic plasticity. EPO may also simultaneously bind to EPOR 
present of diverse neighboring cells, which would be ready to differentiate into 
neurons on demand. Taken together (Fig. 53), these integrative steps may explain the 
consistently enhanced cognitive function upon EPO administration as well as delineate 
physiological mechanisms, which would accomplish lasting adaptation to challenge via 
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7. Appendices. 
7.1. List of Abbreviations. 
 
14C – Isotope Carbon – 14 
ALV – Alveus of the hippocampus 
APs – Apical Progenitor cells 
ARNT – Aryl Hydrocarbon Receptor Translocator 
BBB – Blood Brain Barrier 
BD – Bipolar Disorder 
BDNF – Brain Derived Neurotrophic Factor 
bFGF – basic Fibroblast Growth Factor 
BMPs – Bone Morphogenetic Proteins 
BPs – Basal Progenitor cells 
BrdU – Bromodeoxyuridine 
CBP – CREB Binding Protein 
CCA – Canonical Correlation Analysis 
CNS – Central Nervous System 
CP – Cortical Plate 
CRW – Complex Running Wheel 
CSF – Cerebrospinal Fluid 
CTIP2 – Chicken ovalbumin upstream promoter transcription factor interacting 
protein 2 
DAB – 3, 3’-diaminobenzidine  
DAPI – 4’, 6’-diamidino-2-phenylindole 
DCX – Doublecortin 
DG – Dentate Gyrus 
DKK1 – Dickkopf- 1 
EdU – 5-Ethynyl-2’-deoxyuridine 
EGF – Epidermal Growth Factor 
ENs – Endothelial Cells 
EP300 – E1A binding Protein p300 
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EPO – Erythropoietin 
EPOR – Erythropoietin Receptor 
EPs – Ependymal Cells 
ER – Estrogen Receptor 
ESCs – Embryonic Stem Cells 
FBS – Fetal Bovine Serum 
FCS – Fetal Calf Serum 
FGF-2 – Fibroblast Growth Factor-2 
FMRP – Fragile X Mental Retardation Protein 
GDNF – Glial Cell Line Derived Neurotrophic Factor 
GFAP – Glial Fibrillary Acidic Protein 
Gli1 – Gliotactin 1 
GO-terms – Gene Ontology terms 
HBBS – Hanks Balanced Salt solution 
HIFs – Hypoxia Inducible Factors 
HMG – High Mobility Group 
HPCs – Hematopoietic Progenitor Cells 
HREs – Hypoxia Regulatory Elements 
HSCs – Hematopoietic Stem Cells 
Hsp90 – Heat Shock Protein 90 
I.P. – Intraperitoneal Injection 
IGF-1 – Insulin like Growth Factor-1 
IHC – Immunohistochemistry 
IPs – Intermediate Progenitors 
IPSCs – Induced Pluripotent Stem Cells 
ISH – In-Situ Hybridization 
KLF4 – Krüppel-like Factor-4 
LBD – Ligand Binding Domain 
LncRNAs – Long Non-Coding RNAs 
LTP – Long Term Potentiation 
MPPs – Multipotent Precursors  
  APPENDICES – LIST OF ABBREVIATIONS 
 
  
DEBIA WAKHLOO 168 
 
MS – Multiple Sclerosis 
NeuroD – Neurogenic Differentiation 1 
Ngn2 – Neurogenin 2  
NO – Nitric Oxide 
NPCs – Neural Precursor Cells 
NR – Non-Runner 
NR2E1 – Nuclear Receptor Subfamily 2 Group E Member 1 
NRSF – Neuron Restrictive Silencer Factor 
NSCs – Neural Stem Cells 
OB – Olfactory Bulb 
ODD – Oxygen Dependent Degradation 
OPCs – Oligodendrocyte Precursor Cells 
PAA – Penicillin/Streptomycin 
Pax6 – Paired-box 6 
PBS – Phosphate Buffered Saline 
PCA – Principle Component Analysis 
PFO – Perfluro-octanol 
PHD1/PHD2/PHD3 – Prolyl Hydroxylases 
PNS – Peripheral Nervous System 
QRT-PCR – Quantitative Real Time Polymerase Chain Reaction 
REST – Repressor of Element 1-Silencing Transcription 
RGCs – Radial Glial Cells 
RGLs – Radial Glial Like Cells 
RMS – Rostral Migratory Stream 
RMST – Rhabdomyosarcoma 2-associated Transcript  
Satb1 – Special AT-rich DNA binding protein 1 
SCF – Stem Cell Factor 
scRNA-Seq – Single Cell Transcriptome RNA sequencing 
sFRP3 – Secreted Frizzled Related Protein 3 
SGZ – Sub-Granular Zone 
SHH – Sonic Hedgehog 
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SNN – Shared Nearest Neighbor 
Sox2 – Sex Determining Region Y – Box 2 
SP – Sub-Plate 
SR – Stratum Radiatum 
SSC – Saline-Sodium Citrate buffer 
SVZ – Sub-Ventricular Zone 
TAPs – Transit Amplifying Progenitors 
Tbr1 – T-box Brain Gene 1 
Tbr2 – T-box Brain Gene 2 
TFs – Transcription Factors 
Tle4 – Transducin-like enhancer family member 4 
TRD – Treatment Resistant Depression 
tSNE – t-distributed Stochastic Neighbor Embedding 
UMI – Unique Molecular Identifier 
VEGF – Vascular Endothelial Growth Factor 
VHL – Von-Hippel-Lindau protein 
 
 
 
 
 
 
 
 
 
 
 
